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Purines are the basic building block for essential biomolecules such as DNA, RNA, 
NADH, CoA, and several essential vitamin cofactors. Most organisms have the ability to 
synthesize purines through the de novo purine biosynthesis pathway.  
 
The de novo purine biosynthesis pathway contains a rare metabolic divergence within the 
eukaryotes. Animals convert CO2 and aminoimidazole ribonucleotide (AIR) to 
carboxyaminoimidazole ribonucleotide (CAIR) using the enzyme aminoimidazole 
ribonucleotide carboxylase (PurE2), while other eukaryotes, archaea, and bacteria use 
two enzymes, N5-carboxyaminoimidazole ribonucleotide synthetase (PurK) and N5-
carboxyaminoimidazole ribonucleotide (NCAIR) mutase, PurE (PurE1). PurE catalyzes 
formation of the sole carbon-carbon bond formed during purine biosynthesis. 
 
Both PurE classes are proposed to generate a carbon-carbon bond using similar 
chemistry. We can monitor the carbon-carbon bond forming reaction in real-time using 
changes in intrinsic fluorescence that report upon electrostatic changes within the active 
site. To simplify fluorescence responses, we generated mutants of PurE1 from 
Acetobacter aceti (AaPurE1-W34F,W165F) and PurE2 from Treponema denticola 
(TdPurE2-F79W) that have a single tryptophan fluorophore, which responds to changes 
upon ligand addition as assessed by fluorescence titrations. Surprisingly, a Tyr residue,  
 
! xv 
with ambiguous electron density in a 1.35 Å AaPurE1-W34F,W165F structure, 
contributes to fluorescence.  
 
Both PurE1 and PurE2 have similar structures and active sites. A universally conserved 
serine is the sole polar contact with the substrate aminoimidazole ring and any PurE side 
chain. Serine donates a hydrogen bond to the aminoimidazole N3 but may flip polarity in 
PurE2 at low pH. We generated a series of serine mutants in AaPurE1 and TdPurE2, 
which confirm a hydrogen-bonding role for serine, as the mutants with the highest 
detectable activity are able to donate (or accept, at low pH) a hydrogen bond. Serine is 
more important for PurE2 function and its role appears to be different between the two 
classes.  
 
The PurE2 active site contains a strictly conserved, class-specific lysine. Due to the 
difficult task of acquiring CO2 from solution, the lysine was proposed to form a 
carboxylated intermediate in PurE2 catalysis. We generated the TdPurE2-K41R mutant, 
which retained both AIR carboxylase and CAIR decarboxylase activity, indicating that 
formation of a lysine-carbamate is not an obligatory intermediate for PurE2 function. 
 
PurE2 catalyzes the formation of CAIR from AIR and CO2 without any detectable side 
reaction. Functional complementation assays and a crystal structure both indicated the 
“inactive” TdPurE2-H40N mutant may destroy AIR, CAIR, or both. We demonstrated 
that this “inactive” mutant does indeed destroy AIR in a slow O2-dependent oxygenase 
activity reaction. 
 
Due to the unusual divergence in purine biosynthesis, PurE1 is a potential antimicrobial 
target; however, no enzyme activity assay is suitable for high throughput screening. We 
developed a simple chemical quench that fixes the PurE1 substrate/product ratio for 24 h, 
as assessed by the Bratton-Marshall assay (BMA) for diazotizable amines. The ZnSO4 
stopping reagent is proposed to chelate CAIR, allowing later analysis of this acid-labile 





1.1 Background and Significance !!
Purines are Essential in Biological Systems. Purine biosynthesis supplies the precursors 
for RNA, DNA, and coenzymes like NADH and CoA. In addition, purines serve as 
starting materials for vitamins like folic acid, B12, and riboflavin1 and for the universal 
methylating agent and radical initiator S-adenosylmethionine.2  
Prebiotic Purine Synthesis.! Organic compounds of biochemical significance, such as 
amino acids, can be synthesized from simple inorganic precursors under conditions 
thought to be resemble those on primitive Earth.3 Prebiotic syntheses precede evolution. 
Purine synthesis requires an activated ribose and a base, each of which could have been 
formed in a prebiotic era. Adenine can be formed from the oligomerization of hydrogen 
cyanide and sugars can be produced from formaldehyde by the formose reaction.4,5 
Biological evolution produces customized molecular interfaces, enzymes, and ultimately 
multistep biochemical pathways.6,7 
Purine Biosynthesis. Contemporary purine synthesis occurs by two routes, a salvage 
pathway and the de novo purine biosynthetic pathway. The purine salvage pathway 
couples an activated ribose, phosphoribosyl pyrophosphate (PRPP), with bases recovered 
from the degradation of nucleic acids and nucleotides.8 While energy efficient, purine 
salvage requires a ready source of purine heterocycles. When purine bases are not 
available, purines are biosynthesized from PRPP and various small molecules, with 




Purine Biosynthesis May Have Evolved from Preexisting Pathways. New metabolic 
pathways are composed of enzymes that acquire new functions or biochemical roles8 in 
the context of existing metabolic pathways. New enzymes evolve from gene duplication 
and functional diversification of ancestral genes. The extant purine biosynthetic pathway 
appears to have been assembled from two older pathways, histidine and thiamine 
biosynthesis, which unlike purine biosynthesis, have no alternative biosynthetic 
pathways. 
  
Histidine biosynthesis generates 5-aminoimidazole-4-carboxamide ribonucleotide 
(AICAR) as a byproduct.9 Ancient microbes may have evolved PurP and PurO enzymes 
as a way to recycle AICAR from IMP.10 Thiamine contains a pyrimidine derived in all 
organisms from aminoimidazole ribonucleotide (AIR).11,12 Cells require very little 
thiamine, meaning the AIR demand for this biosynthesis is very low.13 Excess AIR is an 
intrinsically reactive molecule and is actively eliminated from cells. This may have 
spurred the evolution of PurE, PurK, PurC, and PurB as a “biosynthetic bridge” to 
convert any excess AIR to AICAR. PurB was already necessary to convert 
adenylosuccinate to AMP; it appears to have acquired a promiscuous function and an 
additional role, in AICAR biosynthesis.14  
 
Only a few molecules of thiamine are required for cell viability, which yields a very low 
flux pathway (purines are required in a 1000:1 ratio over thiamine for growth).15 The 
evolution of PurF, PurD, PurT, PurL (or its multiprotein equivalent PurSQL), and PurM 
would provide a high flux route for AIR production well in excess of thiamine demand. 
 
Finally, the folate-dependent enzymes (PurN and PurH) would have only evolved after 
folate appeared. The formate dependent alternatives PurT and PurP would have been 
available first, and some are still used, since archaea lack folates.10,16  
 
In summary, the purine pathway likely “evolved backwards” from AICAR to AIR to 
PRPP and was very clearly driven by the high demand for adequate purines for growth.  
 !
3 
The de novo Purine Biosynthesis Pathway Contains a Rare Metabolic Divergence. The 
modern de novo purine biosynthetic pathway requires either 10 or 11 enzymatic steps. 
The additional step is catalyzed by PurK and represents a rare metabolic divergence in 
the carboxylation of AIR to form 4-carboxy-5-aminoimidazole ribonucleotide (CAIR). 
Animals convert CO2 and AIR to CAIR using a class II PurE (PurE2; AIR carboxylase, 
EC 4.1.1.21) while other eukaryotes, archaea, and bacteria use two enzymes, PurK and 
class I PurE (PurE1; N5-carboxy-AIR [NCAIR] mutase, EC 5.4.99.18) (Figure 1.2).17,18 
PurE1 and PurE2 catalyze the formation of the sole carbon-carbon (C−C) bond installed 
during purine biosynthesis. Other pathway steps build up the purine base by forming 
C−N bonds. 
Carbon-Carbon Bond Chemistry. Biochemistry is the study of the molecular basis of 
biology. C−C bond formation is of central importance to all life. These covalent bonds 
are generally formed by a complex process that requires the intermediate formation of a 
negatively charged carbon atom (carbanion), which then functions as a nucleophile in a 
subsequent condensation reaction. Carbanions are typically formed by either 
decarboxylation or deprotonation of a carbon acid, which is difficult for both 
thermodynamic (e.g., high pKa values) and kinetic reasons.19,20 Removal of the proton is 
challenging, however, the key difficulty in carbanion generation may be controlling the 
reactivity for this highly unstable species.  
Decarboxylases. Decarboxylases catalyze the general reaction shown in equation 1.1, 
which is almost always irreversible due to the entropy gain associated with the loss of 
gaseous CO2. Decarboxylases lower the barrier to carbanion cleavage of a C−C bond, an 
easier task than the one confronted by carboxylases (see below). Decarboxylations are 
involved in many different biological processes: isocitrate dehydrogenase (TCA cycle), 
thiolase (fatty acid synthesis), glycine cleavage system (glycine catabolism), orotidine 5′-
monophosphate decarboxylase (pyrimidine biosynthesis), acetoacetate decarboxylase 
(ketone body metabolism), and pyruvate decarboxylase (fermentation).  
 
R-CO2⊖ + H+ → R-H+ + CO2   Equation 1.1 
 !
4 
Several decarboxylases have carbanion stabilization strategies similar to both PurE1 and 
PurE2. Acetoacetate decarboxylase proceeds through a Schiff base intermediate that 
stabilizes the carbanion formed by decarboxylation. The Schiff base stabilizes a 
carbanion on the α-carbon (Figure 1.2A). Thiamine-dependent decarboxylases, like 
pyruvate decarboxylase, stabilize the carbanion produced by loss of CO2 from α-keto 
acids (Figure 1.2B). Again the carbanion is stabilized by resonance with an “electron 
sink” a positively charged nitrogen adjacent to the decarboxylated carbon. PurE1 and 
PurE2 both decarboxylate CAIR to form a similar resonance-stabilized carbanion β-
iminium zwitterion, from which CO2 does not immediately separate. Unlike most 
decarboxylases, PurE1 and PurE2 are both a decarboxylase and a carboxylase. !
Carboxylases. Carboxylases catalyze the general reaction shown in equation 1.2. They 
solve two difficult challenges: forming carbanions and trapping CO2. Like 
decarboxylases, carboxylases are involved in many different biological processes: acetyl-
CoA carboxylase (fatty acid synthesis), pyruvate carboxylase (gluconeogenesis), 
phosphoenolpyruvate carboxylase (TCA cycle), and Rubisco (photosynthesis).  
 
    R-H + CO2 → R-CO2⊖ + H+     Equation 1.2 
 
Several other carbanion-forming enzymes share similarities to the C−C bond formation 
catalyzed by PurE. The citrate synthase mechanism has been extensively studied and 
serves as a model for enzymatic C−C bond formation. The reaction proceeds by 
formation of an acetyl-CoA carbanion (enolate), which then attacks a highly polarized 
carbonyl in enzyme-bound oxaloacetate (OAA). The polarization of OAA can be directly 
observed by infrared and 13C NMR spectroscopy.21,22 The subsequent steps in C−C bond 
formation can be monitored by changes in pre-steady state fluorescence.23  
 
Unlike citrate synthase, PurE1 and PurE2 have a single substrate and it is challenging to 
detect carbonyl polarization by PurE. The C−C bond forming steps, however, are 
amenable to study by the same fluorescence-based approach used for citrate synthase. 
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Citrate synthase highlights an additional difficulty C−C forming enzymes encounter; it is 
not enough to simply generate a carbanion, a suitably reactive acceptor must also be 
present to avoid quenching by protonation. PurE1 and PurE2 may use hydrogen bonds to 
further polarize AIR and promote the reaction between the AIR carbanion and bound 
CO2 (Figure 1.3).  
 
PurE2 and Rubisco share the rare ability to fix CO2 directly, without the need for 
additional energy input or other enzymes.23–25 Rubisco cleaves ribulose 1,5-bisphosphate 
in competing irreversible carboxylase and oxygenase reactions. The Rubisco oxygenase 
reaction saps photosynthetic productivity.24–26 The chemistry of initial attack on CO2 
shared by PurE2 and Rubisco is fundamentally different from all other known enzymes. 
However, neither PurE2 nor PurE1 has any known oxygenase activity. We speculate that 
the reason for this substrate specificity is PurE2 flips the sequence of steps in C−C bond 
formation relative to Rubisco: AIR reacts with CO2 before carbon deprotonation (Figure 
1.2). This chemical strategy may account for the vastly improved selectivity of 
PurE2•AIR for CO2 over O2. 
 
PurE1 and PurE2 Acquire CO2 Differently. PurE1 and PurE2 are thought to break and 
form C−C bonds through a common ternary complex, PurE•AIR•CO2.26–28 One absolute, 
class-specific difference is the source of CO2: PurE1 produces it by the decarboxylation 
of bound NCAIR, while PurE2•AIR acquires CO2 directly from solution (Figure 1.2). 
 
Subtle Structural Differences in PurE1 and PurE2 Regulate Substrate Specificity. Minor 
structural differences in PurE1 and PurE2 must encode the divergent substrate specificity. 
First, PurE2 cannot use NCAIR26 as a substrate and appears structurally unable to 
accommodate the “flipped” ring of NCAIR.29 Second, the PurE2•AIR•CO2 ternary 
complex reversibly dissociates CO2, unlike the corresponding PurE1 complex, which 
quantitatively retains CO2.30 Polarization of PurE1 or PurE2-bound AIR forms the 




CO2 in PurE1 preserves the investment made by PurK, which uses ATP to activate 
bicarbonate (Figure 1.1).  
PurE2•AIR contains a 6 Å long portal leading to the carboxylate/CO2-binding site that is 
not present in “closed” PurE1•AIR structures. 26,28 The portal may allow CO2 to enter the 
active site after AIR and bind underneath it while allowing protons to exit. The portal 
also creates a polar, solvent accessible active site in PurE2. It is unclear how these class 
specific differences in PurE sequence, structure, and CO2 acquisition evolved while still 
maintaining similar C−C bond forming chemistry though a common PurE•AIR•CO2 
ternary complex. 
The 40s Loop Residues May Have Different Roles in Each PurE Class. Both PurE1 and 
PurE2 have similar structures, apart from two active site loops (Figure 1.3).31,32 The 40s 
loop, SAH[R/K], contains a conserved His that functions as a general acid/base that is 
necessary for activity in both classes.26,28,29 The 40s loop Ser is the sole polar contact with 
the substrate aminoimidazole ring and any PurE1 or PurE2 side chain (Figure 1.3). An 
earlier study of PurE2 suggests that the hydrogen bond between Ser and aminoimidazole 
N3 might flip polarity as a function of pH.26 No similar function is expected for PurE1. In 
contrast, its first protonation equilibrium (pK1) is associated with inhibition of activity.28 
Ser may have a different role in PurE1 and PurE2, producing subtle mechanistic 
differences between them.  
The differentially conserved 40s loop basic residue, Arg in PurE1 and Lys in PurE2, 
contacts the phosphate moiety of the nucleotide (Figure 1.3). The challenging acquisition 
of CO2 by PurE2 has been suggested to involve intermediate formation of an N-
carboxylated species on this Lys, which is strictly conserved in PurE2.30 Lys-carbamates 
are produced in Rubisco and urease 25,33,34 active sites, and a N-terminus carbamate is 
formed in hemoglobin to carry CO2.34 While this could serve to accumulate a CO2 
equivalent near the active site, carbamate formation decreases electrophilic reactivity, 




Ancestral PurEs were single proteins. Several purine biosynthesis enzymes exist as 
fusion proteins containing two or more independent enzyme active sites in distinct 
domains.31,35 As a general rule, bacteria have monofunctional single enzyme purine 
biosynthesis proteins. Bacteria contain a single domain, monofunctional PurE1.28,36 Yeast 
and plants have a bifunctional PurE1-PurK fusion protein and vertebrates have a 
bifunctional PurE2PurC fusion protein.32,37 The fusion proteins in higher eukaryotes 
suggest the possibility of metabolite channeling or other regulatory phenomena added to 
the essential pathway architecture not necessarily used in the ancestral monofunctional 
proteins.  
It is considerably more difficult to study an enzyme within a bifunctional complex 
especially where the same substrate compound binds to both active sites. Until recently, it 
was not possible to study PurE unless it was fused to PurK (PurKPurE fusion ADE2 in 
yeast)37 or PurC (PurE2PurC fusion in Gallus gallus and PAICS in humans)32,38. A 
monofunctional PurE2 from the spirochete Treponema denticola (TdPurE2) was 
discovered and verified to be a bona fide PurE2 by our laboratory.26 This allowed the 
characterization of a monofunctional PurE2, without interference from a separate active 
site that also binds CAIR, for the close comparison to PurE1 needed for mechanistic 
studies. 
Which PurE Class was First? In many cases, enzyme divergence can be traced back to a 
common ancestor (or ancestral form) by phylogenetic analyses. When it comes to PurE, 
an unambiguous hypothesis about its evolutionary history has proven elusive. Phylogenic 
analyses do not provide a clear hypothesis that can account for the contemporary 
distribution of PurE classes or reveal how they many have diverged.26 One might 
presume that, enzymes in higher eukaryotes (e.g. PurE2) are the more modern form, 
diverged from ancestral forms in microbes (PurE1). However, PurE2 is found throughout 
all kingdoms of life and eukaryotes have PurE1 and PurE2 in about equal numbers.26 
PurE2 is used by animals (many of which have readily available CO2 via the 
bloodstream); but PurE2 is also found in a small number of bacteria, pathogenic protozoa 
(primitive eukaryotes), and archaea (Figure 1.4).39–46 Lateral gene transfer may have 
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happened from an animal host in all but the last case. In addition, de novo purine 
biosynthesis is not present in many parasites, the simpler eukaryotes that might help 
reconstruct the evolutionary history of eukaryotic PurE. 
 
Does an Ambidextrous PurE1/PurE2 Exist? Evolutionary analysis is extremely 
problematic to perform with current forms of PurE1 and PurE2. Like PurE, mammalian 
paraoxonases were a family of enzymes with poorly understood evolutionary origins. The 
discovery of structurally similar bacterial enzymes with similar activity was used in the 
reconstruction of a phylogenetic tree, which established evolutionary origin and revealed 
the sequence divergences that led to the modern family of paraoxonases. Going one step 
further, the authors designed and characterized an ancestral paraoxonase with 
ambidextrous activity.47,48  
 
Phylogenic analysis similar to those discussed above might require the discovery (or 
design) of an ambidextrous PurE1/PurE2. Characterization of an ambidextrous 
PurE1/PurE2 could help to pinpoint the key residue differences associated with PurE 
sequence and structure that occurred during the divergence of one PurE class from the 
other.  
 
Does CO2 Availability Dictate the Selection of a Particular PurE Class? CO2 availability 
is the leading candidate to explain the “choice” of PurE class: bicarbonate is abundant in 
air-exposed water, charged, easy to bind, and unreactive; CO2 is the opposite.49  
 
PurE2 can directly use CO2, while, PurE1 requires NCAIR as a ready source of CO2. 
NCAIR is formed either from bicarbonate and ATP by PurK (Figure 1.1) or by the 
spontaneous carboxylation of AIR N6 under high CO2 and high pH. NCAIR is highly 
labile with a half–life of only 0.9 min-1 at 37 °C and pH 7.8.18  
 
Environmental pH also influences CO2 availably. At low pH, NCAIR is less stable and 
CO2 is favored over bicarbonate. The PurE equilibria are also influenced by pH: CAIR 
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formation is favored over decarboxylation at high pH in PurE1 and PurE2. PurE2 favors 
CAIR decarboxylation in acid or at low pCO2.26,27,36 
 
We will consider the four environmental conditions presented in Figure 1.5.  
 
1) High CO2 and high pH, such as the bloodstream or the gastrointestinal tract in 
animals and deep-sea hydrothermal fields,50,51 may support any PurE 
configuration. 
 
2)  High CO2 and low pH, such as sediments and the deep sea surrounding deep-
sea hydrothermal vents,51,52 may support organisms possessing PurE2 since 
NCAIR formation is disfavored. 
 
3)  Low CO2 and high pH, such as atmospheric conditions or shallow fresh water 
like tide pools and the littoral zone of lakes and rivers,53,54 would require 
PurE1+PurK. PurK would be necessary to incorporate bicarbonate into 
NCAIR, as a ready source of CO2.  
 
4)  Low CO2 and low pH, such as deep-sea hydrothermal vents,55 could support 
organisms possessing either PurE2 or PurE1+PurK (potential reasons for 
PurE2 are discussed further in Chapter 5). 
 
We hypothesize that CO2 availability could influence the presence of a certain PurE class 
within an organism. However, the possibility of random inheritance cannot be ruled out. 
 
Newly Identified Microbial pure2 Genes are Found in Organisms from Predicted 
Environments. Prior to the work done with T. denticola PurE2, only a single other 
microbial purE2 gene had been identified.26 With the abundance of new genome 
sequences available, a BLAST search revealed six new microbial PurE2s from 
thermophilic and green sulfur bacteria (D. thermophilum, O. profundus, D. orientale, M. 
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salmonicolor, B. graminisolvens) and pathogenic protozoa (B. hominis) that inhabit the 
niches we would predict, deep sea environments and the gastrointestinal tract in animals, 
which have high CO2 availability and high pH (Figure 1.4-1.5).39–46  
 
PurE1 is an Unexploited Antibiotic Target. The “magic bullet” concept put forth by Paul 
Ehrlich is the basis for all chemotherapies.56–58 Current antibiotics halt essential microbial 
functions such as cell wall, DNA and protein synthesis and lead to cell stasis or death.59–
61 An emerging focus in anti-infective agents is to target virulence factors rather than 
essential targets, which are under greater selective pressure that leads to the inevitable 
acquisition of drug resistance.62–64 PurE1 has been validated as an anti-infective target 
with inhibitor studies currently underway.65–67 The PurE-associated chemical divergence 
in purine biosynthesis nicely fits the “magic bullet” model: if PurE1 can be selectively 
inhibited, PurE2 should be unaffected. Achieving this challenging level of targeted 
specificity may require a detailed knowledge of the chemical mechanism used by PurE1 
and PurE2. 
 
Characteristics of PurE1 and PurE2 Examined in this Work. PurE1 from Acetobacter 
aceti PurE1 and Treponema denticola PurE2 are used here to explore the chemistry of 
C−C bond cleavage and CO2 acquisition.!!!
Chapter 2 details published work on metal stopping reagents for the PurE1 reaction.  !
Chapter 3 reports on the characterization of single-tryptophan AaPurE1 forms and the 
fluorescence changes associated with ligand binding. The results allowed the 
identification of the primary fluorophore (the molecule responsible for observed emission 
intensity upon excitation) and characterization of its fluorescence responses to ligand 
binding, which further studies can use to elucidate the chemistry of C−C bond formation.  
 
Chapter 4 details the structural and kinetic characterization of 40s loop Ser mutants in 




necessary for activity in both classes, interestingly it may have different roles in PurE1 
and in PurE2.  
 
Chapter 5 is a short description of the role associated with the 40s loop Lys in TdPurE2 
mutants. The results rule out the possibility that a Lys carbamate is an obligatory 
intermediate in catalysis.  
 
Chapter 6 is a short description of oxygenase activity in the “inactive” TdPurE2-H40N 
mutant. The detection of oxygenase activity in the highly CO2 specific PurE2 may further 
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1.3 Figures and Tables !!
!
Figure 1.1 The de novo purine biosynthesis pathway. Steps 1–10 define the pathway in 
animals. Steps 3a, 4a, 6a, 6b, 9a and 10a represent variations of the pathway found in 
microbes, plants, or fungi. Thiamine biosynthesis requires AIR and histidine biosynthesis 



























































































































































Figure 1.2 Decarboxylase reactions. (A) Acetoacetate decarboxylase forms a stabilized 
carbanion. (R = Lys) (B) Thiamine-dependent pyruvate decarboxylase forms a stabilized 
carbanion (R = aminopyrimidine ring and R’ = hydroxyethyl side chain of the thiamine 
cofactor). (C) CAIR decarboxylation (R= ribose 5’-phosphate) begins with protonation, 
avoiding a non-stabilized vinyl carbanion, then decarboxylation. Both PurE1 and PurE2 
form a ternary PurE•AIR•CO2 complex. The conversion of NCAIR→CAIR by PurE1 





Figure 1.3 Sequence alignments and active site contacts in PurE1 and PurE2. (A) The 
40s and 70s loops contain universal (black background) and class-specific (colored 
background) residues. The critical His is indicated with a star. Triangles denote other 
polar contacts with bound nucleotides (hydrogen bond donor, ▲; acceptor, ▼). The 
universally conserved Ser is denoted by a grey triangle, it may flip polarity in PurE2 at 
low pH. Treponema denticola PurE2 (TdPurE2) residue numbers are given. (B) PurE1 
and PurE2 active site contacts with CAIR (A. aceti PurE1 residues shown in blue and T. 




Figure 1.4 Phylogenetic tree illustrating PurE2 exists in diverse organisms throughout all 
three kingdoms. The newly identified PurE2s from green sulfur and thermophilic bacteria 
and pathogenic protozoa from (Figure 1.5) are included.  !!
!
Figure 1.5 Possible PurE combinations in different environmental conditions. There are 
three known PurE combinations to consider: PurE2, PurE1+PurK, or PurE1-only without 
a recognizable PurK.31 No known organisms have both a PurE1 and PurE2, this may be 





































































Figure 1.6 Diagnostic regions in newly identified purE2 genes. (A) The 40s and 70s 
loops contain universal (bold letters) and class-specific (colored background) residues. 
The critical His is indicated with a star. Triangles denote other polar contacts with bound 
nucleotides (hydrogen bond donor, ▲; acceptor, ▼). The universally conserved Ser is 
denoted by a grey triangle, it may flip polarity in PurE2 at low pH. Treponema denticola 
PurE2 (TdPurE2) residue numbers are given. All PurEs shown are microbial, with the 





CHAPTER 2   METAL STOPPING REAGENTS FACILITATE 
DISCONTINUOUS ACTIVITY ASSAYS OF PURE1!!!
2.1 Introduction 
 
De novo purine biosynthesis harbors an unusual divergence in a ubiquitous biosynthetic 
pathway.1 In most microbes and nonmetazoan eukaryotes, a class I PurE [PurE1, N-
carboxyaminoimidazole ribonucleotide (NCAIR) mutase, EC 5.4.99.18] reversibly 
converts NCAIR to 4-carboxy-5-aminoimidazole ribonucleotide (CAIR) (Figure 2.1).2 
Animals produce CAIR by a different route, using a class II PurE (PurE2, 5-
aminoimidazole ribonucleotide (AIR) carboxylase, EC 4.1.1.21)3–5. Microbial 
pathogenesis relies upon purine biosynthesis6 particularly purE1, which is therefore a 
promising but unexploited antibiotic target.7,8 Inhibitors selective for PurE1 could have 
antibacterial, antifungal, or herbicidal activity.9 In this work, we describe a functional 
assay for PurE that is compatible with inhibitor identification by high-throughput 
screening (HTS) methods. 
 
Currently available PurE1 functional assays are not amenable to HTS methods. A 
continuous ultraviolet (UV) assay that monitors the absorbance decrease due to CAIR 
decarboxylation2,10,11 is subject to spectral interference by many candidate inhibitors.  
 
*The text within this chapter is taken from the manuscript written in October 2013 by 
T.J. Kappock, K.L. Sullivan, and E.A. Mullins, with the exception of Figure 2.8 and 
Figures 2.10-2.12 and the text shown in italics throughout. T. J. Kappock performed the 
experiments with NiNTA and NiIDA columns and the nickel stopping experiments with 
EcPurE1. E. A. Mullins performed all HPLC analyses 
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CAIR synthesis assays are complicated by the acid lability of the NCAIR substrate2,12,13, 
the need for multiple coupling enzymes,9,14 and, for discontinuous assays detecting 
inorganic phosphate production, handling of malachite green reagent15 and a background 
due to formation of phosphate by the coupling enzymes. The Bratton-Marshall assay 
(BMA)16 was used in early studies of PurE2,3 but seldom thereafter. The BMA yields 
intensely colored AIR and CAIR derivatives, AIR-BM and CAIR-BM (Figure 2.1), 
which possess characteristic visible absorbance spectra,17 are relatively stable, and 
might be suitable for HTS methods. The BMA, however, requires multiple, timed 
reagent additions that would be difficult to implement during parallel screens. An 
alternative would be to stop the PurE1 reaction prior to BMA workup using a reagent 
that does not alter product yields.  
 
2.2 Materials and Methods !
AICAR (>98% purity) was purchased from Sigma (St. Louis, MO) or Toronto Research 
Chemicals (Toronto, Canada). Other chemicals were purchased from Sigma; all were 
used without further purification. AIR was synthesized by enzyme-mediated 
decarboxylation.1 4-Carboxy-5-aminoimidazole ribonucleoside (CAIRs) was 
synthesized by saponification of 5-aminoimidazole-4-carboxamide ribonucleoside 
(AICARs).18 
NiNTA agarose (Qiagen; Valencia, CA) was placed in a Micro Bio-Spin column 
(BioRad; Hercules, CA). NiIDA was prepared by saturating Chelex 100 (BioRad) with 
NiSO4, followed by extensive water washing to rinse off unbound metal, and a portion 
was transferred to a Micro Bio-Spin column. A 3 mL disposable syringe plugged with 
cotton (cosmetic 100% cotton, 0.5 mL) was washed three times with H2O to remove 
soluble fibers. Another 3 mL disposable syringe containing a layer of sand (0.5 mL) 
sandwiched between cotton layers (0.5 mL each) was washed with H2O and then 




PurE1 from Acetobacter aceti and PurE2 from Treponema denticola were isolated as 
described previously.5,19 Protein concentrations were determined by the method of 
Bradford using bovine serum albumin as the standard.20 
Absorbance spectra were recorded on a Cary 100 UV-vis spectrophotometer or an 
Agilent 8453 diode-array spectrophotometer. Absorbance spectra were vertically shifted 
(by less than 0.001 A) to set the absorbance value at 800 nm at zero. 1H NMR spectra 
were recorded on a Bruker 500 MHz NMR spectrometer, using 5 mm o.d. tubes and 
sample concentrations of ∼25% (w/v) in D2O. 
Synthesis of CAIR. AICAR (50 mg, 0.15 mmol) was placed in a 25 mL round bottom 
flask containing LiOH (8 mL of a 1 M aqueous solution, 8 mmol). The flask was sealed 
with a septum and the mixture was stirred at 125 °C under a N2 atmosphere. A positive 
pressure of N2 was maintained using a balloon, with a small vent needle inserted to 
allow slow solvent evaporation. After ∼2 h, the reaction mixture volume was ∼2 mL. 
The reaction vessel was then sealed under a N2 atmosphere and held for another 2.5 h at 
125 °C. The reaction mixture was cooled to room temperature and deionized H2O (2 
mL) was added with stirring. The mixture was cooled to 0 °C and HCl (2 N) was added 
to adjust the pH to ∼7, as judged by spotting on pH test strips. The solution was forced 
by air pressure through a column packed with cotton to remove particulates. The filtered 
solution was then lyophilized to dryness. The resulting solid was resuspended in cold 
absolute ethanol (3 x 15 mL) and transferred as a suspension to a column packed with 
cotton and sand. Air pressure was used to blow out residual ethanol. Cold deionized H2O 
(20 mL) was applied to the cotton/sand column to dissolve CAIR, which was recovered 
and lyophilized to furnish a white powder (42.5 mg, 85% yield). 1H NMR (500 MHz, 
D2O 4.84): δ 8.03 (s, 1H), 5.73 (d, J = 6.4 Hz, 1H), 4.63 (m, 1H), 4.42 (m, 1H), 4.32 (m, 
1H), 4.03 (m, 2H). 
Fluorescence Emission Spectra. Spectra were recorded on a Horiba Fluoromax-3 
fluorometer thermostated with a Peltier Accessory and a Wavelength Electronics 
temperature controller using a 1 cm pathlength fluorometer cell that contained 2.0 mL of 
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AIR (0-23.8 µM), CAIR (0-23.8 µM), or AICAR (0-33 µM) in 50 mM Tris-HCl, pH 8. 
The excitation wavelength was 295 nm (2 nm slit width) and emission spectra were 
collected from 305 to 450 nm (5 nm slit width). A buffer only-spectrum was subtracted 
from as the background from all spectra.  
 
LiOH Titrations. LiOH titrations (0-6.7 mM, neutralized to pH 8 with HCl, from 100 
mM stock) were performed in 50 mM Tris-HCl, pH 8, with CAIR (10.5 µM) at 30 °C. 
CAIR fluorescence emission spectra were recorded as described above. 
 
CAIR Synthesis Without Plastic Vessels. CAIR synthesis was carried out according to 
the above protocol with a single exception: no plastic vessels were used during 
synthesis. Instead only glassware soaked overnight in concentrated nitric acid was used. 
Fluorescence emission spectra of CAIR from this synthesis were recorded as described 
above. 
 
CAIR Synthesis with Extensive EtOH Washes. CAIR synthesis was carried out according 
to the above protocol with a single exception: the lyophilized CAIR was resuspended in 
cold absolute ethanol (10 x 25 mL) and transferred as a suspension to a column packed 
with cotton and sand. Fluorescence emission spectra of CAIR from this synthesis were 
recorded as described above. 
 
Metal Content of CAIR. CAIR titrations (0-50 µM CAIR, from 600 µM stock) were 
performed in 50 mM Tris-HCl, pH 8, with 8-Hydroxyquinoline-5-sulfonic acid (HQS; 1 
mM) at 30 °C. CAIR fluorescence emission spectra were recorded as described above. 
 
Removal of Metals from CAIR. EDTA titrations (0-20 mM, from a 200 mM stock) were 
performed in 50 mM Tris-HCl, pH 8, with CAIR (33 µM) at 30 °C. CAIR fluorescence 




CAIR (0.5 mL, 1 mM) in 50 mM Tris-HCl, pH 8 was incubated with Chelex-100 resin 
(0.5 mg of the sodium form prepared as in Bio-Rad manual) rocking, for 1 h at 4 °C. 
The CAIR solution was centrifuged (max speed, 30 s), the supernatant transferred, and 
diluted to 33 µM in the same buffer and CAIR fluorescence emission spectra were 
recorded as described above. 
 
CAIR Separation from the Fluorescent Species. CAIR (235 nmoles) was applied to a 
silica column (0.6 cm x 2.2 cm) equilibrated in the one of the following solvents: water, 
25% EtOH, 50% EtOH, 75% EtOH, or 100 % EtOH. A single CV of the same solvent 
was applied, the flow-thru collected, analyzed by BMA for the presence of CAIR, and 
fluorescence emission spectra were recorded as described above 
 
CAIR (490 nmoles) in 50 mM Tris-HCl pH, 8 was mixed with 27 mg of C18 media 
(activated with MeOH and washed with 50 mM Tris-HCl pH, 8) and incubated rocking, 
for 4 h at 4 °C. The C18 mixture was transferred to a mini spin column (Qiagen) and 
eluted by centrifugation at (1000 g for 30 s). The elution was analyzed for the presence 
of CAIR by UV-endpoint assay and fluorescence emission spectra were recorded as 
described above. 
 
CAIR (490 nmoles) in 50 mM Tris-HCl, pH 8 was applied to a ZnIDA (1.5 x 1 cm) 
column equilibrated in the same buffer. Buffer was applied (6 CV) and the flow-thru 
collected. The fractions were analyzed for the presence of CAIR by BMA and ZnSO4 by 
the addition HQS (0.5 mM final concentration). HQS fluorescence was detected using a 
handheld UV lamp. 
 
CAIR Quantitation Assays. CAIR samples (0.5 mL) were mixed 1:1 with orcinol 
reagent, heated to 100 °C for 30 min, cooled to ambient temperature, and quantitated at 
670 nm. A blank spectrum was recorded from a solution containing a 1:1 orcinol reagent 
to water that was processed at described above. CAIR samples were referenced to an 
AMP calibration curve, AMP standards (5-250 µM, 10 mM stock solution standardized 
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at 260 nm, ε260 = 15.4 mM-1 cm-1) were mixed with orcinol reagent and processed as 
described above. Orcinol reagent [0.1% (w/v) orcinol acid and 0.1% (w/v) iron (III) 
chloride hexahydrate in concentrated HCl] was freshly prepared before use. 
Phosphate ashing assays of CAIR were performed using a published method.21 The 
CAIR sample (0.05 mL, 1 mM) in a 13 x 100 mm Pyrex test tube was mixed with and 
equal volume of 10%. Mg(NO3)2•6H2O in ethanol; the mixture was evaporated to 
dryness over a flame with rapid shaking and further heated in the flame until brown 
fumes were no longer observed. The mixture cooled to ambient temperature, 0.3 mL of 
1 M HCl was added, the tube was capped, and heated at 100 °C for 15 min. An ascorbic 
acid mixture (0.7 mL) (1 part 10% ascorbic acid to 6 parts of 0.42% ammonium 
molybdate•4H2O in 1 M H2SO4) was then added and heated at 45 °C for 20 min. The 
solution was then read at 820 nm against a blank containing water in place of the CAIR 
solution. 
Enzyme Activity Assays. A unit is defined as the amount of enzyme that produces 1 µmol 
product per min.  
Continuous assays of PurE1-mediated CAIR decarboxylation were performed using a 
published method.11 A final volume of 0.6 mL in a masked, 1 cm path length cuvette 
containing 50 mM Tris·HCl, pH 8.0, and CAIR (4–80 µM) was incubated at 30 °C for at 
least 3 min. Reactions were initiated by the addition of Acetobacter aceti PurE1 (27 ng; 
2.4 nM subunits). The initial velocity of CAIR decomposition (∆ε260 = 8930 M−1 cm−1) 
was recorded at 260 nm, with a correction for a small background slope. CAIR was 
quantitated by endpoint assay using the same method, except that 50 µg mL−1 
Treponema denticola PurE2 was the enzyme. 
Discontinuous reaction mixtures (Vrxn, 0.15–2.0 mL final volume) contained 50 mM 
Tris·HCl, pH 8, 6-80 µM CAIR (12 nmol total), and 26–320 ng (MPurE1) Acetobacter 
aceti PurE1 (10 nM subunits). After incubation at 30 °C for a period ∆t ranging from 1–
6 min, ZnSO4 (VZn, 6 µL, of a 5 mM stock; equivalent to a three-fold molar excess over 
the amount of CAIR initially present) was added to stop the reaction and the mixture 
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was vortexed briefly. An aliquot (Vrxn/1.2 mL) of each quenched mixture was 
withdrawn, adjusted to either 0.5 or 2.0 mL with buffer, and subjected to BMA analysis 
as described in the caption to Figure 6.7, except that the sample volume was larger. 
The final analyte volume (Va) was either 0.9 or 3.6 mL, depending on the cuvette used 
for analysis. A dilution correction factor Cdil was computed using equation 1. 
!!"# = ! !! !× !!!"#!!!!"!!"#         Equation 1 
The amount of AIR formed was determined from absorbance readings of the BMA 
reaction mixture, containing AIR-BM and CAIR-BM in varying ratios, for both the 
quenched reaction mixtures (!!""! ) and a no-enzyme control, processed in otherwise 
identical fashion (!!""!"#$%"&). The differential extinction coefficient for AIR formation was 
∆ε500 = 13,600 M−1 cm−1. The cuvette pathlength (!) was 1 or 4 cm for Va of 0.9 and 3.6 
mL, respectively. Three replicate assays were performed at each [CAIR]. Reaction 
velocities (v) for AIR formation were computed using equation 2. 
! = ! !!""! !!!""!"#$%"&!ℇ!"" × ! !!!!"#!!!"#$!"                  Equation 2 
 
One set of reaction mixtures (containing 40 µM CAIR) was quenched with ZnSO4 as 
above, then incubated at room temperature for 24 h prior to BMA workup. Kinetic 
constants were obtained by non-linear least-squares fitting to the Michaelis-Menten 
equation with gnuplot (version 4.4). 
Matrix-assisted Laser Desorption/Ionization (MALDI) Mass Spectrometry. BMA 
reaction mixtures containing 25 nmol of nucleotide or nucleoside were prepared as 
described in the caption to Fig. 2. Mass spectra were recorded on an ABI 4800 MALDI 
time-of-flight (TOF)/time-delayed fragmentation (TDF) instrument (AB SCIEX; 
Framingham, MA). The matrix was α-cyano-4-hydroxycinnamic acid in 50% 
acetonitrile and 0.1% trifluoroacetic acid. 
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High-Pressure Liquid Chromatography (HPLC) Analysis of BM Derivatives. HPLC 
analysis was performed using a Waters (Milford, MA) Breeze system equipped with a 
Waters 717plus autosampler. A ZORBAX Eclipse XDB-C18 column (4.6 × 150 mm, 5 
µM; Agilent, Santa Clara, CA) with a C18 guard column (4.6 × 12.5 mm, 5 µM) was 
developed at 0.5 mL/min with dual- wavelength monitoring (260 nm / 500 nm). Buffer 
A was 150 mM sodium acetate, 200 mM sodium phosphate, pH 4.6. Buffer B was buffer 
A containing 30% methanol. The gradient program was: 0–5 min, 0% B; 5–25 min, 0 to 
100% B; 25–30 min, 100% B, 35–55 min, 100 to 0% B; 55–60 min, 0% B. 
Immobilized-Metal Affinity Chromatography (IMAC). NiIDA and NiNTA columns (0.4 
mL bed volume) were equilibrated in 25 mM (N-morpholino)propanesulfonic acid 
(MOPS), pH 7.4. All operations were carried out under gravity flow at room 
temperature. A 1:1 mixture of AIR:CAIR (15 nmol combined, in 0.6 mL MOPS buffer) 
was applied to each column, which were then developed by the adding more MOPS 
buffer one bed volume at a time. Column fractions were analyzed by the BMA. CAIR 
adhering to the washed NiNTA column was completely displaced by the addition of 
excess NiSO4 solution (data not shown). 
Molecular model construction. A CAIR model (residue type C2R) was obtained from 
the HIC- Up server22 and positioned using the Pymol23 Pair Fitting “wizard” onto the 
organic ligands in a template crystal structure. The templates were 5-coordinate, 
distorted square pyramidal complexes [Zn(picH)(pic)Cl] (pic = picolinate, picH = 
picolinic acid)24 and [CuL2(H2O)] (L = 5-amino-1-tolylimidazole-4-carboxylate).25 The 
second complex contains the same heterocycle that is present in CAIR. 
 
2.3 Results  
!
A New Synthesis Produces Highly Pure CAIR. The first task was to determine an 
extinction coefficient for CAIR-BM at 500 nm, a goal that requires pure CAIR. A new 
CAIR synthesis, which uses LiOH to saponify aminoimidazole-4-carboxamide 
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ribonucleotide (AICAR) and thereby facilitates salt removal (see materials and 
methods), furnished CAIR in high yield (85%) and purity (99%). No peak corresponding 
to AIR H2 peak was observed in 1H NMR spectra (Figure 2.2). Mass spectrometry (MS) 
analysis of BMA reaction mixtures revealed only the expected molecular ions for single 
BM adducts and ions present in control mixtures (Table 2.1). HPLC analysis of CAIR 
subjected to BMA workup showed 97% CAIR-BM / 3% AIR-BM (Figure 2.3); a small 
amount of AIR evidently forms during the BMA acid quench step. CAIR-BM appears to 
consist of a mixture of species that cannot be resolved by HPLC but that possess the 
same molecular formula. An isobaric mixture might also account for the complex shape 
of the CAIR-BM visible spectrum (Figure 2.4). Aliquots of a solution containing pure 
CAIR were (1) used to determine an accurate CAIR concentration, by complete 
conversion to AIR followed by BMA analysis, and (2) used to obtain a spectrum of 
CAIR-BM, which gave !!""!"#$!!" = 11,200 M-1 cm-1  (for comparison ε!""!"#!!"= 24,800 
M-1 cm-1. 17  
 
ZnSO4 or NiSO4 are Sufficient to Quench the PurE1 Reaction.  The second task was to 
identify an enzyme quenching method that is compatible with BMA workup and product 
analysis. CAIR and analogues form stable complexes in which aminoimidazole N3 and 
O7 atoms (Figure 2.1) coordinate a transition metal ion. 25 (CAIR)-metal (n = 2 or 3) 
complexes (Figure 2.5) do not bind to or inhibit chicken PurE2 in the presence of excess 
free CAIR 26–28 Mg2+ inhibits PurE2-mediated CAIR decarboxylation but not AIR 
carboxylation, consistent with the formation of a low-affinity metal-CAIR complex.1,10 
To determine if transition metals can rapidly and reversibly form CAIR-metal 
complexes, a ten-fold molar excess (relative to the initial CAIR concentration) of NiSO4 
or ZnSO4 was added to UV-monitored CAIR decarboxylation reaction mixtures. CAIR 
decarboxylation stopped immediately, but could be restarted by the addition of EDTA 
(Fig. 2.6). EDTA had no effect on BMA workup; the initial acidification step apparently 
dissociates CAIR complexes formed with either Ni2+ or Zn2+.  
ZnSO4 is a Better Stopping Reagent than NiSO4.  Zn2+ appeared to form a CAIR 
complex with higher kinetic stability than Ni2+, and to pose fewer concerns with regard 
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to toxicity, spectral overlap with (C)AIR-BM, and redox chemistry. A CAIR 
decarboxylation reaction mixture incubated at 30 °C was stopped at ∼30% completion 
by the addition of ∼3 molar equivalents of ZnSO4 (Figure 2.7). Equivalent yields of 
CAIR-BM were obtained if the BMA workup was delayed by up to 4 h. In contrast, 
Ni2+-stopped reactions lost CAIR at the rate of about 10% per h at 30 °C (data not 
shown). A saturation curve employing ZnSO4 quenching gave kinetic constants similar 
to the standard continuous UV assay (Figure 2.8). Indistinguishable velocities were 
obtained at 40 µM CAIR for a quenched reaction worked up promptly or after a 24 h 
delay. Therefore ZnSO4 is a suitable stopping reagent for PurE1 reaction mixtures. 
Formation of the Ni2+-CAIR Complex is Reversible. Metal stopping reagents are 
proposed to work by rapid substrate depletion, an uncommon mode of enzyme inhibition 
(e.g., vancomycin).29,30 Immobilized metal affinity chromatography (IMAC) was used to 
test if CAIR binds to Ni2+, immobilized on a nitrilotriacetic acid (NTA) column. An 
equimolar mixture of CAIR and AIR was applied to the NiNTA column. The first 
column fraction contained pure AIR, consistent with selective retention of CAIR on the 
column as a CAIR-Ni2+ complex (Figures 2.9 and 2.10). Subsequent fractions contained 
CAIR, indicating that the Ni2+-CAIR interaction was reversible (data not shown). While 
these results do not exclude the possibility that PurE1 is inhibited by direct protein-metal 
interactions, they indicate that the rapid formation of a stable CAIR-transition metal 
complex is sufficient to account for ZnSO4-mediated arrest of CAIR decarboxylation. 
 
CAIR Synthesized by the New Method Contains a Fluorescent Species. We observed that 
CAIR, synthesized by the new method reported in this chapter, contains a fluorescent 
species with a λmax = 405 nm (Figure 2.11). No such signal has been reported for 
AIR/CAIR synthesized by previous methods that use different reaction conditions. 
Therefore, we attempted to identify the source of the fluorescent species. 
  
1.1 We first turned our attention to the synthesis of CAIR. Could the staring materials 
themselves be fluorescent? 
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1.1a Fluorescence emission spectra were obtained for the starting materials 
LiOH and AICAR (data not shown). Neither of these compounds is fluorescent, 
therefore we decided to check the synthesis conditions. 
  
1.2 We considered the fluorescent species could be leached from plastic vessels used 
during CAIR synthesis. 
 
1.2a To ensure fluorescent contaminants could not come from the reaction 
vessels, CAIR was synthesized using only nitric acid washed glassware. 
However, the fluorescent species was still observed (data not shown). The 
fluorescent species does not appear to be a consequence of the plastic vessels 
or the starting materials.  
 
2.1 We then wanted to know if the fluorescent species could be separated from CAIR.  
 
2.1a . The last step of synthesis involves washing CAIR in ice cold EtOH (45 
mL total) we attempted to remove the fluorescent species by extensive washing 
of CAIR in ice cold EtOH (250 mL total). The fluorescence emission spectra had 
slightly diminished intensity, but the additional washes sacrificed the yield of 
CAIR (data not shown), indicating removal of the fluorescent species also 
removes CAIR. Therefore, we attempted several other separation techniques. 
 
2.1b Zn2+ tightly chelates CAIR and we exploited this property to purify CAIR. 
CAIR was applied to a ZnIDA column. However, CAIR strips the metal off the 
column and co-elutes with fluorescent species (data not shown).  
  
2.1c CAIR may absorb to silica. Therefore, silica columns were used to  separate 
CAIR from the fluorescent species. Again, CAIR co-elutes with fluorescent 




2.1d CAIR should not absorb to hydrophobic C18 media. Therefore, C18 media 
was used to purify CAIR. Again, CAIR co-elutes with fluorescent species 
(Figure 2.12). The fluorescent species has a linear correlation to CAIR 
concentration (before and after C18 separation), indicating that the fluorescent 
species is associated with CAIR and was not separated by any of the methods 
attempted. 
   
3.1 We then considered that the fluorescent species could be due to a metal contaminant. 
 
3.1a Metal chelates of HQS fluoresce intensely and the addition of HQS to a 
solution allows one to determine if metals are present. Titration of CAIR into 
HQS confirmed the presence of metals in the solution (data not shown). If these 
metals are responsible for the observed fluorescent species, we may be able to 
remove them and see a decrease in fluorescence intensity.  
  
3.1b Metals were removed from CAIR solution by the addition of EDTA or by 
treatment with chelex. Removal of metals did not alleviate the intensity of the 
fluorescent species, indicating it is not sensitive to the presence of metals. 
  
4.1 All attempts to purify the fluorescent species failed and in each case the fluorescent 
species co-elutes with CAIR. The fluorescent species could be CAIR itself or a 
derivative of CAIR 
 
4.1a CAIR was the only species detected by 1H-NMR (Figure 2.2) and MS 
analysis (data not shown). Therefore, we wanted to confirm that the only 
species in solution is intact CAIR. We performed multiple assays (orcinol-
ribose, phosphate, BMA-N6 of CAIR, UV endpoint-CAIR β-anomer) to 
ensure only intact CAIR was present in solution. The values from these assays  




solution. The use of multiple analytical techniques has not been successful in 
detecting any species other than CAIR. 
The results presented above indicate that only CAIR is present in solution and always 
co-partitions with the fluorescent species. We were therefore forced to conclude that the 




We Have Developed a PurE1 Assay that is Specific and Suitable for HTS. The method 
can be used to screen candidate inhibitors that absorb UV light, a common practical 
concern for detecting initial hits, which often have low potency and therefore require 
high compound concentrations that cause significant spectral interference. PurE1-
mediated CAIR decarboxylation can be stopped by a single liquid addition, of a ZnSO4 
solution, and subjected to the BMA workup hours later. BMA-detected PurE1 screens 
require no other enzymes and can be used to screen candidate inhibitors that do not 
contain diazotizable amines or strong metal chelators. A related method might be 
employed for functional assays of the other enzyme known to use CAIR as a substrate, 
5-aminoimidazole-4-N-succinylcarboxamide ribonucleotide (SAICAR) synthetase 
(PurC, EC 6.3.2.6) the other enzyme known to use CAIR as a substrate. SAICAR has 
recently been shown to activate cancer metabolism via pyruvate kinase isoform M2.31 
CAIR Synthesized by the New Method Contains a Fluorescent Species. AIR and CAIR 
synthesized by an earlier method involving KOH have no intrinsic fluorescence. KOH 
saponified CAIR is less pure, with more AIR present (in as-isolated CAIR), forms more 
dark polymeric decay products (and a greater tendency to form them), and potentially 
quenchers that might mask the intrinsic fluorescence of CAIR. The new CAIR synthesis 
produces a very pure, apparently fluorescent product. This could be an unrecognized 




The Fluorescent Species Cannot be Removed from CAIR. All attempts to remove the 
fluorescent species failed; therefore, to minimize the contribution of the fluorescent 
species (λmax at 405 nm) to fluorescence titration data, emission for all AIR and CAIR 
spectra were monitored at 320 nm. There is less contribution of the fluorescent species 
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Figure 2.1 PurE1 reaction and CAIR/AIR detection by Bratton–Marshall assay (BMA). 
NCAIR decarboxylates to AIR (half-life of 0.9 min at pH 7.8 and 30 °C) during the 
enzyme assay,2 an acid-dependent process that goes to completion during the BMA. R5P 
= ribosyl 5’-phosphate, R = H (AIR-BM) or COO- (CAIR-BM). CAIR aminoimidazole 





Figure 2.2 1H NMR spectrum of CAIR (500 MHz) in D2O. AIR H2 would give a singlet 
with δ ∼ 8.3 ppm; only the CAIR H2 signal is observed in this region (orange box). AIR 
H1′ would give a doublet with δ ∼ 5.80 ppm; only the CAIR H1′ signal is observed in 
this region (blue box). Due to facile solvent exchange, AIR H4 (δ ∼ 6.3 ppm) is typically 




Table 2.1 MALDI-TOF MS analysis of selected BM derivatives. a  
 [M+H+] (m/z)  [M+K+] (m/z) 
BM derivative obs exp  obs exp 
AIR-BM  493.09 493.16  none 531.12 
CAIR-BM  537.11 537.15  575.06 575.11 
CAIRs-BM  457.14 457.18  495.10 495.14 
AICAR-BM 536.09 536.17  574.05 574.12 
AICARs-BM 456.13 456.20  494.09 494.15 
a Observed peaks (obs) were the most abundant molecular ions that were not 
observed in control spectra. BMA controls were prepared without a diazotizable 




Figure 2.3 HPLC analysis of BMA reaction mixtures containing CAIR-BM (red trace, 
26.4 min) or AIR-BM (blue trace, 28.1 min). Contaminating AIR-BM can be seen in the 
CAIR-BM trace as a peak at 27.8 min, as confirmed by co-injection with authentic AIR-













Figure 2.4 Visible absorbance spectra for CAIR-BM (red trace), AIR-BM (blue trace), 
and a 30:70 mixture of AIR-BM:CAIR-BM (black trace). Spectra of AIR-BM and 
CAIR-BM consistently cross at a single wavelength, 541 nm (vertical arrow). Spectra 
were recorded on a Cary 100 spectrophotometer. !
!
Figure 2.5 Wall-eyed stereodiagram depicting a speculative model of a [Zn(CAIR)2Cl] 
complex. The model was built as described above, using a [Zn(picH)(pic)Cl] complex24 
as the template. All atoms are presented in ball-and-stick depictions, in which each 
sphere radius is one-quarter of the van der Waals radius. The dotted sphere depicts the 
full van der Waals radius for Zn2+. In this view, the Zn atom and the front 
aminoimidazole ring are approximately coplanar in the plane of the page. The Zn−Cl 
bond, which is tilted towards the viewer and to the right, defines the tetragonal axis, 

















Figure 2.6 Nickel stops CAIR decarboxylation by E. coli PurE1. The reaction mixture 
(0.7 mL) initially contained 100 µM CAIR in 50 mM Tris·HCl, pH 8.0 (37 °C). CAIR 
decarboxylation was initiated by the addition of PurE1 at t = 0. A unit is defined as the 
amount of PurE1 that catalyzes 1 µmol CAIR decarboxylation per min. Absorbance 
changes at 260 nm (black trace, 0.0021 units) were converted to [CAIR] using the 
differential extinction coefficient Δ!!"#!"#$⟶!"# = 8930 M-1 cm-1. The addition of 1 mM 
NiSO4 stops CAIR decarboxylation (red trace, ∼0 units). Full activity (blue trace, 0.0024 
units) was restored upon the addition of 5 mM EDTA. ZnSO4 also immediately stops 
CAIR decarboxylation but enzyme activity was not restored as quickly after the addition 

















Figure 2.7 Zn2+ ions stop CAIR decarboxylation. Reaction mixtures (1.26 mL final 
volume) at 30 °C contained 50 mM Tris-HCl, pH 8.0, 42 µM CAIR, and 0.13 µg 
Acetobacter aceti PurE1 (0.005 units).19 At 5 min, ZnSO4 (0.1 mM) was added to one 
reaction. Aliquots (0.2 mL) were removed prior to the addition of enzyme (zero time 
point) and at indicated intervals, and immediately added to a 1.7 mL centrifuge tube 
containing a freshly prepared mixture of 20% (w/v) trichloroacetic acid / 1.33 M 
potassium phosphate, pH 1.4, (0.1 mL) and 0.1% (w/v) sodium nitrite (0.1 mL). After 3 
min, 0.5% (w/v) ammonium sulfamate (0.1 mL) was added to destroy excess nitrite. 
After an additional min, Bratton–Marshall reagent [0.1 mL of 0.1% (w/v) N-(1-
naphthyl)ethylenediamine dihydrochloride] was added. After 10 min, the solution (0.6 
mL) was centrifuged (16,000g, 30 s) to eliminate bubbles and the absorbance at 500 nm 
(A500) was recorded. CAIR consumption was quantitated using a differential extinction 
coefficient for CAIR to AIR conversion, ∆!!"" = !!""!"#!!" − !!!!!!"#$!!" =13,600 ± 1600 
M-1 cm-1. [CAIR] values at time t were determined using (!!""!"#!!" − !!""! )/Δε500,  
where !!""!"#!!" was from a control reaction in which CAIR was completely converted to 
AIR. The symbols and error bars represent the mean and standard deviation, 
respectively, for at least three independent replicates of ZnSO4-quenched (filled circles) 
and unquenched control (open circles) reactions. Concentrations determined at t > 5 min 
were significantly different in quenched and control reaction mixtures [one-tailed t-test, 
P-value <0.01 (**) or <0.001 (***)]. The slope of the line connecting the first two points 
corresponds to 0.003 units of enzyme activity, comparable to the 0.004 units expected 





Figure 2.8 PurE1 saturation curves for continuous assays (open circles and blue trace) 
and discontinuous ZnSO4-quenched, BMA-detected assays (filled circles, black trace). 
The symbols and error bars shown for the discontinuous assays represent the mean and 
standard deviation of three replicate measurements at each [CAIR]. One triplicate assay 
was subjected to BMA analysis 24 h after the quenching step (red symbol). Each solid 
line is a non-linear least-squares fit to the Michaelis-Menten equation: continuous assay, 
Vmax = 40 ± 2 units mg−1 and Km = 11 ± 1 µM; discontinuous, Vmax =40 ± 2 units mg−1 





















Figure 2.9 CAIR reversibly binds Ni2+. A 1:1 mixture of AIR:CAIR was applied to 
IMAC columns developed in MOPS buffer (pH 7.4). BMA derivatives were prepared 
from the fractions emerging from Ni2+-loaded nitrilotriacetic acid (NTA) and 
iminodiacetic (IDA) columns. Spectra correspond to BMA derivatives of the first 
fractions recovered from NiIDA (black trace) or NiNTA (blue trace) columns of equal 
volume. A NiIDA–NiNTA difference spectrum (red trace) is consistent with the 
spectrum of pure CAIR-BM (Figure 6.4). A reference spectrum (purple trace) obtained 
using the undiluted 1:1 AIR:CAIR mixture applied to both columns shows the same 
proportion of BMA derivatives present in the NiIDA fraction. Spectra were recorded on 
an Agilent 8453 spectrophotometer. !
!
Figure 2.10 Fractions from IMAC columns loaded with a 1:1 mixture of CAIR:AIR 
then derivatized by the BMA. A NiNTA fraction (center tube) contains mainly the 
orange-colored AIR-BM. A NiIDA fraction (left tube) resembles a standard (15 nmol 
total AIR+CAIR) containing BM derivatives of the mixture applied to each column 
















Figure 2.11 CAIR and AIR fluoresence emission spectra. CAIR and AIR (0 µM-23.8 
µM, 0.6 mM stocks) were added to 50 mM Tris-HCl, pH 8.0.  (A) CAIR emission 
spectra. (B) AIR emission spectra. Black line- no nucleotide present, light gray line- 






























Figure 2.12 Fluorescence emission spectra of C18 separation of fluorescent species. (A) 
Emission spectra of the CAIR solution prior to the C18 cleanup. (B) Emission spectra of 
the CAIR solution after cleanup by C18 media. (C) F at λmax (405 nm) is plotted vs. 






Figure 2.13 Selection of a wavelength to monitor AIR/CAIR titrations. Florescence 
emission spectra were recorded in 50 mM Tris-HCl, pH 8.0 at 25 °C with and excitation 
wavelength of 295 nm. Emission spectra with 0.4 µM AaPurE1-H59N (black line), 23.5 
µM AIR (blue line), and both AaPurE1-H59N and AIR at the concentrations given (red 
line). The green line represents the sum of individual AaPurE1-H59N and AIR spectra. 
An increase due the impurity in AIR is obvious at the λmax of AaPurE1-H59N (~338 





















Figure S10: Selection of a wavelength for titrations that is minimally affected by a fluo-
rescent impurity in AIR. Fluorescence emission spectra recorded at 25  C with an exci-
tation wavelength of 295 nm. Spectra are AaPurE-H59N (0.4 µM, black line), AIR (23.5
µM, blue line), and a mixture of AaPurE-H59N and AIR (same concentrations, red line).
Fluorescence enhancement due to ligand binding is evident by comparing the spectrum
of the protein-AIR mixture to the computed sum of the individual AaPurE-H59N and
AIR spectra (green line). Th contribution of the fluorescent impurity in AIR is smaller





CHAPTER 3 FLUORESCENCE CHANGES ASSOCIATED WITH LIGAND 
BINDING TO SINGLE-TRYPTOPHAN FORMS OF PURE1 AND PURE2
 !!!
3.1 Introduction !
Monitoring intrinsic protein fluorescence changes can be a powerful tool to study ligand 
binding, catalysis, conformational changes, and protein folding.1–3 The use of intrinsic 
fluorescence requires the aromatic amino acids tryptophan (Trp), or tyrosine (Tyr), and 
occasionally phenylalanine (Phe). Protein fluorescence is dominated by the Trp 
fluorophore. The number and position of Trp residues is of particular importance. If we 
have a detailed understanding of the photophysical basis of Trp fluorescence changes, 
then one can go beyond using them as empirical reporter groups to understanding 
something about the enzyme chemistry.  
 
Monitoring CC bond Formation by Intrinsic Fluorescence. Changes in intrinsic 
fluorescence can be used to monitor an enzymatic reaction in real time. In particular, 
fluorescence is sensitive to the charge distribution within the active site that occur as an 
intact enzyme reacts with its natural substrate. This method has been successfully used to 
detect CC bond formation by citrate synthase (Chapter 1).4  
 
Our long-term goal is to learn how the mechanism of CC bond formation differs in 
PurE1 and PurE2 using fluorescence changes as a real time reporter. As a prerequisite, 
we must first determine how fluorescence due to each Trp residue responds to ligand 
binding in both PurE1 and A. aceti. (AaPurE1) and PurE2 from T. denticola (TdPurE2). 
 !
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Single-Trp Proteins Simplify Fluorescence Changes. The fluorescence properties of Trp 
and its parent indole have been extensively studied and are sensitive to changes within 
the environment within a given protein.3–5 Environmental changes can be monitored by 
changes in emission wavelength (maximum at λmax), fluorescence quantum yield (Φ, the 
ratio of photons emitted by the fluorophore to the number absorbed), fluorescence decay 
rates, accessibility to quenchers (Stern-Volmer interactions), resonance-energy transfer 
(FRET), and other phenomena. Some of these properties are not variable and are useless; 
however, the λmax and Φ are highly variable among proteins and rely on the environment 
of the Trp(s).  
For proteins, like AaPurE1, containing multiple Trps (Figure 3.1), changes in 
fluorescence or shift of the λmax could result from a single-Trp fluorophore or could be 
due to contributions from several fluorophores. Single-Trp proteins, whether naturally 
occurring or engineered, are used to simplify the photophysics of an enzyme and allow 
one to link changes in intrinsic fluorescence to changes in the protein.4,6–12  
Fluorescence Responses are Difficult to Predict. Upon ligand addition, the intrinsic 
fluorescence of a protein may be enhanced, quenched, or remain unchanged. It is easy to 
measure fluorescence changes, but it is challenging to understand the photophysical 
origin of a particular fluorescence change. For instance Trp fluorescence quenching by an 
acceptor quencher can occur by electron transfer or nonradiative energy transfer.3,13 
Differentiation between the two types of quenching is important because we need to 
know what intermediates are in catalysis and how these could relate to Trp fluorescence 
quenching. 
 
Photo-excited indoles and indole derivatives such as Trp can be transiently oxidized 
leading to rapid quenching of fluorescence.14,15 The addition of an electron-withdrawing 
fluorine to the indole ring raises the ionization potential which makes oxidation difficult 




Trp Analogs. Trp analogs can be incorporated into a protein of interest by recombinant 
expression in a bacterial strain that is auxotrophic for Trp (Table 3.1 and Figure 3.2).17 
Fluorinated Trp analogs are often used as 19F NMR probes,18,19 but are also useful as 
fluorescence probes.20–24 If fluorescence changes occur due to electron transfer from the 
Trp indole, these should be diminished upon replacement by 5-fluorotryptophan (5FW).  
 
E. coli PurE1 and A. aceti PurE1 Have Opposite Fluorescence Responses to CAIR 
Binding. Mutation of the conserved active site His to a neutral amino acid eliminates 
PurE1 decarboxylase activity, allowing for the determination of CAIR dissociation 
constants (Kds) by fluorescence titrations. The fluorescence of EcPurE1-H45N or H45Q 
is strongly quenched by the addition of CAIR, but the fluorescence of AaPurE1-H59N or 
H59Q is moderately enhanced.25,26  
 
A. aceti (AaPurE1) and E. coli PurE1 (EcPurE1) have a 58% sequence identity and 
similar 3D structures.27 Each PurE1 contains multiple Trps, but AaPurE1 contains a Trp 
(Trp97) that has no equivalent in EcPurE1.  
 
This divergent effect of CAIR binding on fluorescence may be due to the additional Trp 
in AaPurE1 or a different nucleotide complex bound within the active site. EcPurE1-
H45N forms a complex containing CAIR (PDB codes 2nsl; H45Q is 2nsj), but AaPurE1-
H59N (PDB code 2fwp) contains the AIR•CO2 ternary complex (Figure 3.2). The 
different fates of CAIR suggest a difference between the two similar proteins. A variation 
in a polar side chain could explain the difference in bound nucleotide; however, no 
changes were observed within 10 Å of CAIR or AIR•CO2.  
 
Our working hypothesis is that the difference in fluorescence responses between the two 
forms of PurE1 is due to the presence of Trp97 in AaPurE1.  !
This chapter examines how each Trp fluorophore responds to ligand binding in both 
PurE1 and A. aceti. (AaPurE1) and PurE2 from T. denticola (TdPurE2). Once we  
 !
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understand the photophysical basis of Trp fluorescence changes of PurE1 and PurE2, we 
are positioned to use these fluorescence changes as a real time reporter of CC bond 
formation.  
 
3.2 Materials and Methods 
 
Materials. Chemicals were obtained from Sigma or Fisher in the highest purity available 
unless otherwise noted. CAIR was prepared as described in Chapter 1.28 AIR was 
synthesized from CAIR using Treponema denticola PurE2 (TdPurE2) and quantitated by 
Bratton-Marshall assay as described previously.29 Oligodeoxynucleotides (ODNs) were 
obtained from Integrated DNA Technologies and used without further purification. 
Restriction endonucleases, Q5 DNA polymerase, CIP, and T4 DNA ligase were obtained 
from New England Biolabs. Mutagenesis was accomplished using Quikchange 
Mutagenesis using kits (Agilent). Phenyl Sepharose CL-6B was obtained from Sigma 
Hydroxyapatite (Bio-Gel® HT) and Bradford reagent were obtained from Bio-Rad. PD-
10 desalting columns were obtained from GE Health Care.  
 
Methods. Protein concentrations were determined by the method of Bradford with bovine 
serum albumin as the standard.30 Protein concentrations of 5-fluorotryptophan containing 
proteins were determined by the method of Scopes by measuring protein concentrations 
at 205 nm in 0.1 M potassium sulfate, 5 mM potassium phosphate, adjusted to pH 7 with 
potassium hydroxide.31 Small-scale centrifugation steps were performed using an 
Eppendorf 5424 centrifuge. All other centrifugation steps were performed using a 
Beckman Avanti J-E centrifuge with a JLA-10.5 or JA-20 rotor. Cell disruption was 
performed by sonication using a Fisher Scientific Dismembrator 550 at 25% output, (1 
min each separated by 1 min cooling intervals) at 4 °C. Spectroscopic measurements 
were recorded on a Varian CARY-100 UV/Vis spectrophotometer thermostated by a 
Cary Dual Peltier Accessory temperature controller. Steady state fluorescence 
measurements were recorded on a Horiba Fluoromax-3 fluorometer thermostated with a 
Peltier Accessory and a Wavelength Electronics temperature controller. Data were 
 !
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analyzed using Origin (OriginLab, Northampton, MA) or using gnuplot 4.4 by T. J. 
Kappock. Plasmid DNA was sequenced by the staff of the Purdue University Genomics 
Core Facility. Full-length protein masses were determined by matrix-assisted laser 
desorption/ionization mass spectrometry (MALDI-MS) on a Voyager-DE PRO mass 
spectrometer (Applied Biosystems, Framingham, MA) by Connie Bonham. Liquid 
chromatography-mass spectrometry (LC-MS) was performed using an Accela HPLC 
system (Thermo) connected to a Finnigan LTQ mass spectrometer (Thermo) operated in 
positive ion mode by Tzu-Yi Yang. 
 
Standard Conditions for Q5 PCR. Standard PCRs (50 µL final volume) contained Q5 
DNA polymerase (1 unit), two ODNs (50 nmol each, Table 3.3), template DNA (14 ng), 
dNTPs (25 nmol each), MgCl2 (2 mM), and Q5 buffer (1x, proprietary components). PCR 
products were amplified with standard conditions: annealing temperature of 52 °C with a 
30 s hot start followed by melting, annealing, and extension times of 10 s, 30 s, and 30s 
for 25 cycles with a final extension time of 5 min. 
 
Standard Conditions for Quikchange PCR. Standard PCRs (50 µL final volume) 
contained PfuUltra polymerase (1 unit), two ODNs (50 nmol each, Table 3.3), template 
DNA (70 ng), dNTP mix (1 µL of proprietary stock concentration), and reaction buffer 
(1x, proprietary components). PCR products were amplified with standard conditions: 
annealing temperature of 52 °C with a 30 s hot start followed by melting, annealing, and 
extension times of 60 s, 60 s, and 8 min for 16 cycles with a final extension time of 7 
min. 
 
Construction of AaPurE1 Plasmids for Protein Expression. Plasmid pJK175 which 
encodes the wild-type AaPurE1 with an extra methionine and plasmid pJK283 which 
encodes the catalytically inactive AaPurE1-H59N were used as templates for the 
generation of mutants.26 Catalytically active mutants were generated using Quikchange II 
mutagenesis kits with plasmid pJK175 (70 ng) as template and an appropriate ODN pair 
(Table 3.3) to create plasmids pJK505 (AaPurE1-W34F), pJK506 (AaPurE1-W165F), 
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pJK507 (AaPurE1-W34F, W165F), pJK525 (AaPurE1-W34F,W97Y), pJK526 
(AaPurE1-W97Y,W165F), pJK559 (AaPurE1-W34F,Y154F,W165F), pJK562 
(AaPurE1- W34F,Y154L,W165F), pJK563 (AaPurE1-W34F,Y154I,W165F), pJK601 
(AaPurE1-Y154F), pJK603 (AaPurE1-W34F,Y154F), and pJK663 (AaPurE1-
Y154F,W165F). Catalytically inactive mutants were generated using Quikchange II 
mutagenesis kits with plasmid pJK283 (70 ng) as template and an appropriate ODN pair 
(Table 3.3) to create plasmids pJK508 (AaPurE1-W34F,H59N,W165F), pJK509 
(AaPurE1-W34F,H59N), pJK510 (AaPurE1-H59N,W165F), pJK600 (AaPurE1-
W34F,H59N,Y154F, W165F), pJK602 (AaPurE1-H59N,Y154F), pJK604 (AaPurE1-
W34F,H59N,Y154F), pJK664 (AaPurE1-H59N,Y154F,W165F), pJK665 (AaPurE1-
W34F,H59N,W97Y), and pJK666 (AaPurE1-H59N,W97Y,W165F). 
 
Construction of AaPurE1fwf Plasmid for Expression with T5 Promoter. A 0.2 kb product 
containing the T5 promoter32 was amplified using standard Q5 PCR conditions from 
template plasmid acs1 (25 ng), using ODNs 2410 and 2411. The PCR product was 
purified using a Qiagen PCR purification kit, digested with BglII and NdeI, and ligated 
into the same sites of the destination vector pJK507 to yield AaPurE1-W34F,W165F 
expression plasmid pJK698.  
 
Construction of TdPurE2–F79W Plasmid pJK648. A 0.32 kb primary PCR product 
containing purE2 was amplified using standard Q5 PCR conditions from template 
pJK376 (14 ng), using ODNs 2124 and 2329. The crude product was digested with DpnI 
and purified using a Qiagen PCR purification kit. A 0.421 kb primary PCR product 
containing purE2 was amplified using standard Q5 PCR conditions from template 
pJK376 (14 ng), using ODNs 2125 and 2330. The crude product was digested with DpnI 
and purified using a Qiagen PCR purification kit. Cross-over PCR product was obtained 
using standard Q5 PCR conditions, with a single exception: the annealing time was 
increased to 1 min, from a mixture containing primary PCR products (25 ng each) and  




and ligated into the same sites of the destination vector pET23a to yield TdPurE2-F79W 
expression plasmid pJK648.  
 
AaPurE1 Overexpression and Isolation. AaPurE1 was overexpressed and isolated 
according to a previously published protocol.26 BL21(DE3) cells transformed with the 
appropriate plasmid (Table 3.4 and Table 3.5) were grown to saturation at 37 °C in LB 
containing 100 µg mL-1 ampicillin (Amp). After a 1:50 dilution into fresh medium, cells 
were grown at 37 °C to OD600 = 0.6. IPTG (0.4 mM) was added and growth was 
continued for an additional 4 h. All subsequent steps were performed at 4 °C. Cells (4 g 
L-1 of culture) were harvested by centrifugation (5000 g, 15 min), resuspended in 50 mM 
Tris-HCl, 100 mM KCl, pH 8 (6 mL g-1 of cells), and disrupted by sonication. The lysate 
was cleared by centrifugation (30000 g, 30 min) and the supernatant adjusted to 1% 
streptomycin from a 10% (w/v) stock. Solids were removed by centrifugation (30000 g, 
30 min) and the supernatant adjusted to 35% saturation (208 g L-1) by the addition of 
solid ammonium sulfate over 30 min, with continuous stirring. After stirring overnight, 
solids were collected by centrifugation (30000g, 10 min). The pellet was redissolved in a 
minimal volume of 10 mM potassium phosphate, pH 8 (Buffer A) and applied in 2.5 mL 
portions to a PD10 column (1.5 × 5 cm) equilibrated in Buffer A. Desalted protein 
fractions were applied to a hydroxyapatite column (2.5 × 1.5 cm) equilibrated in Buffer A 
and AaPurE1 was eluted with 10 column volumes (CV) of Buffer A. Fractions containing 
AaPurE1, which does not adsorb to hydroxyapatite, were pooled and concentrated to > 3 
mg mL-1 with an Amicon ultrafiltration device containing a YM30 membrane. The 
protein solution was frozen by drop-wise addition to liquid N2 and stored at -80 °C. 
 
Mutant AaPurE1 Overexpression and Isolation. All AaPurE1 forms were overexpressed 
and isolated as detailed above for wild-type AaPurE1.26 Fresh column media were used 
for each mutant to avoid any possibility of cross-contamination. AaPurE1 mutants were 
concentrated to >3 mg mL-1 with an Amicon ultrafiltration device containing a YM30 




Biosynthetic Incorporation of the 5FW Analog in AaPurE1fwf. AaPurE1fwf was 
overexpressed by adapting previously published protocols.18,33 DL41 cells transformed 
with plasmid pJK698 and pCDFDuet (to incorporate the lacI gene)34 were grown on LB 
+ 1% glucose medium containing 100 µg mL-1 ampicillin and 100 µg mL-1 streptomycin 
(LB-Amp/Stm). A single colony was used to inoculate a LB-Amp/Stm + 1% glucose 
culture (5 mL) that was grown to OD600 = 0.8 at 37 °C. Cells were harvested by 
centrifugation (2500 g, 10 min), resuspended in sterile glycerol (1 mL; 50% v/v) and 
stored at -80 °C. A LB-Amp/Stm + 1% glucose culture (50 mL) was inoculated from the 
frozen stock, grown to an OD600 = 0.8, and harvested by centrifugation (2500 g, 10 min). 
Cells were resuspended in sterile glycerol (5 mL 50% v/v) and stored at -80 °C. The 
larger frozen starter culture was used to inoculate a M9 minimal media-Amp/Stm + 0.5% 
glucose culture (1L) supplemented with amino acids (40 mg L-1 of each amino acid in 
water; prepared by weighing out each amino acid separately and adjusting to pH to 7 with 
sodium hydroxide) and thiamine (0.01 mM) and grown at 37 °C until OD600 = 0.5. Cells 
were washed twice with 0.9% NaCl (250 mL) and resuspended into fresh M9 minimal 
media-Amp/Stm (1L) supplemented with amino acids (40 mg L-1 of each amino acid 
except tryptophan; prepared as above), DL-5-fluorotryptophan (100 mg L-1), and 
thiamine (0.01 mM). The resuspended culture was incubated for 10 min before IPTG 
addition (1 mM) and grown at 37 °C for an additional three hours before harvesting the 
cells by centrifugation (5000 g, 15 min). AaPurE1fwf-5FW was isolated as wild-type 
AaPurE1.26  
 
Mutant TdPurE2 Overexpression and Isolation. TdPurE2-F79W was overexpressed and 
isolated like wild-type TdPurE2.29 CC1215 cells transformed with plasmid pJK648 and 
were grown to saturation at 37 °C in MGD media35 containing 100 µg mL-1 ampicillin 
(Amp). After a 1:100 dilution into fresh ZYM 5052-Amp35 medium, cells were grown at 
37 °C for 4.5 h and shifted to 15 °C for an additional 16 h. All subsequent steps were 
performed at 4 °C. Cells (4 g L-1 of culture) were harvested by centrifugation (5000 g, 15 
min), resuspended in 50 mM Tris-HCl, 100 mM KCl, pH 8 (5 mL g-1 of cells), and 
disrupted by sonication. The lysate was cleared by centrifugation (30000 g, 30 min), and 
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the supernatant adjusted to 1% streptomycin from a 10% (w/v) stock. Solids were 
removed by centrifugation (30000 g, 30 min), and the supernatant adjusted to 70% 
saturation (472 g L-1) by the addition of solid ammonium sulfate over 30 min with 
continuous stirring. After stirring overnight, solids were pelleted by centrifugation 
(30000g, 10 min). The supernatant was applied in to a Phenyl Sepharose column (2.5 × 8 
cm) equilibrated in 20 mM Tris-HCl, 1.5 M ammonium sulfate, pH 8 (Buffer B). The 
column was washed with 5 CV of Buffer B and then developed with a linear gradient of 
Buffer B to 20 mM Tris-HCl, pH 8 (Buffer C) (10 CV x 10 CV). Fractions containing 
TdPurE2 were pooled and buffer exchanged into Buffer C with an Amicon ultrafiltration 
device containing a YM30 membrane. The desalted TdPurE2 solution was then applied 
to a hydroxyapatite column (2.5 × 3 cm) equilibrated in 10 mM phosphate, pH 8  (Buffer 
A). The column was washed with 5 CV of Buffer A and developed with a linear gradient 
of Buffer A to 500 mM phosphate, pH 8 (10 CV x 10 CV). Fractions containing TdPurE2 
were pooled, buffer-exchanged into Buffer A, and concentrated to > 3 mg mL-1 with an 
Amicon ultrafiltration device containing a YM30 membrane. The protein solution was 
frozen by drop-wise addition to liquid N2 and stored at -80 °C. 
 
PurE1 and PurE2-mediated Decarboxylation Assays. Continuous assays of PurE1- or 
PurE2-mediated CAIR decarboxylation were performed according to a published 
method.26 A final volume of 0.6 mL in a masked, 1 cm pathlength cuvette containing 50 
mM Tris-HCl, pH 8 and 100 µM CAIR was incubated at 30 °C for at least 3 min. 
Reactions were initiated by addition of either an AaPurE1 or TdPurE2 mutant (12-80 ng, 
1.4-8.4 nM [subunits]). The initial velocity of CAIR decarboxylation to AIR (∆ε260 
=8930 M-1 cm-1) was recorded at 260 nm, with a small background decarboxylation rate 
subtracted. CAIR was quantitated by endpoint assay using the same method, except that 
50 µg mL−1 TdPurE2 was the enzyme. A unit is defined as the amount of enzyme that 
forms 1 µmol of product per minute. 
Quantum Yield Determinations. Quantum yields of AaPurE1fwf and AaPurE1fwf-5FW 
were determined according to a previously published protocol.4 Fluorescence emission 
spectra were recorded at 25 °C using an excitation wavelength of 295 nm and slit widths 
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of 1.5 nm (excitation) and 5 nm (emission). A buffer only-spectrum was subtracted from 
as the background from all spectra. To calculate the quantum yield, the unobservable 
portions of the spectra were estimated by obtaining a spectrum using a lower excitation 
wavelength (280 nm) and normalizing the maxima to spectra obtained with an excitation 
of 295 nm. These normalized 280nm spectra were then used to estimate the unobservable 
area. The normalized spectra were superimposable with the spectra obtained from 
excitation at 295 nm. The integrated fluorescence intensity was determined using the 
peak analyzer module in Origin (OriginLab, Northampton, MA). Quantum yields were 
determined using equation 3.1, where Φ and is the quantum yield, OD is the absorbance 
at 295 nm, and ! is the refractive index of the solution, with the subscript R denoting the 
reference sample.3,36 
Φ = !!! !!! !!"!!" !!!!!!        Equation 3.1 
Quantum Yield Determinations with Ligands. Quantum yields of AaPurE1fwf and 
AaPurE1fwf-5FW with citrate or AIR (present at 5 times Kd 0.014-1 mM citrate and 2.5-7 
µM AIR) were determined according to above protocol for AaPurE1fwf-5FW with one 
exception: citrate bound spectra were obtained in 50 mM potassium acetate, 100 mM 
KCl, pH 4.6 at 25 °C. NATA emission spectra were recorded with each ligand and the 
integrated fluorescence was corrected for any inner filter effect. 
 
EcPurE1 Single-Trp Fluorescence Emission Spectra. Fluorescence emission spectra were 
recorded using an excitation wavelength of 295 nm and slit widths of 2 nm (excitation) 
and 5 nm (emission). Spectra were recorded in a 1 cm pathlength fluorometer cell that 
contained 30 µM EcPurE1-W20F or EcPurE1-W151F (isolated by S. Tranchimand) in 50 
mM Tris, pH 8 in a total volume of 2 mL. 
 
Fluorescence Titrations. Spectra were obtained using a 1 cm pathlength fluorometer cell 
that contained 2.0 mL prior to the titration. The excitation wavelength was 295 nm (2 nm 
slit width) and emission spectra were collected from 305 to 450 nm (5 nm slit width). A 
buffer only-spectrum was subtracted from as the background from all spectra. The 
 !
62 
intensity of the fluorescence emission F for each titration point was measured at 320 nm 
and then corrected for dilution. 
 
Citrate Titrations (0-25 mM final concentration, added from a 200 mM stock, pH 4.6) 
were performed in 50 mM potassium acetate, 100 mM KCl, pH 4.6, with varying 
amounts of AaPurE1 or TdPurE2 at 25 °C. Emission intensities at 320 nm (F) were 
divided by the intensity at zero ligand (L) concentration (F0) to obtain fractional 
saturation values. The AaPurE1 titration data were fit using gnuplot 4.4 and TdPurE2 
were fit using Origin to a binding isotherm (equation 2.2) by allowing Kd and ΔF (the 
value of F/F0 as [L] →∞) to vary. 
!!! = 1− ΔF! [!][!]!!!        Equation 3.2 
AIR titrations (0-25 µM final concentration, added from a 600 µM stock in 50 mM Tris-
HCl, pH 8) were performed in 50 mM Tris-HCl, pH 8 with varying amounts of AaPurE1 
or TdPurE2 at 30 °C. Emission intensities at 320 nm (F) were divided by the intensity at 
zero ligand (L) concentration (F0) to obtain fractional saturation values. The TdPurE2 
data were fit using Origin to a binding isotherm (equation 3.2) by allowing Kd and ΔF 
(the value of F/F0 as [L] →∞) to vary. AaPurE1 titration data were, with the exception of 
AaPurE1fyw-H59N, fit using gnuplot 4.4 to a binding isotherm that accounts for ligand 
depletion (equation 3.3) assuming that AIR binds to a maximum of half the enzyme 
subunits (E =0.5[subunit]). The half-sites assumption is based upon the observation that 
only four AIR molecules bind to a single face of the AaPurE1 octamer (PDB id 2fwj). 26  
!!! = 1+ !!! ! !! + ! + !! − !! + ! + !! ! − 2!" !!!!!!!!Equation 3.3 
CAIR titrations (0-25 µM final concentration, added from a 600 µM stock in 50 mM 
Tris-HCl, pH 8) were performed in 50 mM Tris-HCl, pH 8 with varying amounts of 
AaPurE1 at 30 °C. Emission intensities at 320 nm (F) were divided by the intensity at 
zero ligand (L) concentration (F0) to obtain fractional saturation values. The titration data 
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were, with the exception of AaPurE1fyw-H59N, fit using gnuplot 4.4 to a binding 
isotherm that accounts for ligand depletion (equation 3.3). 
Solution Studies of AaPurE1s. Solution aggregation state was determined on an AKTA 
FPLC system (Amersham) using a Pharmacia G200-16/60 high-load column. The mobile 
phase was 50 mM Tris-HCl, 100 mM KCl, pH 8 that was applied at 1 mL min-1. 
Injections (100 µL) contained 0.5 mg of protein adjusted to 5% (v/v) glycerol. Protein 
solution sizes and aggregation states were determined by comparison with protein size 
standards (29-669 kDa; Sigma MW-GF-1000), blue dextran (2 MDa; Vo), and acetone 
(60 Da, Vi) using the Kav partition coefficient method 37. 
 
Crystallization of AaPurE1s. AaPurE1 forms intended for crystal production were buffer 
exchanged into 5 mM Tris-HCl, 15 mM NaCl, pH 8 and concentrated to 10 mg mL-1 
using Millipore Ultra spin columns (MWCO 30000). Crystals were grown by the hanging 
drop vapor diffusion method using reservoir solutions containing 25-35% PEG 4000, 200 
mM LiSO4, 100 mM Tris-HCl, pH 8.3.  
 
X-ray Data Collection and Processing. Prior to data collection, crystals were placed 
briefly into a cryoprotectant solution that consisted of artificial mother liquor with an 
additional 2% PEG 4000 and 15% (v/v) ethylene glycol. Crystals were immediately 
flash-cooled in liquid N2. X-Ray diffraction data were collected on either a MAR-225 or 
MAR-300 CCD detector at the LS-CAT beamline (Advanced Photon Source - Argonne 
National Laboratory). Diffraction data were indexed, integrated, and scaled with HKL-
2000. 
 
Crystals used for subsequent mass spectrometric analysis were subjected to irradiation at 
the LS-CAT beamline, by collecting 360 frames with a delta of 1 degree.  
 
Structure Determination and Refinement. All crystals had the same space group with 
similar unit cell parameters, previously observed in structures of AaPurE1.26,27 Molecular 
replacement was performed using AutoMR/Phaser38 with the AaPurE1 monomer (PDB 
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code 2fw1 chain A) as the search model. Structures for AaPurE1-Y154F, AaPurE1fwf-
Y154F, and AaPurE1fwf-Y154L were determined by using the AaPurE1fwf monomer 
(PDB code 4ycb) as the search model. First, 15 rounds of TLS with all B-factors set to 30 
were performed followed by subsequent rounds using rigid body, TLS, Cartesian 
coordinate optimization, individual isotropic temperature factor refinement, and 
automatic water picking in PHENIX.39 Later rounds of refinement were performed using 
Cartesian coordinate optimization, individual isotropic temperature factor refinement, 
TLS, and occupancy refinement. Model building, manual inspection, and rebuilding were 
performed using Coot.40 Coordinates and structure factors have been deposited in the 
RCSB Protein Data Bank (PDB) with accession numbers 4ycb (AaPurE1fwf), 4ycc 
(AaPurE1fwf-Y154L), 4ycd (AaPurE1fwf-Y154F), and 4ycj (AaPurE1-Y154F). Figures 
were prepared using PyMOL.41  
 
Previously deposited models of AaPurE1s lack a hydrogen bond between the Asn78 
carboxamide oxygen and the Tyr154 phenol.26,27 For comparison with the newly obtained 
structures, structure factors were obtained from EDS, the Asn78 side chain was flipped, 
and a single round of one round of refinement performed using Cartesian coordinate 
optimization, individual isotropic temperature factor refinement, and occupancy 
refinement.  
 
Mass Spectrometry of AaPurE1fwf. Each AaPurE1 form (0.8 mg) was dried and 
resuspended in 50 µL of 70% (v/v) formic acid containing 0.5 M cyanogen bromide. 
After 24 h at room temperature, the solvent was removed in a rotary evaporator. Solids 
were dissolved in 80 µL of 50 mM ammonium bicarbonate and a portion (20 µL) was 
mixed with trypsin (2 µg, Sigma proteomics grade from pig pancreas T6567) in a final 
volume of 120 µL. After 18 h at 37 °C, 100 µL of 0.1% formic acid was added and the 
reaction mixture was lyophilized, and stored at -80 °C. Dried peptide samples (~2 µg) 
were resuspended in 25 µL of water:acetonitrile:trifluoroacetic acid (50:50:0.1 ratio) and 




(Kinetex 1.7 µ, 50 x 2.10 mm; Phenomenex) that was developed at 0.5 mL min-1 in a 
linear gradient of acetonitrile (5-65%) in 0.1% formic acid. 
 
Mass Spectrometry of Dissolved AaPurE1fwf Crystals. Crystals of AaPurE1s were 
prepared for mass spectrometric analysis by adapting a published method.42 Cryo-cooled 
AaPurE1 and AaPurE1fwf crystals were washed twice with acetonitrile and dissolved in 
10 mM potassium phosphate, pH 8. The dried protein was then digested and analyzed as 




Creation and Isolation of EcPurE1 Mutants. EcPurE1 single-Trp mutants were generated 
by Yi Li and isolated by Sylvain Tranchimand to investigate the fluorescence response of 
each individual Trp fluorophore upon ligand binding  
 
Fluorescence Emission Spectra of EcPurE1 Single-Trp Mutants. EcPurE1 was previously 
used to elucidate mechanistic details of the reaction catalyzed by PurE1.25 EcPurE1 
contains two Trp residues per monomer and like AaPurE1 it would be advantageous to 
use a single-Trp form.  
 
Fluorescence emission spectra were obtained for single-Trp mutants of EcPurE1. The 
single-Trp EcPurE1 forms have a 7 nm difference in λmax (EcPurE1-W20F λmax = 330 nm 
and EcPurE1-W151F λmax = 337 nm) indicating the Trps occupy different local 
environments (Figure 3.5). This does not occur with the corresponding AaPurE1 single-
Trp mutants, which do not display significant shifts in λmax (Appendix Figures A1-A22). 
 
Another caveat unique to the EcPurE1 single-Trp forms is the large amount of enzyme 
necessary to produce adequate signal (30 µM subunit concentration). This concentration 
is 40 times higher than used for wild-type EcPurE1 titrations.25 Therefore, we could not 
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perform fluorescence titrations to determine the fluorescence response of each Trp to 
ligand addition.  
 
Creation of AaPurE1 Mutants. AaPurE1 Trp mutants were generated to investigate the 
fluorescence response of each individual Trp fluorophore upon ligand binding. AaPurE1 
Tyr mutants were generated in an effort to resolve the structural ambiguity observed in 
the AaPurE1fwf structure. Quikchange site directed mutagenesis was successful in 
generating a suite of combinatorial Trp and Tyr mutants (Table 3.3).  
 
Purification of Recombinant AaPurE1s. The previously published isolation protocol26 
was successfully used to isolate all AaPurE1 forms with varying specific activites and 
high purity (Table 3.6, Figure 3.4 and Figure 3.5).  
 
Identities of each AaPurE1 form were also established by MALDI analysis (Table 3.4). 
Five full-length forms of AaPurE deviated from the excepted mass by more than 3 Da. 
AaPurEwwf-H59N was 5 Da higher, AaPurEwwf-H59N,Y154F was 8 Da lower, 
AaPurEyfw-H59N was 7 Da higher, AaPurEfyw was 8 Da lower, and AaPurEfyw-H59N was 
4 Da higher than expected. !
Physical Characterization of AaPurE1s. Analytical size exclusion chromatography was 
used to determine the biological unit and relative stabilities of the AaPurE1 mutant forms. 
Gel-filtration analyses confirmed the presence of the PurE1 octamer for all forms, but 
also high molecular weight aggregate. The amount of aggregation roughly correlates to 
the number of mutations in each form (Figures 3.8, 3.9, and 3.10). AaPurE1s lacking 
Trp34 and Trp165 appear to be associated with increased aggregate, whether in a single 
or multiple Trp form. Forms lacking Trp165 also appear to dissociate into tetramers as 
evidenced by a peak at ~76 Da (Figure 3.9 and 3.10). Despite having an increased portion 
of aggregate, it was possible to crystallize all forms with two exceptions: any proteins 
lacking Trp97 and the quadruple mutant AaPurE1fwf-H59N, Y154F. !
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Kinetic Parameters of AaPurE1s. All proteins containing the critical active site His retain 
at least 50% of wild-type activity. The AaPurE1 forms that have lower relative specific 
activites tend to dissociate in solution studies (Table 3.7 and Figures 3.8-3.10). The 
W79Y AaPurE forms had the lowest activity, indicating this form is especially unstable. 
Structure of AaPurE1fwf. The crystal structure of AaPurE1fwf was obtained to aid in 
interpretation of single-Trp fluorescence data. This single AaPurE1fwf crystal resulted in 
the highest resolution data set of any available PurE1 (PDB code 4ycb) (Table 2.8 and 
2.9). At 1.35 Å, there is a great level of detail; the dimer in the asymmetric unit contains 
25 residues with alternative conformations (including Trp97), a PEG molecule 
coordinated to potassium, several ethylene glycols, and acetate.  
 
The previously deposited AaPurE1 structure (PDB code 1ull) was aligned with 
AaPurE1fwf and root-mean squared differences (RMSDs) calculated for all residues 
within 10 Å of the all three Trp residues. No significant difference in the environment is 
observed when the Trps are replaced by Phes: residue 34, 0.24 Å; residue 97, 0.22 Å; and 
residue 165, 0.22 Å. Trp97 is present in both structures and has an RMSD between 
structures that is equal or similar to the Phe34 and Phe165 replacements. The Phe/Trp 
replacements do not appear to alter the surrounding structure (Figure 3.11). This is 
beneficial for interpretation of single-Trp fluorescence data, because the environment 
surrounding the Trp replacements has not been notably changed. !
Another observation unique to the high resolution AaPurE1fwf structure is that the 
orientation Asn78 side chains in previously deposited structures, 26,27 should be flipped. 
This new orientation allows the Asn78 carboxamide to form a hydrogen bond with the 
Gly76 backbone carbonyl oxygen. The Asn78 is likely a hydrogen bond acceptor for 
Tyr154 from the same subunit, thus creating a “chain” of hydrogen bonds. 
 
Tyr154s at the Dimer Interface. The most puzzling residues within AaPurE1fwf are two 
Tyr154s, from adjacent subunits, that sit at the dimer interface. An iterative-build 
simulated annealing composite omit map43 appears to contain continuous electron density 
across the dimer interface and incomplete density for some Tyr154 atoms. Fo –Fc 
 !
68 
difference maps show positive density peaks between the CE2 atoms at the interface, and 
negative peaks for CD1, CE1, and OH of the phenol (Figure 3.12 panel C). Residue 68 is 
the only other Tyr in AaPurE1, which has excellent electron density in both subunits 
consistent with an unmodified residue (Figure 3.13). Any molecule that could be derived 
from Tyrs at the dimer interface, which fits to the density, had unrealistic bond lengths 
and angles (data not shown).  
To study the ambiguous density at the dimer interface, mutations were introduced at 
position 154. Structures were obtained for AaPurE1-Y154F (PDB code 4ycj), AaPurE1-
Y154L (PDB code 4ycc), and AaPurE1fwf-Y154F (PDB code 4ycd) (Table 2.8 and 2.9). 
In stark contrast to Tyr154 structures, those containing a Phe at position 154 had clear 
unambiguous density for the benzene ring with real space correlation coefficients 
(RSCCs) near unity (Table 3.10 and Figure 3.12). The structure containing Leu154 was 
less ordered and is populated by multiple rotamers (Figure 3.12 panel F).  
A single deposited AaPurE1-H59F structure (PDB code 2fw9) contains Tyr154s that 
superimpose on the Phe154s (PDB codes 4ycd and 4ycj) and make hydrogen bond 
contacts with the Asn78s (Figure 3.12, panels B, D, and E). This structure and the Phe154 
position provided the prototypal Tyr poses. In this prototypal pose, the Tyr phenols are 
almost perpendicular in almost parallel planes with a dihedral of 87° between the Cβ-OH 
axes. The phenol oxygen makes a hydrogen bond contact to the Asn78 carboxyamide as 
discussed prior. In addition to the prototypal pose, each Tyr154 has an alternative 
conformation. Tyr154 from subunit A reaches across the dimer interface and occupies the 
density previously assigned to the cross-link. Tyr154 from subunit B is pointed out into 
solvent (Figure 3.12, panel C).   
 
The first assumption about the Tyr154 chemical identity was it might be a tyrosine 
derived cross-link spanning the dimer interface. Dityrosine and isodityrosine crosslinks 
are common structural features and oxidative stress markers in proteins44–48 and 
formation of radiation-induced Tyr dimerization in solution has been observed.49 The 
chemical structure consistent with the observed electron density in AaPurE1fwf is not 
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dityrosine or isodityrosine. The crosslink is not evident in solution; the protein always 
runs as a monomer on SDS-denaturing page gels (Figure 3.5), and LC-ESI-MS analyses 
show the expected mass for non-cross-linked peptides of AaPurE1, AaPurE1-Y154F, 
AaPurE1fwf, and AaPurE1fwf-Y154F (Figures 3.14-3.17). 
Inspection of the AaPurE1 structures deposited in the PDB revealed that all contain some 
extent of disorder at Tyr154 (Figure 3.23). Tyr154 RSCCs average 0.91 in all AaPurE1 
models (Table 3.10). The source of radiation and crystallization conditions had no clear 
effect on Tyr154 RSCC.  
 
Fortunately, for direct comparison, two data sets were collected on a single AaPurE1fwf 
crystal. The first data set was collected on home source and a second at the 
synchronotron. Electron density was similar at the Tyr154 for both home source and 
synchronotron data sets. In addition, comparison of early to late frames of synchrotron 
data showed no difference in electron density (data not shown). Therefore, the “damage” 
or density that spans across the subunit interface is always present regardless of the type 
of energy the crystal is exposed to. 
 
Crystals of AaPurE1 and AaPurE1fwf (radiated and un-radiated) were dissolved, run on 
SDS-denaturing page, and visualized with silver staining. These ran exclusively as 
monomers (Figure 3.18). LC-ESI-MS analysis of radiated crystals did not produce 
useable signal (data not shown). LC-ESI-MS analysis of dissolved and digested un-
radiated crystals of AaPurE1 show no evidence of a cross-link, only peptides 
corresponding to Tyr154 were observed (Figure 3.19).  
 
Citrate Titrations of AaPurE1s. Citrate is a non-substrate active site ligand that binds 
AaPurE1 weakly, under acidic conditions, leading to protein fluorescence quenching.26 
While it has little resemblance to CAIR, citrate interacts with the protonated form of the 
key His59 and all nucleotide-binding residues, except for the phosphate contact Ser32 
and the exocyclic amine contacts in the 70s loop backbone. Therefore, titrations were 
carried out in 50 mM potassium acetate, 100 mM KCl, pH 4.6 with all AaPurE1 forms to 
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determine the fluorescence response of each mutant upon citrate addition. It is possible 
that the acidic conditions destabilize the multiple-mutant variants more than others.  
The fluorescence of all forms of AaPurE1s, with the exception of AaPurE1fyw-H59N, was 
quenched by the addition of citrate (Table 3.7, Figure 3.20, and Appendix Figures A.1-
A.21). A comparison the single-Trp AaPurE1 mutants shows Trp34 and Trp165 have 
opposing effects on fluorescence, and that most of the quenching is due to Trp97. 
Interestingly, we do not observe the enhancement of Trp165 fluorescence unless an 
inactive mutant is used. 
The inactive AaPurE-H59N mutants show similar trends, but have lower citrate affinity 
and a smaller quenching magnitude (Figure 3.20). The effect of H59N on fluorescence 
quenching depends on the Trps present: H59N is associated with less quenching of Trp 
fluorescence upon citrate binding, unless Trp97 and Trp165 are both present.  
Surprisingly, AaPurE1 forms containing the Y154F mutation had diminished quenching 
intensity, suggesting that it enhances the quenching of Trp97 fluorescence (Figure 3.12).  
 
AIR Titrations of AaPurE1s. AIR is not a substrate for PurE1, it instead acts as a non-
competitive inhibitor.50 The addition of AIR to EcPurE1 does not result in an observable 
fluorescence change,25 and it is small for AaPurE1 (C. Z. Constantine, unpublished 
observations). This small increase in fluorescence proved to be the result of a fluorescent 
species present in AIR (Chapter 2), which was derived from CAIR that had been 
synthesized using LiOH mediated saponification procedure.28 To minimize the 
contribution of the fluorescent species to saturation plots, titrations were performed using 
an emission wavelength of 320 nm, which has less contribution from the fluorescent 
species than at the AaPurE1 λmax of 338 nm. 
AIR titrations were carried out in 50 mM Tris-HCl, pH 8.0 to determine the fluorescence 
response of proteins containing only one Trp to determine which Trp fluorophore is the 




The addition of AIR to AaPurE1 or single-Trp AaPurE1 mutants had little or no effect on 
fluorescence emission intensity (Table 3.7, Figure 3.21, and Appendix Figures A.1-
A.21).  
A much larger change was observed for the addition of AIR to inactive forms containing 
H59N (Figure 3.21). The H59N forms are impaired at binding AIR relative to active 
AaPurE1s. Single-Trp AaPurE1-H59N mutants showed approximately equal 
contributions from Trp34 and Trp97 to fluorescence enhancement, with Trp165 having a 
smaller quenching response.  
The obvious difference between the inactive and active forms is presence of His59. This 
critical active site residue influences the overall fluorescence change and likely 
camouflages the fluorescence enhancement seen in the inactive forms.  
The AaPurE1 forms containing the Y154F mutation had no effect on AIR titrations 
(Figure 3.21). Tyr154 has a slight effect with citrate and a marked effect with CAIR. The 
electrostatic properties of the ligand may determine if Tyr154 has an effect on Trp97. 
CAIR Titrations of Inactive AaPurE1s. CAIR is a substrate for the decarboxylation 
reaction catalyzed by PurE1, and its addition results in an enhancement of AaPurE1-
H59N fluorescence.25 Conversely, CAIR addition to EcPurE1-H59N quenches 
fluorescence. Therefore, CAIR titrations were carried out in 50 mM Tris-HCl, pH 8.0 to 
determine the response of each AaPurE1 Trp fluorophore to CAIR addition.  
The addition of CAIR to AaPurE1-H59N and single-Trp variants showed a similar trend 
as the AIR titrations, with positive contributions from Trp34 and Trp97 and a quenching 
contribution from Trp165 (Table 3.7, Figure 3.22, and Appendix Figures A.1, A.4-6, A.9-
10, A.13, A.15, A.18-20).  
Mutant AaPurE1 Kds were slightly higher than AaPurE1-H59N with the exception of 




The Y154F mutation had a complicated effect, with enhancement relative to AaPurE-
H59N, suppression for two-Trp mutants, and elimination of the fluorescence 
enhancement of AaPurEfwf-H59N (Table 3.7, Figure 3.22, and A.1, A.4-6, A.9-10, A.13, 
A.15, A.18-20). 
Identification of the Primary Emitter. A primary emitter is defined as the fluorophore that 
is the most sensitive to ligand binding. There are three Trps within AaPurE1; however, 
results indicate that Trp97 which, is not conserved in EcPurE1, is the primary 
fluorophore. Therefore, further studies reported here will focus on Trp97 (or its 
equivalent in TdPurE2). 
 
Generation of AaPurE1fwf Containing 5FW. Incorporation on 5FW can be used to 
determine the quenching mechanism associated with the primary emitter Trp97. The 
addition of an electron-withdrawing fluorine to the indole ring of Trp raises the ionization 
potential which should suppress quenching due to electron transfer.16 A diminution in 
fluorescence! quenching upon incorporation of 5FW, would indicate if electron transfer 
from the Trp indole is responsible. 
 
Creation of AaPurE1fwf Plasmid with a T5 Promoter. AaPurE1 is normally produced 
using a T7 system in BL21(DE3) cells, however this system does not tightly control 
protein expression prior to induction. The successful incorporation of a 5FW analog into 
AaPurE1fwf with a high yield requires tight expression control. Therefore, we created an 
AaPurE1fwf plasmid with a T5 promoter to for protein expression in a DL41 Trp 
auxotrophic strain. Standard molecular biology techniques were used to successfully 
generate the AaPurE1fwf plasmid under the control of a T5 promoter (Table 3.3).  
 
Expression and Isolation of AaPurE1fwf with 5FW. Control of induction is critical for 
successful 5FW analog incorporation. The plasmid pCDFDuet, which contains the lacI 
gene, was co-transformed with plasmid pJK698 to ensure AaPurE1fwf expression was 
tightly controlled. Adding lacI cultures, which in addition were supplemented with 
excess glucose (to suppress plasmid expression) and kept in log phase was necessary to 
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control AaPurEfwf expression. These combined strategies allowed for the expression of 
AaPurEfwf-5FW in DL41 cells without detectable protein expression until IPTG induction 
(Figure 3.23).  
 
AaPurE1fwf-5FW was successfully isolated using the previously published isolation 
protocol26 with relatively high specific activity and purity (Figure 3.5-lane 21). To 
confirm incorporation of 5FW, full-length proteins were analyzed by MALDI mass 
spectrometry (Table 3.6). Only peaks corresponding to AaPurE1fwf-5FW were observed 
and no signal corresponding to unlabeled AaPurE1fwf was identified (data not shown).  
 
Absorbance and Fluorescence Emission Spectra of AaPurE1fwf. The incorporation of 
5FW into AaPurE1fwf should have an effect on the absorbance and fluorescence emission 
spectra. Absorbance spectra were obtained in 50 mM Tris-HCl, pH 8.0 containing either 
AaPurE1fwf (168 µg mL-1) or AaPurE1fwf -5FW (123 µg mL-1) present and the same 
solution was used to obtain fluorescence emission spectra with excitation at 295 nm. 
AaPurE1fwf-5FW has shifted λmax values for both absorbance and fluorescence emission 
spectra relative to AaPurE1fwf, with a large difference in the Stokes shift (AaPurE1fwf  λmax 
= 277 nm and 366 nm, and AaPurE1fwf -5FW λmax = 264 nm and 341 nm; for absorbance 
and fluorescence respectively) (Figure 3.8). This indicates that 5FW was successfully 
incorporated and suggests a difference in local environment for the residue at position 97, 
or a small structural change in AaPurE1fwf-5FW. All attempts to obtain a crystal structure 
of AaPurE1fwf -5FW resulted in poor diffraction.  
 
Replacement of Trp with of 5FW analog typically results in a red shift of the 
fluorescence emission spreturm.16,21,51 However, the AaPurE1fwf-5FW emission spectrum 
is blue shifted by 5 nm. This change could be due to rearrangement of residues in close 
proximity to the Trp or a conformational change somewhere else in AaPurE1fwf-5FW. 
Quantum Yields of AaPurE1s. We obtained the λmax for absorbance and fluorescence 
emission of AaPurE1fwf -5FW, next we wanted to obtain the other variable fluorescence 
property, quantum yield. The AaPurE1fwf -5FW quantum yield was about twice that of 
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AaPurE1fwf (Figure 3.9, Table 3.6). This was surprising, as the quantum yield of 5FW is 
the same as the Trp in solution (Table 3.1).36 The environment surrounding 5FW in 
AaPurEfwf may significantly enhance the quantum yield. Two possibilities exist to 
enhance a quantum yield, either a positive charge is relocated near the benzene ring of 
Trp97 or some intramolecular quenching group such as an amide is removed. However, 
we do not have a crystal structure to examine either of these possibilities. 
Quantum yields of AaPurE1s with Ligand Bound. If quenching of Trp97 fluorescence 
occurs by electron transfer, then quantum yields with 5FW incorporated should be 
diminished. Quantum yields for AaPurE1fwf and AaPurE1fwf -5FW were recorded in the 
presence of either AIR or citrate (5 times the Kd). Citrate and AIR had no or very little 
inner filter effect (0-4%) on the integrated fluorescence intensity of NATA (data not 
shown). Quantum yields for AaPurE1fwf were determined using equation 3.1, after 
correcting the integrated fluorescence values for any inner filter effect. 
If ligand dependent quenching of Trp97 fluorescence is due to electron transfer, we 
expect to see a lower quantum yield in AaPurE1fwf-5FW with citrate present. However, 
the overall change in fluorescence observed in the presence of citrate is higher for 
AaPurE1fwf-5FW (Table 3.11), indicating that fluorescence quenching does not occur by 
electron transfer from the Trp indole.  
We see the same effect when AIR is present (AaPurE1fwf-5FW quantum yield is not 
diminished).  
Citrate Titrations of AaPurE1fwf-5FW. AaPurE1fwf-5FW was quenched to about the same 
extent as AaPurE1fwf. Incorporation of the 5FW analog produced very different binding 
parameters, the citrate Kd for AaPurE1fwf-5FW is 88 times lower than AaPurE1fwf (Table 
3.7 and Figure 3.26). Incorporation of 5FW may alter the environment of the active site, 
which could lead to increased affinity. 
 
AIR Titrations of AaPurE1fwf-5FW. Little increase in fluorescence occurred in 
AaPurE1fwf-5FW upon AIR addition, which is consistent with data for other active PurE1 
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forms (Figure 3.27). Incorporation of 5FW reduced the AaPurE1fwf-5FW Kd 2.8 times 
lower than AaPurE1fwf (Table 3.7). Incorporation of 5FW alters the affinity of AaPurE1fwf 
for both AIR and citrate. Again, indicating 5FW may alter the environment of the active 
site, which may lead to increased affinity. 
 
Mechanism of Ligand-Dependent Trp97 Fluorescence Quenching. The replacement of 
Trp97 with 5FW was used to probe the mechanism of ligand-dependent fluorescence 
quenching. No diminution in fluorescence upon ligand binding was observed in either 
quantum yield determinations or titrations with AIR or citrate. The results indicate that 
quenching occurs by non-radiative processes and not electron transfer.  
 
Creation of TdPurE2-F79W Mutant. TdPurE2 does not contain any Trp residues. 
Therefore, a TdPurE2 Trp introduction mutant (analogous to Trp97) was generated to 
investigate the fluorescence response of the Trp fluorophore upon ligand binding. 
Quikchange site directed mutagenesis repeatedly failed and instead cross-over PCR was 
employed to generate the TdPurE2-F79W mutant. Sequencing confirmed that only the 
intended mutations were obtained. 
 
Purification of Recombinant TdPurE2 Tryptophan Introduction Mutant. The published 
isolation protocol29 was successfully used to isolate TdPurE2-F79W with relatively high 
specific activity and purity (Table 3.6. and Figure 3.28).  
 
Citrate Titrations of TdPurE2-F79W. Citrate titrations have never been done before with 
any TdPurE2. Therefore, titrations were carried out to determine if citrate binds to 
TdPurE-F79W and has any effect on Trp79 fluorescence. The TdPurE2-F79W mutant 
was quenched by the addition of citrate (Table 3.7 and Figure 3.29). The addition of 
Trp79 to TdPurE2 produces fluorescence changes similar to AaPurE1fwf. However, there 
is an obvious red shift in λmax that does not occur with AIR titrations of TdPurE2-F79W 




AIR Titrations of TdPurE2-F79W. Unlike AaPurE1, AIR is a substrate for TdPurE2. AIR 
titrations were carried out in 50 mM Tris-HCl, pH 8.0. TdPurE2-F79W showed little 
change in fluorescence (8% ΔF/F0) upon addition of AIR, consistent with earlier studies 
of active PurE1s (Table 3.7 and Figure 3.16).26,25 It was however, enough of a signal 
change to obtain a Kd.  
TdPurE2-F79W has an AIR affinity similar to AaPurE1 wild-type (Table 3.7). This is 
slightly surprising because AIR is a substrate for TdPurE2, but is not a substrate for 
AaPurE1. AIR inhibits AaPurE1 and PurK may serve to not only supply NCAIR, but to 
also lower the concentration of AIR. 
The single TdPurE2-F79W mutant is stable and is suitable for fluorescence titrations. 
However, the addition of any additional mutations appears to destabilize the enzyme to 
an extent that fluorescence titrations become impractical (Chapter 4).Therefore, TdPurE2 
may prove to be unsuitable for fluorescence experiments. PurE2 from extremophilic 





Initially this study had a single goal: to dissect the molecular basis of AaPurE1 and 
TdPurE2 fluorescence responses to ligand binding using single-Trp forms. These forms 
could then be used to monitor PurE1- and PurE2-medaited CC bond forming, in real 
time. However, a single high-resolution AaPurE1fwf crystal structure revealed two 
unexpected but relevant features: the primary emitter Trp97 adopts multiple rotamers and 
a residue at the dimer interface (Tyr154), adopts multiple conformations and may be 
chemically modified. This high-resolution structure led to the work discussed here: 1) 
Investigation of changes in fluorescence induced by the binding of ligands to defined 
single- and double-Trp forms of AaPurE1 and TdPurE2. 2) Characterization of the 
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mutants of AaPurE1 position 154 to determine whether this disordered Tyr pair 
contributes to net protein fluorescence and ligand-dependent fluorescence changes. 
  
(1) Investigation of fluorescence changes in single-Trp AaPurE1s and TdPurE2. 
 
Trp97 is Responsible for the Differing Effects of CAIR on EcPurE1 and AaPurE1 
Fluorescence. We determined that Trp97 is the primary fluorophore in AaPurE1. Our 
initial hypothesis, based on simple sequence alignments, was that Trp97 would be 
responsible for CAIR-dependent changes in the fluorescence of inactive H→N mutants 
of EcPurE1 (fluorescence quenching) and AaPurE1 (fluorescence enhancement). No 
evidence inconsistent with this hypothesis was found; Trp97 is therefore the best 
candidate to explain the observed difference between highly homologous PurE1 forms.  
 
Citrate Titrations Report on the Introduction of an Electron-Deficient Carbonyl Carbon 
into the Carboxylate/CO2 Binding Pocket. Both PurE classes are proposed to generate a C
C bond using similar chemistry. We can monitor the CC bond forming reaction in 
real-time using changes in intrinsic fluorescence that report upon electrostatic changes 
within the active site. In order to follow these changes, and the reaction in real time, we 
must first understand how AaPurE1 fluorescence is affected by the introduction of 
electrostatics (electron-deficient carbonyl carbon of citrate or CO2 from CAIR and the 
electron-rich aminoimidazole ring of AIR) into the active site.  
 
Citrate is not a substrate for AaPurE1, but it binds to a region of the active site that 
overlaps the nucleotide-binding site, leading to progressive quenching of protein 
fluorescence.26  
 
Citrate interacts with the critical active site His59 and several other residues that contact 
the nucleotide portion of AIR or CAIR. In the wild-type AaPurE1 crystal structure with 
citrate bound (PDB code 1u11), the pro-R arm of citrate interacts with Asp33 (the residue 
that contacts the AIR 2’ and 3’ hydroxyls) and the central carboxylate forms a hydrogen 
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bond with the protonated δ1-nitrogen of the His59 imidazole.26,27 The inactive AaPurE1-
H59N mutant binds citrate in a different position, with the pro-R arm occupying the 
carboxylate/CO2 binding pocket and the pro-S arm interacting with Asp33. The central 
carboxylate instead forms a hydrogen bond with the δ2-nitrogen of the Asn59. 
Differences in citrate binding modes may account for some of the observed differences in 
citrate Kds for active and inactive AaPurE1 mutants. 
 
The addition of citrate (carrying an electron-deficient carbonyl carbon)52 appears to 
quench the intrinsic fluorescence of TdPurE2-F79W and all AaPurE1 forms with one 
exception, AaPurE1fyw-H59N. In the crystal structure of AaPurE1-H59N (PDB entry 
2fwp) the indole ring of Trp165 is positioned near the central carboxylate of citrate 
(Figure 3.1). The proximity of an electron-deficient carbonyl carbon to Trp165 may 
slightly enhance its fluorescence unless His59 is also present. Since protonated His and 
imidazole derivatives are known to quench indole fluorescence5,53,54 it seems possible 
that a protonated His59 present in the active AaPurE1 forms might “mask” the 
fluorescence-enhancing effect of Trp165. This apparent electrostatic effect may resemble 
the effect of introducing an electron-deficient carbonyl carbon into the carboxylate/CO2 
pocket during catalysis. 
 
AIR Enhances Fluorescence in Inactive AaPurE1. Fluorescence enhancement is observed 
upon the addition of AIR to inactive AaPurE1 forms but not to active AaPurE1 forms or 
TdPurE-F79W.26 The only difference between these active and inactive AaPurE1 is the 
active site His. Replacement of the positively charged His by the neutral Asn abrogates 
catalytic activity, but may also alleviate intramolecular fluorescence quenching. This is 
again consistent with the possibility that Trp97 fluorescence is sensitive to the 
electrostatic environment within the active site pocket, with an effect proportional to the 
net charge (i.e. more negative = more quenching).  
 
Intramolecular quenching by a protonated His59 could explain the large fluorescence 
enhancement upon AIR binding observed in inactive forms of AaPurE1. Protonated His 
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contains an imidazolium ion capable of accepting an electron.14 Therefore, the His may 
be an endogenous quencher of Trp97 fluorescence enhancement in the AIR bound 
complex. There is some precedence for such an effect: the active site His in the well-
studied barnase has a similar intramolecular quenching effect. 55,56  
Two rotamers of Trp97 were detected in the crystal structure of AaPurE1fwf, which are 
present at about equivalent occupancies. The Trp97 A rotamer has a !1 = -83° while the 
Trp97 B rotamer has a !1 = -97°. Both the rotamers have closer values for the !2 = -59 to 
-65°. In the AaPurE1 structure bound to AIR (PDB code 2fwj), Trp97 adopts only the A 
rotamer. Our working hypothesis is that the enhancement of AaPurE1 fluorescence upon 
addition of AIR or CAIR is caused by increasing the contribution of the Trp97 A rotamer. 
That is, a mixed population of Trp97 A and B rotamers may have lower fluorescence, but 
the more florescent A rotamer predominates as AIR or CAIR binds. 
 
CAIR Enhances AaPurE1 Fluorescence to a Lesser Extent than AIR. CAIR is a substrate 
for AaPurE1 so binding equilibrium studies could only be performed using inactive 
enzymes. Even in the “inactive” mutants, CAIR decarboxylates to the stable ternary 
AIR•CO2 complex, directly detected in crystals of AaPurE1-H59N (PDB code 2fwp).26 
Therefore, the fluorescence enhancement seen upon CAIR binding likely results from the 
AIR•CO2 complex and not CAIR. To the extent that AIR binds to AaPurE1-H59N in the 
presence or absence of CO2 - a somewhat controversial notion given that AIR is neither a 
PurE1 substrate nor a particularly powerful competitive inhibitor – a comparison with 
AIR titrations should give information on the net effect of CO2 in the active site. 
 
The presence of CO2 could account for the differences in fluorescence enhancement 
observed in titrations with AIR or CAIR. The results indicate that the additional presence 
of CO2 leads to a smaller enhancement of protein fluorescence when AIR binds to a 
given AaPurE-H59N form. Just as an electron-deficient carbonyl carbon (citrate) 
quenches AaPurE1 fluorescence, the presence of CO2 in the CO2/carboxylate pocket may 




AaPurE1fwf Fluorescence Quenching Does Not Occur by Electron Transfer. AaPurE1fwf-
5FW was used to determine if fluorescence quenching is the result of excited state 
electron transfer from the Trp indole to a quenching moiety (Q = quenching moiety in 
Figure 2.31). Indoles and indole derivatives such as Trp are good electron donors.14,15 
However, the addition of a fluorine atom to the indole raises the ionization potential, 
which should suppress ligand-dependent quenching caused by photoinitiated electron 
transfer from the indole to an acceptor (quencher).16 If electron transfer is the mechanism 
of quenching, one expects a smaller fluorescence change in a protein containing 5FW 
instead of Trp.  
 
The incorporation of 5FW did not affect the fluorescence changes linked to the binding of 
either AIR or citrate, indicating that electron transfer from the Trp indole is not primarily 
responsible in the observed fluorescence changes. Instead, the observed quenching of 
fluorescence is likely due to some other form of radiationless energy transfer. However, 
we cannot rule out that 5FW favors rotamer A since we have no structure. 
 
TdPurE2-F79W is Not Suitable for Fluorescence Experiments. The long-term goal of this 
project was to generate isostructural single-Trp forms of AaPurE1 and TdPurE2 to 
monitor their CC bond forming reaction in real time, using stopped-flow spectroscopy. 
This would provide a head-to-head comparison of the CC bond forming steps involved 
in PurE1 and PurE2. Unfortunately, TdPurE2-F79W does not appear to be resilient 
enough to mutations to permit a suitable comparison with AaPurE1. 
 
While TdPurE-F79W appears to be stable enough for AIR fluorescence titrations, we it 
eventually shows signs consistent with destabilization. A more significant problem is that 
any additional mutation appears to create significantly less stable enzyme (Chapter 4). 
Several purE2 genes have been recently annotated from thermophilic bacteria (Chapter 
1), one or more of which may prove to be suitable for fluorescence studies comparing 




(2) Characterize the Tyr at the dimer interface of AaPurE1 and investigate its 
contribution to fluorescence. 
 
No Evidence for Formation of an Intersubunit Cross-Link in AaPurE1fwf. Collectively, 
the results obtained from mass spectrometric and SDS-PAGE analyses indicate that no 
more then ~10% of Tyr154 is modified, which places an upper limit on the fraction of 
protein subunits that may be covalently linked. Since a cross-link has not been detected 
by any means other than macromolecular crystallography, motional disorder and 
conformational heterogeneity at this dimer interface is most probable cause for the 
crystallographic findings. Refined crystal structures show that Tyr154 from each subunit 
adopts two alternative conformations. One Tyr154 conformer in the AaPurEfwf structure 
(PDB code 4ycb) closely resembles with the Phe154 conformer observed in both crystal 
structures of Y154F mutants (PDB codes 4ycd and 4ycj).  
 
Tyr154 has an Unexplained Contribution to Protein Fluorescence. Relative to Trp, Tyr is 
not expected to have a large contribution to protein fluorescence. The excitation 
wavelength used (295 nm) has little overlap with Phe and Tyr absorption spectra at 
258nm and 275 nm, respectively. Tyr154 appears to relay information on ligand binding 
to Trp97. The proximity of the phenol ring in each subunit could allow excited state 
interactions between Tyr154 residues to red shift its excitation envelope.   
 
AaPurE1 forms in which Trp97 is the sole fluorophore showed substantial difference 
between AIR and CAIR titrations (Figures 3.20 and 3.21). The difference is particularly 
pronounced for AaPurE1fwf-H59N,Y154F fluorescence, which was unchanged by the 
addition of CAIR. The corresponding AaPurE1fwf-H59N still maintains moderate 
fluorescence change in response to the addition of CAIR, indicting that the deletion of a 
fluorophore (Tyr 154), which relays information on CAIR binding to Trp97 may be 
responsible for the loss of AaPurE1fwf-H59N,Y154F fluorescence change. Alternatively, 




A rotamer as well as other AaPurE1 forms. Therefore, we do not observe any 
fluorescence enhancement upon CAIR addition. 
 
The presence of CO2 within the PurE1•AIR•CO2 ternary complex and to a much lower 
extent, the carboxylate of citrate in the CO2/carboxylate binding site appears to determine 
if Tyr154 has any role in fluorescence response to ligand binding. If a protein is 
engineered to contain Trp97 as the sole and primary fluorophore the presence of Tyr154 
is required to elicit a fluorescence change in response to the electron deficient carbon in 
the PurE1•AIR•CO2 complex. 
 
Summary of Fluorescence Response in AaPurE1. Fluorescence changes that can be used 
to monitor AaPurE1 kinetic parameters would be beneficial in investigating CC bond 
breakage and formation using real-time, using pre-steady state kinetics methods like 
stopped-flow fluorescence spectroscopy.   
 
Fluorescence quenching occurs from the addition of an electron-deficient carbonyl 
carbon in citrate, and to a lesser extent of CO2 in the stable ternary AIR•CO2 complex. 
Upon excitation, the electron density of the Trp is shifted from the pyrrole ring to the 
benzene ring, increasing the permanent dipole moment of the indole (Figure 3.32). This 
interaction of the electron-deficient carbonyl carbon (CO2 or citrate) in the 
CO2/carboxylate pocket with the Trp indole may result in quenching of fluorescence. 
 
Fluorescence enhancement results from the addition of AIR, unless His59 is present. Our 
working hypothesis is that enhancement of fluorescence may result from a shift in a 
mixed population of the fluorescent A and less-fluorescent B Trp97 rotamers to a 
population predominated by the of the Trp97 A rotamer. Alternatively, enhancement of 
fluorescence could result from the interaction of the electron-rich AIR aminoimidazole 




Quenching and enhancement of fluorescence is not due to electron transfer from the Trp 
indole. It does appear that some form of resonance energy transfer is occurring between 
the distant Tyr154 and the predominant fluorophore, Trp97.  
 
The combined results indicate AaPurE1 and in some cases, AaPurE1fwf  are the best forms 
of PurE1 to use in future fluorescence studies. While AaPurE1fwf did not provide any 
clear advantage over AaPurE1 in steady state fluorescence analysis, the single-Trp form 
may be a cleaner reporter for pre-steady state analysis. A more stable PurE2 is needed for 
future fluorescence studies  
 
3.5 Future Directions 
 
Acquisition of pre-steady state kinetic parameters with both active and inactive forms 
should be done using stopped-flow with AaPurE1fwf and AaPurE1fwf-H59N. 
 
A thermophilic PurE2 (preferably containing a Trp) should be characterized for future 
experiments with the ultimate goal to compare CC bond formation mechanisms in each 
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3.7 Figures and Tables !
 
Figure 3.1 AaPurE1 octamer with Trps and Tyr154 shown. (A) AaPurE1 (PDB code 
2fwj) octamer shown along its four-fold symmetry axis (AIR depicted as spheres) and 
each subunit shown in a different color. (B) Orientation of the AaPurE1 octamer shown 
in cutaway in panel C. (C) AaPurE1 octamer presented in cutaway view to show Trp and 
Tyr154 positions relative to AIR. Colors of subunits are the same as panels A and B. The 
gray plane is the interior of the protein; all residues shown are between the plane and the 
viewer. All distances (in Å) between AIR N3 and the nearest indole or phenol are 
indicated. 
 
Table 3.1 Fluorescence emission properties of Trp analogs. 
Analog  λmax, nma Φb 
N-Acetyl-L-tryptophanamide 356 0.14 
5-hydroxytryptophan 341 0.22 
7-azatryptophan 415 0.01 
5-fluorotryptophan 358 0.14 
4-fluorotryptophan na ≤0.0014 
a λmax values from literature 3,23 





! ! ! ! !
Figure 3.2 Commonly used tryptophan analogs.      
   
 
Figure 3.3 Structures of AaPurE1-H59N and EcPurE1-H45N with AIR•CO2 and CAIR 
bound. Left: AaPurE1-H59N (PDB code 2fwp). and Right: EcPurE1-H45N (PDB code 
2nsl) active sites are shown with active site contacts to AIR•CO2 and CAIR shown. CAIR 
has different chemical outcomes between the PurE1s and might lead to different 
fluorescence responses. The AIR and CO2 are not co-planar in AaPurE1, but are co-
planar in EcPurE1. Electron density maps for 2Fo-Fc (blue mesh) are contoured at 1.0 σ 




































Figure 3.4 Illustration of cross-over PCR used to generate the TdPurE2-F79W mutant. 
 
Table 3.2 E.coli strains used in this chapter. 
Strain Description Source 
DH5α F′ φ80lacZΔM15 Δ(lacZYA-argF)U169 deoR recA1 endA1 
hsdR17(rK− mK+) phoA supE44 thi-1 gyrA96 relA1 
 
Lab stock 
BL21(DE3) F– ompT gal dcm lon hsdSB(rB- mB-)  
λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 nin5])  
 
Lab stock 
CC1215 F– ompT gal dcm lon hsdSB(rB- mB-) ΔpurE736::kan 
λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 nin5])  
 
Lab stock 


























Table 3.3 Oligodeoxynucleotides (ODNs) used in this chapter.  
ODN Sequence (5’→3’) a  
2042 CCAGTCAGACTtcGAAACCATGCGCCA AaPurE1-W34F 
2043 TGGCGCATGGTTTCgaAGTCTGACTGG AaPurE1-W34F 
2044 CCTTGAAACATttCGCGCATTGCAG AaPurE1-W165F 
2045 CTGCAATGCGCGaaATGTTTCAAGG AaPurE1-W165F 
2048 GTTTCAGCAaATCGTACGCCAGACCGGTTGGC AaPurE1-H59N 
2049 CGTACGATtTGCTGAAACAATGAGGGTTTCATGCG AaPurE1-H59N 
2109 GTATGTGTGCGGCATatACACGCCTGCCCGTG AaPurE1-W97Y 
2110 CACGGGCAGGCGTGTATatGCCGCACACATAC AaPurE1-W97Y 
2170 GGGCCGGGTTAaACAGTGCAAGAATGG AaPurE1-Y154F 
2171 CCATTCTTGCACTGTtTAACCCGGCCC AaPurE1-Y154F 
2172 GCAAGGGCCGGGTTtaACAGTGCAAGAATGG AaPurE1-Y154L 
2173 CCATTCTTGCACTGTtaAACCCGGCCCTTGC AaPurE1-Y154L 
2174 GGCAAGGGCCGGGTTgatCAGTGCAAGAATGG AaPurE1-Y154I 
2175 CCATTCTTGCACTGatcAACCCGGCCCTTGCC AaPurE1-Y154I 
2329 GGTTGCACCTTTGACccAGCCATCAACAAAG AaPurE1-F79W 
2330 CTTTGTTGATGGCTggGTCAAAGGTGCAACC AaPurE1-F79W 
2410 CCGAGATCTCCCCGAAAAGTGCCACCTG T5 promoter region 
2411 GCTCATCATATGTTAATTTCTCCTCTTTAATGAATTC T5 promoter region 
a Changes in the coding region that deviate from the genomic sequence are in lower case. 
 
 
Table 3.4 Previously published plasmids used in this chapter. 
Plasmid Description  Source Protein encoded 
pET23a Expression vector Novagen na 
pCDFDuet Expression vector Novagen na 
acs1 acs1 in pQE80 Addgene  na 
pJK175 purE1Aa in pET23a 26 AaPurE 
pJK283 purE1Aa-H59N in pET23a 26 AaPurE-H59N 
a!na- not applicable!  
 !
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Table 3.5 Newly generated plasmids used in this chapter. 
Plasmid Description  Protein encoded 
Three Trp   
pJK601 purE1Aa-Y154F in pET23a AaPurE-Y154F 
pJK602 purE1Aa-H59N,Y154F in pET23a AaPurE-H59N,Y154F  
Two Trp   
pJK506 purE1Aa-W165F in pET23a AaPurEwwf 
pJK663 purE1Aa-Y154F,W165F in pET23a AaPurE wwf-Y154F 
pJK510 purE1Aa-H59N,W165F in pET23a AaPurEwwf-H59N 
pJK664 purE1Aa-H59N,Y154F,W165F in pET23a AaPurE wwf-H59N 
pJK505 purE1Aa-W34F in pET23a AaPurEfww 
pJK603 purE1Aa-W34F, Y154F in pET23a AaPurE fww-Y154F 
pJK509 purE1Aa-W34F, H59N in pET23a AaPurEfww-H59N 
pJK604 purE1Aa-W34F,H59N,Y154F in pET23a AaPurE fwwH59N-Y154F 
One Trp   
pJK526 purE1Aa-W97Y,W165F in pET23a AaPurEwyf 
pJK666 purE1Aa-H59N,W97Y,W165F in pET23a AaPurE wyf-H59N 
pJK507 purE1Aa-W34F, W165F in pET23a  AaPurEfwf 
pJK508 purE1Aa-W34F, H59N, W165F in pET23a AaPurEfwf-H59N 
pJK600 purE1Aa-W34F,H59N,Y154F,W165F in pET23a AaPurEfwf-H59N,Y154F 
pJK559 purE1Aa-W34F,Y154F,W165F in pET23a  AaPurEfwf-Y154F 
pJK562 purE1Aa-W34F,Y154L,W165F in pET23a AaPurEfwf-Y154L 
pJK525 purE1Aa-W34F,W97Y in pET23a AaPurEfyw 
pJK665 purE1Aa-W34F,H59N,W97Y in pET23a AaPurE fyw-H59N 
pJK698 purE1Aa-W34F, W165F in pET23a with T5 promoter  AaPurE fwf 
pJK500 purE1Ec-W20F in pET23a EcPurE1-W20F 
pJK501 purE1Ec-W20F in pET23a EcPurE-W151F 




Figure 3.5 Fluorescence emission spectra of EcPurE1-W20F and EcPurE1-W151F. 
EcPurE1s were present at 30 µM [subunit]. The excitation wavelength was 295 nm. The 




















Table 3.6 Mass spectrometric analysis of AaPurE1 forms. 
AaPurE1form Observed Mass (Da) Expected Mass (Da)a  Difference 
Three Trp    
AaPurE1 (wild-type) 18867b 18867 0 
AaPurE1-H59N 18845c 18844 -1 
AaPurE1-H59N, Y154F 18827 18828 +1 
AaPurE1-Y154F 18850 18852 +2 
Two Trp    
AaPurE1wwf 18829 18828 -1 
AaPurE1wwf-Y154F 18812 18812 0 
AaPurE1wwf-H59N 18810 18805 -5 
AaPurE1wwf-H59N,Y154F 18790 18798 +8 
AaPurE1fww 18830 18828 -2 
AaPurE1fww-Y154F 18813 18812 -1 
AaPurE1fww-H59N 18805 18805 0 
AaPurE1fww-H59N, Y154F 18791 18789 -2 
One Trp    
AaPurE1wyf 18802 18805 +3 
AaPurE1wyf-H59N 18789 18782 -7 
AaPurE1fwf 18790 18789 -1 
AaPurE1fwf-H59N 18766 18766 0 
AaPurE1fwf-H59N, Y154F 18752 18750 -2 
AaPurE1fwf-Y154F 18774 18773 -1 
AaPurE1fwf-Y154L 18739 18739 0 
AaPurE1fyw 18797 18805 -8 
AaPurE1fyw-H59N 18786 18782 -4 
AaPurE1fwf-5-FW 18804 18806 +2 
aMolecular masses ([M+H+]+) were determined by MALDI. Expected masses were calculated using 
ExPaSy ProtParam. All AaPurE1s have an additional N-terminal Met26.                                                                                                                  
bESI-MS observed 18865 (expected 18865.7).26                                                                                       c 





Figure 3.6 SDS-PAGE analysis of a representative AaPurE1 Trp mutant (AaPurE1fwf) 
isolation. A 12% polyacrylamide gel was loaded with 5 ug protein per lane: M, Sigma 
biotinylated marker; S, soluble lysate; CL, cleared lysate; HA, hydroxyapatite input; and 
ISO, isolated AaPurE1-S57V. Molecular weights (kDa) are denoted along the left side of 
the gel.  !
 
 
Figure 3.7 SDS-PAGE analysis of isolated AaPurE1 forms. A 12% polyacrylamide gel 
was loaded with 5 ug protein per lane: M, Sigma biotinylated marker; AaPurE1 is 
denoted by wt; 1, AaPurE1-H59N; 2, AaPurE1-H59N,Y154F; 3, AaPurE1-Y154F; 4,  
AaPurE1wwf; 5, AaPurE1wwf-Y154F; 6, AaPurE1wwf-H59N; 7, AaPurE1wwf-H59N,Y154F; 
8, AaPurE1fww; 9, AaPurE1fww-Y154F; 10, AaPurE1fww-H59N; 11, AaPurE1fww-
H59N,Y154F; 12, AaPurE1wyf; 13, AaPurE1wyf-H59N; 14, AaPurE1fwf; 15, AaPurE1fwf-
H59N; 16, AaPurE1fwf-H59N,Y154F; 17, AaPurE1fwf-Y154F; 18, AaPurE1fwf-Y154L; 
19, AaPurE1fyw; 20, AaPurE1fyw-H59N; and 21, AaPurE1fwf-5FW. Molecular weights 
















Figure 3.8 Gel-filtration analysis of AaPurE1 forms containing all three Trps. The traces 
are shifted 0.01 A280. The PurE1 octamer elutes at ~57 mL and aggregate elutes within 
the excluded volume. The completely excluded (Vo, 44.7 mL) and included (Vi, 113.6 





















Figure S1: Gel-filtration analysis of AaPurE forms containing all three Trp residues.
Successive traces are shifted 0.01 A280. The completely excluded (Vo, 44.7 mL) and





Figure 3.9 Gel-filtration analysis of AaPurE1 forms containing two Trps. The traces are 
shifted 0.01 A280. The PurE1 octamer elutes at ~57 mL and aggregate elutes within the 
excluded volume. The completely excluded (Vo, 44.7 mL) and included (Vi, 113.6 mL) 
volumes are indicated with arrows above.  A small peak (~76 mL) is observed in some 








































Figure S2: Gel-filtration analysis of AaPur forms containin t r residues. Succes-
sive traces are shifted 0.01 A280. The completely exclude (Vo, 44.7 mL) and included





Figure 3.10 Gel-filtration analysis of AaPurE1 forms containing a single-Trp. The traces 
are shifted 0.01 A280. The PurE1 octamer elutes at ~57 mL and aggregate elutes within 
the excluded volume. The completely excluded (Vo, 44.7 mL) and included (Vi, 113.6 
mL) volumes are indicated with arrows above. A small peak (~76 mL) is observed in 











































Figure S3: Gel-filtration analysis of AaPurE forms containing a single Trp residue. Suc-
cessive traces are shifted 0.01 A280. The completely excluded (Vo, 44.7 mL) and included




Table 3.7 Specific activities and dissociation constants for selected proteins. 
  ΔF  Kd (µM) 
PurE1 or PurE2 form rSAa Citrateb AIRc CAIRc  Citrateb AIRc CAIRc 
AaPurE1 (wild-type) 1.0d -0.214 0.040 nae  275f 2.2 na 
AaPurE1-H59N ~0d -0.198 0.309 0.140  560g 0.61 0.96h 
AaPurE1-H59N, Y154F ~0 -0.154 0.310 0.314  870 1.3 1.4 
AaPurE1-Y154F 0.8 -0.214 -0.024 0.312  275 0.6 na 
AaPurE1wwf 1.0 -0.319 ~0 na  247 isi na 
AaPurE1wwf-Y154F 0.87 -0.366 ~0 na  390 is na 
AaPurE1wwf-H59N ~0 -0.199 0.382 0.21  700 1.45 3.5 
AaPurE1wwf-H59N,Y154F ~0 -0.294 0.302 0.078  530 1.36 1.4 
AaPurE1fww 0.8 -0.326 -0.050 na  820 1.1 na 
AaPurE1fww-Y154F 0.6 -0.234 -0.051 na  285 1.2 na 
AaPurE1fww-H59N ~0 -0.326 0.337 0.33  820 1.57 2.8 
AaPurE1fww-H59N, Y154F ~0 -0.177 0.290 0.24  780 1.57 4.8 
AaPurE1wyf 0.54 -0.233 ~0 na  220 Is na 
AaPurE1wyf-H59N ~0 -0.117 0.235 0.208  420 1.60 3.8 
AaPurE1fwf 0.90 -0.368 -0.050 na  210 1.4 na 
AaPurE1fwf-H59N ~0 -0.285 0.268 0.107  520 4.3 5.7 
AaPurE1fwf-H59N, Y154F ~0 -0.221 0.236 ~0  500  3.5 is 
AaPurE1fwf-Y154F 0.7 -0.228 -0.062 na  283 1.3 na 
AaPurE1fwf-Y154L 0.7 -0.213 -0.090 na  259 1.8 na 
AaPurE1fyw 0.59 -0.170 ~0 na  180 is na 
AaPurE1fyw-H59N ~0 0.088 -0.069 j -0.051j  900 2.7 0.31j 
AaPurE1fwf-5-FW 0.78 -0.393 -0.078 na  2.4 0.47 na 
TdPurE2-F79W 93 -0.240 -0.110 na  43 3 na 
a rSA, specific activity relative to wild-type AaPurE1(39 units per mg protein,  determined at 0.1 mM CAIR, pH 8, and °C). 
b Determined at pH 4.6 and 25 Representative spectra and fits to equation 3.1 are given in the Appendix as panels A and B of Figures A.1-A.22. 
c  Determined at pH 8 and 30 °C
 
Representative spectra and fits to equation 3.2 (except as noted) are given in the Appendix as panels C and D of Figures 
A.1-A.22(AIR) and panels E and F of Appendix Figures A.1, A.4-6, A.9-10, A.13, A.15, A.18-20 (CAIR). 
d rSA, % specific activity in the CAIR decarboxylation reaction relative to wild-type AaPurE1 (39 U mg-1) and TdPurE2 (185 U mg-1) at 100 µM CAIR, 
pH 8.0, 30 °C. 
e na, not applicable 
f 0.4 mM reported previously.26 
g 2 mM reported previously.26 
h 0.78 µM reported previously.26 
i is, insufficient signal change.  




Figure 3.11 Electron density maps for the residues 34, 97, and 165 in AaPurE1.  
Individual Phes and Trps and the residues within 10 Å are shown for AaPurE1 (PDB 
code 1u11) in dark gray and AaPurE1fwf (PDB code 4ycb) in yellow. (A) Trp34 of 
AaPurE1 shown. (B) Trp97 of AaPurE1 shown. (C) Trp165 of AaPurE1 shown. (D) 
Phe34 of AaPurE1fwf shown. (E) Trp97 alt conformations of AaPurE1fwf shown. (F) 
Phe165 of AaPurE1fwf shown. (G-I) The alignment of residue 34, Trp97, and residue 165 
of AaPurE and AaPurE1fwf are shown. Electron density maps 2Fo-Fc (blue mesh) are 















Table 3.8 X-ray data collection statistics. 
 AaPurE1fwf  AaPurE1 
 - Y154L Y154F  Y154F 
PDB entry 4ycb 4ycc 4ycd  4ycj 
Beamline 21-ID-G 21-ID-F 21-ID-F  21-ID-G 
Wavelength (Å) 0.97856 0.97872 0.97872  0.97856 
Space group b I422 I422 I422  I422 








 a=b= 99.761, 
c= 165.008 








No. meas. refl. 1,319,978 158,696 419,831  429,790 
No. unique refl. 90,070 (3925) 19,660 (950) 51,530 (2538)  35,774 (1748) 
Completeness (%) 99.2 (87.5) 98.9 (99.6) 100 (100)  100 (100) 
Multiplicity 14.7 (22.9) 8.1 (20.7) 8.1 (20.3)  12.0 (11.7) 
Rmerge (%) c 7.1 (52.3) 10.2 (22.8) 8.7 (53.8)  7.8 (55.1) 
Mean I/σ (I) 48.1 (2.0) 37.2 (10.6) 26.8 (3.6)  44.1 (5.4) 
VM (Å3 Da-1) d 2.49 2.49 2.53  2.48 
Est. solvent (%) 50.5 50.6 51.5  50.4 
a Values in parenthesis are for the highest resolution shell. 
b All have α=β=γ=90°. 
c Rmerge = 
!!!"!!!|!!!! !!" ! !(!!") |!!!"!!!!!!(!!")  , where Ii (hkl) is the ith measurement of the intensity of reflection hkl and !(ℎ!")  is its mean value. 




Table 3.9 Summary or refinement statistics. 
 AaPurE1fwf  AaPurE1 
 - Y154L Y154F  Y154F 










No. reflections used      
working 89999 19350 49684  34671 
test set 3547 933 1966  1481 
Completeness (%) 99.2 96.2 96.0  95.8 
Rcrystb(%) 14.0 (23.43) 13.5 (14.3) 15.6 (17.6)  13.5 (15.1) 
Rfreec(%) 14.9 (25.8) 17.2 (20.2) 17.4 (22.6)  15.4 (68.8) 
No. of atoms      
all atoms 2963 2554 2752  2841 
protein atoms 2519 2328 2341  2446 
solvent atoms 397 215 396  355 
R.m.s. deviations from ideality      
Bondlengths (Å) 0.011 0.008 0.006  0.007 
Bond angles (°) 1.110 1.089 1.091  0.985 
Average isotropic B factors (Å2)      
protein atoms 13.8 26.7 14.1  20.6 
ligand atoms 40.7 54.3 45.9  49.6 
solvent atoms 35.7 27.9 31.2  38.8 
Ramachandran plot statistics (%)      
Residues in favored regions 99.1 98.8 98.8  98.8 
Residues in allowed regions 0.7 1.3 1.2  0.7 
Outliers 0.4 0.4 0.4  0 
MolProbity score [percentile] 1.27 (94) 1.13 (100) 1.03 (100)  1.07 (98) 
MolProbity clashscore 
[percentile] 
5.12(89) 3.35 (99) 5.50 (99)  2.79 (99) 
a Values in parenthesis are for the highest resolution shell. 
b Rcryst = = 
!!!"!||!!!"#!|! !!"#!|!!!"!|!!!"#!|  




Figure 3.12 Electron density at residue 154 in multiple AaPurE1 forms. Each panel 
represents the pseudo two-fold NCS symmetry axis at the dimer interface; the axis runs 
through each figure from the bottom right corner to the upper left corner between 
residues 154A and 154B. Electron density maps (shown for residues 78 and 154) for 2Fo-
Fc (blue mesh) are contoured at 1.0 σ, Fo-Fc positive differences (green mesh) are 
contoured at +3.0 σ, Fo-Fc negative differences (red mesh) are contoured at -3.0 σ, and all 
maps have a carve radius of 2.0 Å. (A) AaPurE1 (PDB code 1u11). (B) AaPurE1-H59N 
(PDB code 2fw9). (C) AaPurE1fwf (PDB code 4ycb). (D) AaPurE1fwf-Y154F (PDB code 





Figure 3.13 Electron density at Tyr68 in both AaPurE1fwf subunits. (PDB code 4ycb) 
Electron density maps for 2Fo-Fc (blue mesh) are contoured at 1.0 σ, Fo-Fc positive 
differences (green mesh) are contoured at +3.0 σ, Fo-Fc negative differences (red mesh) 
are contoured at -3.0 σ, and all maps have a carve radius of 2.0 Å around residue 68. (A) 
Tyr68 from subunit A. (B) Tyr68 from subunit B.  
 
Table 3.10 R-Factors and RSCC154 values for AaPurE1 structures. 
PDB entry AaPurE1 dmin (Å) Rwork (%) Rfree (%) RSCC154b Ref. 
1u11a WT 1.55 16.2 17.7 0.785/0.785 27 
2fw1a WT 2.00 17.3 18.1 0.869/0.875 26 
2fw6a H59N 1.85 16.3 17.9 0.856/0.813 26 
2fw7a H59N 1.75 16.1 17.5 0.856/0.860 26 
2fw8a H89G 1.75 16.7 18.8 0.904/0.820 26 
2fw9a H59F 1.75 16.4 18.6 0.890/0.856 26 
2fwaa H89N 1.90 17.4 19.3 0.799/0.821 26 
2fwba H89F 2.00 17.3 19.0 0.885/0.866 26 
2fwia H59D 1.94 16.6 18.1 0.872/0.843 26 
2fwja WT 1.95 16.1 18.7 0.815/0.869 26 
2fwpa H59N 1.85 17.3 20.1 0.827/0.858 26 
4ycb fwf 1.35 16.2 17.3 0.877/0.816 This study 
4ycd fwf-Y154F 1.65 14.8 18.2 0.981/0.976 This study 
4ycc fwf-Y154F 2.25 15.6 17.4 0.948/0.954 This study 
4ycj Y154F 1.84 15.7 16.9 0.979/0.969 This study 
a Previously deposited-RSCC values are computed after the Asn78 flip was completed. 





Figure 3.14 LC-MS analysis of AaPurE1 peptide from solution. (A) Total ion count 
chromatogram (TIC) of peptide injected into the MS. (B-D) Elution profiles from LC that 
contain masses corresponding to the peptide of interest (666 and 999 m/z). (E) Mass 
spectrum from elutions (4.88-4.99 min) that contains the expected masses for the +2 (999 
Da) and +3 (666 Da) peptide of interest. 
  




Figure 3.15 LC-MS analysis of AaPurE1-Y154F peptide from solution. (A) Total ion 
count chromatogram (TIC) of peptide injected into the MS. (B-D) Elution profiles from 
LC that contain masses corresponding to the peptide of interest (661 and 991 m/z). (E) 
Mass spectrum from elutions (5.28-5.36 min) that contains the expected masses for the 







Figure 3.16 LC-MS analysis of AaPurE1fwf peptide from solution. (A) Total ion count 
chromatogram (TIC) of peptide injected into the MS. (B-D) Elution profiles from LC that 
contain masses corresponding to the peptide of interest (666 and 999 m/z). (E) Mass 
spectrum from elutions (6.73-6.93 min) that contains the expected masses for the +2 (999 








Figure 3.17 LC-MS analysis of AaPurE1fwf-Y154F peptide from solution. (A) Total ion 
count chromatogram (TIC) of peptide injected into the MS. (B-D) Elution profiles from 
LC that contain masses corresponding to the peptide of interest (661 and 991 m/z). (E) 
Mass spectrum from elutions (7.04-7.29 min) that contains the expected masses for the 









Figure 3.18 SDS-PAGE analysis of irradiated and dissolved AaPurE1 crystals. A 12% 
polyacrylamide gel was loaded with 25 ng protein per lane and visualized with silver 
staining. AaPurE1 is labeled on the left gel and AaPurE1-Y154F is on the right gel. Key 
to symbols: M, Sigma wide molecular weight marker; S, protein from solution; C, 
dissolved crystals; and IR, irradiated and dissolved crystals. Molecular weights (kDa) are 









Figure 3.19 LC-MS analysis of dissolved AaPurE1 crystals. (A) Total ion count 
chromatogram (TIC) of peptide injected into the MS. (B-D) Elution profiles from LC that 
contain masses corresponding to the peptide of interest (666 and 999 m/z). (E) Mass 
spectrum from elutions (5.15-5.23 min) that contains the expected masses for the +2 (999 





Figure 3.20 Fluorescence titrations of wild-type and inactive AaPurE1 forms with citrate. 
Observed fluorescence emission intensity at 320 nm, as a function of AIR is represented 
by the symbols: AaPurE1 (black filled circles), AaPurE1-H59N (red open circles), 
AaPurE1wyf-H59N (cyan filled triangles), AaPurE1fwf-H59N (green filled diamonds), 
AaPurE1fwf-H59N, Y154F (blue open diamonds), and AaPurE1fyw-H59N (purple filled 
inverted triangles). Solid lines are the observed data fit using gnu plot with equation 3.2  !
 
Figure 3.21 Fluorescence titrations of wild-type and inactive AaPurE1 forms with AIR.  
Observed fluorescence emission intensity at 320 nm, as a function of AIR is represented 
by the symbols: AaPurE1 (black filled circles), AaPurE1-H59N (red open circles), 
AaPurE1wyf-H59N (cyan filled triangles), AaPurE1fwf-H59N (green filled diamonds), 
AaPurE1fwf-H59N, Y154F (blue open diamonds), and AaPurE1fyw-H59N (purple filled 
inverted triangles). Solid lines are the observed data fit using gnu plot with equation 3.3, 




Figure 3.22 Fluorescence titrations of inactive AaPurE1 forms with CAIR. Observed 
fluorescence emission intensity at 320 nm, as a function of CAIR is represented by the 
symbols: AaPurE1-H59N (red open circles), AaPurE1wyf-H59N (cyan filled triangles), 
AaPurE1fwf-H59N (green filled diamonds), AaPurE1fwf-H59N, Y154F (blue open 
diamonds), and AaPurE1fyw-H59N (purple filled inverted triangles). Solid lines are the 
observed data fit with equation 3.3.  !
 
Figure 3.23 SDS-PAGE analysis of AaPurE1fwf-5FW and pCDFDuet expression in 
DL41. A 12% polyacrylamide gel was loaded with 5 µg protein per lane: M, Sigma 
biotinylated marker; C, crude lysate; and S, soluble lysate. The Pre-IPTG samples were 
taken before washing steps and the post-IPTG samples were taken after final harvest of 











Figure 3.24 Absorbance spectra and fluorescence emission spectra for AaPurE1fwf and 
AaPurE1fwf-5FW. AaPurE1fwf absorbance spectra are shown in red and fluorescence 
emission spectra (Excitation at 295 nm) are shown in dark red. AaPurE1fwf -5FW 
absorbance spectra are shown in light blue and fluorescence emission spectra are shown 
in dark blue. The λmax for absorbance and fluorescence spectra of AaPurE1fwf and 
AaPurE1fwf-5FW are Abs = 277 nm, F = 366 nm and Abs = 264 nm, F = 341 nm; 
respectively.  !
Table 3.11 Quantum yields for AaPurE1fwf and AaPurE1fwf-5FW. 









a nd nd 9.0 
L-Trp 0.14
b 0.14 0.14 8.4 
AaPurE1fwf 0.039 ± 0.004 0.042 0.039 168 
AaPurE1fwf -5FW 0.088 ± 0.002 0.096 0.083 123 
a not determined. 




Figure 3.25 Fluorescence emission spectra used to determine quantum yields for 
AaPurE1fwf and AaPurE1fwf-5FW. Emission spectra of NATA, L-Trp, AaPurE1fwf and 
AaPurE1fwf-5FW with excitation at 295 nm. All solutions had an absorbance of 0.06 AU 
and quantum yield values are listed in Table 2.5. !!
 
Figure 3.26 Fluorescence titrations with AaPurE1fwf-5FW with citrate. Excitation 
wavelength was 295 nm. Citrate titrations were performed with 0.2 µM [subunit] in 50 
mM  acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. Kd values 
are given in Table 3.7. (A) Fluorescence emission spectra with increasing amounts of 
citrate. (B) Recorded emission at 320 nm upon citrate addition was plotted as a function 


























Figure 3.27!AIR Fluorescence titrations with AaPurE1fwf-5FW. Excitation wavelength 
was 295 nm. AIR titrations were performed with 0.18 µM [subunit] in 50 mM Tris-HCl, 
pH 8 at 30 °C and data were fit to equation 3.2. Kd values are given in Table 3.7. (A) 
Fluorescence emission spectra with increasing amounts of AIR. (B) Recorded emission at 
320 nm upon AIR addition was plotted as a function of [AIR] and data were fit using 
equation 3.6 using gnu plot. The Kd values are listed in Table 3.7. 
 
!
Figure 3.28 SDS-PAGE analysis of isolated TdPurE2 Trp introduction forms. A 12% 
polyacrylamide gel with 5 ug protein loaded per lane: 12% polyacrylamide gel was 
loaded with 5 ug protein per lane: M, Sigma biotinylated marker. Each mutation in Ser 38 
is indicated by the one letter code directly above each lane. Each mutation to introduce a 
Trp into TdPurE2 is indicated above the solid line. Molecular weights (kDa) are denoted 









Figure 3.29 Citrate fluorescence titrations of TdPurE2-F79W. Excitation wavelength was 
295. Citrate titrations were performed with 0.4 µM [subunit] in 50 mM potassium acetate, 
100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.5. Kd values are given in 
Table 3.7. (A) Fluorescence emission spectra of TdPurE2-F79W recorded in 50 mM 
potassium acetate, 100 mM KCl, pH 4.6 at 25 °C with an excitation of 295 nm. (B) 
Fluorescence emission intensity at 320 nm was plotted as a function of [citrate] and data 
were fit using equation 3.5 using Origin software. The Kd values are listed in Table 3.7.           
                             
 
Figure 3.30 AIR fluorescence titrations of TdPurE2-F79W. Excitation wavelength was 
295 AIR titrations were performed with 0.56 µM [subunit] in 50 mM Tris-HCl, pH 8 at 
30 °C. (A) Fluorescence emission spectra with increasing amounts of AIR. (B) Recorded 
emission at 320 nm upon AIR addition. Titrations were performed with [subunit] of 0.4 
µM. Fluorescence emission intensity at 320 nm was plotted as a function of [AIR] and 







Figure 3.31 Scheme for excited state electron transfer from the Trp indole to a quenching 
moiety (Q). Q could be the ligand or some other intramolecular quenching group in the 
protein (e.g. a backbone amide).  !!
!
Figure 3.32 Electron density of the Trp indole in the excited state. The teal circles 
represent the relative electron density in Trp at the ground state or excited state. When 
excited, the electron density shifts from the pyrrole ring to the benzene ring and creates a 
temporary dipole. !!
 















PurE1 and PurE2 have similar structures and similar active sites. Crystal structures of 
PurE1 and PurE2 with AIR bound (PDB codes 2fwj and 3rgg)1,2 reveal that the 
universally conserved Ser is the sole polar contact between the substrate aminoimidazole 
ring and any PurE side chain. Due to its strict conservation in both PurE classes, Ser was 
thought to have a similar role in both enzymes. 
   
PurE1 and PurE2 Carbon-Carbon Bond-Forming Chemistry is Conserved. PurE1 and 
PurE2 appear to form a new C−C bond, the conversion of PurE•AIR•CO2 to PurE•CAIR, 
the same way (Figure 4.1).3 An absolute difference is the source of CO2: PurE1 acquires 
it by decarboxylation of bound NCAIR (or CAIR), while PurE2 binds it directly.  
PurE1 converts either NCAIR or CAIR to a PurE•AIR•CO2 ternary complex from which 
CO2 does not escape (brackets in Figure 4.1). Confining CO2 in PurE1 preserves the 
investment made by PurK, which uses ATP to activate bicarbonate (Chapter 1). A strong 
electrostatic interaction between the polarized C4 of AIR and CO2 may help PurE1 to 
achieve quantitative retention of the transiently formed CO2 within the active site.  
Hydrogen bonds involving AIR N3 with the conserved 40s loop Ser and the 70s loop 
backbone carbonyls with the exocyclic amine N6 may further polarize AIR and promote 




The 40s Loop Ser May Have Different Roles in Each PurE Class. The PurE1 and PurE2 
active sites differ most in two active site loops (Figure 4.2).4,5 The 40s loop contains a 
class-specific motif, SAH[R/K] in PurE1 and PurE2, respectively. The conserved active 
site His serves as the general acid/general base catalyst and is essential for activity.1,2,6 
The 40s loop Ser is proposed to serve as a hydrogen bond donor to AIR N3 and is the 
sole polar contact between the substrate aminoimidazole ring and any side chain of PurE1 
and PurE2 (Figure 4.2).1,2  
Decarboxylation of CAIR gives a ternary PurE•AIR•CO2 complex, which only 
dissociates from PurE2. In contrast, the PurE1 reaction continues with an aminoimidazole 
ring flip and NCAIR formation. Ser may provide a hydrogen bond to AIR N3 and, in 
PurE1 only; function as a pivot-point for the aminoimidazole ring to rotate and position 
either AIR C4 or N6 of the exocyclic amine for attack on the bound CO2 to form either 
NCAIR or CAIR, respectively (Figure 4.1).6  !
The pH rate profiles for PurE1 are bell-shaped and the basic arm (pK2) is unambiguously 
assigned to the active site His.1,6 The acidic pK1 likely corresponds to the protonation of 
CAIR N3, which is mutually exclusive with protonation at C4 (Figure 4.2). Ser may 
function as a hydrogen bond donor to (C)AIR N3, favoring protonation by the conserved 
His at C4 instead of N3. This would be an example of “negative catalysis” in that the 
hydrogen bonding interaction prevents an unproductive event but is not itself required. 
This contrasts with a conclusion based on non-enzymatic model studies, where the N3 
protonation occurs first and the proton is transferred to the C4 position for 
decarboxylation to occur.7,8 While, N3 protonation is inhibitory for PurE1, it may allow 
PurE2 to do different chemistry at low pH. 
In PurE2, an increase in velocity at acidic pH (pK1) has been proposed to correspond to a 
change in polarity in the hydrogen bond formed between Ser and the aminoimidazole 
N3.2 At low pH, Ser could accept a hydrogen bond from the protonated N3. Furthermore, 
the order of CAIR protonation and decarboxylation events may be reversed by this 
interaction, as C4 protonation would pose serious electrostatic barriers (two positive 
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charges on the aminoimidazole ring). Instead, decarboxylation may lead to formation of a 
nitrogen ylide of AIR (yAIR), which is a proposed intermediate for decarboxylation of 
CAIR ribonucleoside.8 Similar intermediates have been proposed for both 3-
aminopicolinic acid decarboxylation and orotidine 5’-monophosphate decarboxylase.9,10 
Characteristics of PurE1 and PurE2 Examined in this Chapter. This chapter details the 
kinetic and structural analysis of Ser mutants from Acetobacter aceti (AaPurE1) and 
Treponema denticola (TdPurE2). Several functional mutants have pH-dependent activity 
that indicates a class-divergent role for this residue. The requirement a hydrogen bond 
donor at the Ser position is more important for PurE2 function. Our working hypothesis 
is that the hydrogen bond provided by Ser is important to ensure efficient C4 protonation 
and without it decarboxylation may occur through a different mechanism beginning with 
N3 protonation.  
 
4.2 Materials and Methods 
 
Materials. Chemicals were obtained from Sigma or Fisher in the highest purity available 
unless otherwise noted. CAIR was prepared from 5-aminoimidazole-4-carboxamide 
ribonucleotide (Toronto Research Chemicals, catalogue number: A611705) as described 
previously.11 AIR was generated enzymatically from CAIR using Treponema denticola 
PurE2 (TdPurE2) and quantitated by Bratton-Marshall assay as described previously.2 
Oligodeoxynucleotides (ODNs) were obtained from Integrated DNA Technologies and 
used without further purification. Restriction endonucleases, Vent polymerase, Q5 DNA 
polymerase, CIP, T4 PNK, and T4 DNA ligase were obtained from New England 
Biolabs. Mutagenesis was accomplished using Quikchange Mutagenesis using kits 
(Agilent). Phenyl sepharose CL-6B was obtained from Sigma. Hydroxyapatite (Bio-Gel 
® HT) and Bradford reagent were obtained from Bio-Rad. PD-10 desalting columns were 
obtained from GE Health Care. Protein concentrations were determined by the method of 
Bradford with bovine serum albumin as the standard.12 Solution makeup was determined 
on an AKTA FLPC system (Amersham). Small-scale centrifugation steps were 
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performed using an Eppendorf 5424 centrifuge. All other centrifugation steps were 
performed using a Beckman Avanti J-E centrifuge with a JLA-10.5 or JA-20 rotor. Cell 
disruption was performed by sonication using a Fisher Scientific Dismembrator 550 at 
25% output for 3 cycles (1 min each with 1 min cooling periods in-between) at 4 °C. 
Spectroscopic measurements were recorded on a Varian CARY-100 UV/Vis 
spectrophotometer thermostated by a Cary Dual Peltier Accessory temperature controller. 
Steady state fluorescence measurements were recorded on a Horiba Fluoromax-3 
fluorometer thermostated with a Peltier Accessory and a Wavelength Electronics 
temperature controller. . Data were analyzed using Origin (OriginLab, Northampton, 
MA) or using gnuplot 4.4 by T. J. Kappock. Plasmid DNA was sequenced by the staff of 
the Purdue University Genomics Core Facility. Full-length protein masses were 
determined by Matrix-assisted laser desorption/ionization mass spectrometry (MALDI-
MS) on a Voyager-DE PRO mass spectrometer (Applied Biosystems, Framingham, MA) 
by Connie Bonham.  
 
Standard Conditions for Vent PCR. Standard PCRs (50 µL final volume) contained Vent 
DNA polymerase (1 unit), two ODNs (50 nmol each, Table 4.2), template DNA (14 ng), 
dNTPs (25 nmol each), MgCl2 (2 mM), and 1x thermopol buffer (20 mM Tris-HCl, 10 
mM (NH4)2SO4, 10 mM KCl, 0.1% Trition® X-100, pH 8.8). PCR products were 
amplified with standard conditions: annealing temperature of 52 °C with a 30 s hot start 
followed by melting, annealing, and extension times of 30 s, 60 s, and 30s for 25 cycles 
with a final extension time of 5 min. 
 
Generation of Protein Production Strain CC1215. Strain CC1215 was created using a 
previously published protocol.13 P1 lysates [W3110] were a gift of Dr. Ronald 
Somerville. The Keio strain JW0512 served as the donor and BL21(DE3) served as the 
recipient strain. 
 
P1 Lysate Preparation: JW0512 cells were grown overnight on LB-Kan plates and a 
single colony was used to inoculate a 5 mL overnight LB-Kan culture. A portion of the 
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saturated overnight culture (50 µL) was mixed with 2.5 mL of molten top agar and plated 
onto LB soft agar plates supplemented with CaCl2 (2.5 mM). P1 [W3110] lysate (50 µL) 
was spotted onto the solidified top agar and grown overnight. Lytic plaques were excised 
from the top agar with a nickel spatula and transferred to 0.5 mL of LB in a sterile 15 mL 
falcon tube. Tubes were then vortexed and incubated at room temperature for 30 min. A 
portion of saturated overnight JW0512 culture (100 µL) was added to each tube and 
incubated at room temperature for an additional 30 min. A control incubation was carried 
out lacking any P1 lysate. Molten top agar (2.5 mL) was added to each tube, mixed 
gently, and then poured on top of LB soft agar plates supplemented with CaCl2 (2.5 mM). 
Plates were grown at 37 °C for 8 h until they had a “lacey” appearance. After 8 h, the 
plates were flooded with 3-5 mL of LB and placed at 4 °C overnight. Lysate was pipetted 
off, transferred into sterile glass screw-cap vials, and chloroform (~100 µL) was added. 
The tubes were shaken forcefully and then centrifuged (2000 g, 10 min) at 4 °C to pellet 
bacteria. Lysates (P1 [JW0512]) were then decanted into sterile glass screw-cap vials for 
storage at 4 °C. Portions of the lysates were streaked onto LB plates to ensure the lysate 
had no bacterial contamination. 
 
P1 Transduction: BL21(DE3) cells were grown overnight on LB plates and a single 
colony chosen to inoculate a 5 mL overnight LB culture. A 10 mL LB culture was 
inoculated at 1:100 and grown at 37 °C, shaking for 2-3 h to reach log phase (OD600=0.3-
0.7). The cells were centrifuged (5000 g, 15 min) at 4 °C, the resulting supernatant 
discarded, and cells resuspended in 1 mL of LB. Donor strain lysate, P1 [JW0512], was 
mixed with an equal volume of sterile 0.85% (w/v) saline (1 mL) in a 60 x15 mm petri 
dish. The dish was placed ~30 cm under a UV-lamp (254 nm), with the lid removed, and 
incubated for 5 min. Transductions were carried out in duplicates: 1 mL irradiated lysate, 
0.05 mL CaCl2 (0.5 M stock), and 0.1 mL of concentrated log phase BL21(DE3) cells. 
Control transductions contained 0.1 mL of LB in place of irradiated lysate. The 
transductions were incubated at 37 °C for 20 min and then a portion (0.1 mL) was plated 
undiluted, 1:3, and 1:15 on LB Kan plates. The resulting colonies were streaked onto M9 
minimal media plates lacking exogenous purines and grown overnight at 37 °C to test for 
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purine autotrophy. Kan cassette insertion from the donor strain JW0512 into BL21(DE3) 
was confirmed by PCR with ODNs 1161 and 1164. 
Construction of AaPurE1 Plasmids for Protein Expression. Plasmid pJK175, which 
encodes the wild-type AaPurE1, was used as a template for the generation of serine 
mutants.1 Mutants were generated using Quikchange II mutagenesis kits (with standard 
PCR conditions outlined in in Chapter 3) with plasmid pJK175 (25 ng) as template, and 
the appropriate ODNs (Table 4.2) to create plasmids pJK582 (AaPurE1-S57A), pJK583 
(AaPurE1-S57C), pJK584 (AaPurE1-S57T), pJK608 (AaPurE1-S57D), pJK677 
(AaPurE1-S57V), and pJK686 (AaPurE1-S57N). 
Construction of TdPurE2 Plasmids for Protein Expression. Plasmid pJK376, which 
encodes the wild-type TdPurE2, was used as a template for the generation of serine 
mutants.2 Mutants were generated using Quikchange II mutagenesis kits (with standard 
PCR conditions outlined in in Chapter 3) with plasmid pJK376 (25 ng) as template, and 
the appropriate ODNs (Table 4.2) to create plasmids pJK607 (TdPurE2-S38C), pJK617 
(TdPurE2-S38A), pJK684 (TdPurE2-S38V), and pJK685 (TdPurE2-S38N).  
Construction of TdPurE2–S38T Construct Plasmid pJK643.  The general cloning strategy 
is illustrated in Chapter 3 (Figure 3.4). A 0.21 kb primary PCR product containing purE2 
was amplified using standard Vent PCR conditions from template pJK376 (14 ng), using 
ODNs 2124 and 2316. The crude product was digested with DpnI and purified using a 
Qiagen PCR purification kit. A 0.55 kb product containing purE2 was amplified using 
standard Vent PCR conditions from template pJK376 (14 ng), using ODNs 2125 and 
2317. The crude product was digested with DpnI and purified using a Qiagen PCR 
purification kit. Cross-over PCR product was obtained using standard Vent PCR 
conditions, with a single exception: the annealing time was increased to 1 min, from a 
mixture containing primary PCR products (25 ng each) and ODNs 2124 and 2125.  The 
0.79 kb cross-over was digested with NdeI and XhoI, and ligated into the same sites of the 




Construction of TdPurE2–S38D Construct Plasmid pJK644. A 0.21 kb primary PCR 
product containing purE2 was amplified using standard Vent PCR conditions from 
template pJK376 (14 ng), using ODNs 2124 and 2320. The crude product was digested 
with DpnI and purified using a Qiagen PCR purification kit. A 0.55 kb product 
containing purE2 was amplified using standard Vent PCR conditions from template 
pJK376 (14 ng), using ODNs 2125 and 2321. The crude product was digested with DpnI 
and purified using a Qiagen PCR purification kit. Cross-over PCR product was obtained 
using standard Vent PCR conditions, with a single exception: the annealing time was 
increased to 1 min, from a mixture containing primary PCR products (25 ng each) and 
ODNs 2124 and 2125. The 0.79 kb cross-over product was digested with NdeI and XhoI, 
and ligated into the same sites of the destination vector pET23a to yield TdPurE2-S38D 
expression plasmid pJK644.  
 
Construction of TdPurE2–S38T,F79W Construct Plasmid pJK653. A 0.21 kb primary 
PCR product containing purE2 was amplified using standard Vent PCR conditions from 
template pJK648 (14 ng), using ODNs 2124 and 2316. The crude product was digested 
with DpnI and purified using a Qiagen PCR purification kit. A 0.55 kb product 
containing purE2 was amplified using standard Vent PCR conditions from template 
pJK648 (14 ng), using ODNs 2125 and 2317. The crude product was digested with DpnI 
and purified using a Qiagen PCR purification kit. Cross-over PCR product was obtained 
using standard Vent PCR conditions, with a single exception: the annealing time was 
increased to 1 min, from a mixture containing primary PCR products (25 ng each) and 
ODNs 2124 and 2125. The 0.79 kb cross-over product was digested with NdeI and XhoI, 
and ligated into the same sites of the destination vector pET23a to yield TdPurE2-
S38T,F79W expression plasmid pJK653.  
 
Construction of TdPurE2–S38C,F79W Construct Plasmid pJK659. A 0.21 kb primary 
PCR product containing purE2 was amplified using standard Vent PCR conditions from 
template pJK648 (14 ng), using ODNs 2124 and 2366. The crude product was digested 
with DpnI and purified using a Qiagen PCR purification kit. A 0.55 kb product 
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containing purE2 was amplified using standard Vent PCR conditions from template 
pJK648 (14 ng), using ODNs 2125 and 2367. The crude product was digested with DpnI 
and purified using a Qiagen PCR purification kit. Cross-over PCR product was obtained 
using standard Vent PCR conditions, with a single exception: the annealing time was 
increased to 1 min, from a mixture containing primary PCR products (25 ng each) and 
ODNs 2124 and 2125 The 0.79 kb cross-over product was digested with NdeI and XhoI, 
and ligated into the same sites of the destination vector pET23a to yield TdPurE2-
S38C,F79W expression plasmid pJK659. !
Construction of T. denticola purE2–H17W,S38T Construct Plasmid pJK692. A 0.651 kb 
product containing pur2E was amplified using standard Q5 PCR conditions from 
template pJK643 (14 ng), using ODNs 2125 and 2393 with a extension time of 1 min. 
The PCR product was digested with NdeI and XhoI, and ligated into the same sites of the 
destination vector pJK643 to yield TdPurE2-H17W,S38T expression plasmid pJK692.  
Construction of TdPurE2–M15W,S38T Construct Plasmid pJK697. The general cloning 
strategy is illustrated in Figure 3.6. ODNs 2398 and 2399 (100 nmol each) were 
phosphorylated, annealed, and ligated at a 1:20 molar ratio of vector: linker into the NheI 
and BamHI sites of destination vector pJK692 to yield TdPurE2-M15W,S38T expression  
plasmid pJK697. 
Cell Growth Media. M9 minimal media plates (1 L) contained: 750 mL H2O autoclaved 
with 20 g of agar, was mixed with 200 mL sterile 5x M9 salts, 20 mL sterile 20% 
glucose, 10 mM thiamine, 100 ug mL-1 Amp and 70 ug mL-1 Kan (30 mL media per 
plate). A control set of plates was supplemented with hypoxanthine (0.1 mM) as an 
exogenous source of purines. Autoinduction media (ZYM-5052) used for expression of 
TdPurEs was prepared as previously published.14 
Functional Complementation of JW0512. Plasmids containing AaPurE1-S57X and 
TdPurE2-S38X mutants and pET23a (negative control) were transformed into Keio strain 
JW0512 (ΔpurE) and assessed for their ability to restore purine prototrophy on solid M9 
minimal media. Cells were grown for 16 h on LB-Amp/Kan plates and a single colony 
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was used to inoculate a 5 mL LB-Amp/Kan culture that was then grown to log phase 
(OD600=0.3-0.7) at 37 °C. Cultures were back-diluted to OD600=0.0005 and 10 µL was 
applied to solid M9 minimal media. A duplicate set of plates was grown in a high CO2 
environment. This high CO2 environment was achieved by placing the plates along with a 
lit candle into a desiccator. The desiccator was sealed and the candle was allowed to 
extinguish. The desiccator was then placed into a large 37 °C incubator. 
Mutant AaPurE1 Overexpression and Isolation. AaPurE1-S57X mutants were 
overexpressed and isolated like wild-type AaPurE11 (Chapter 3), with a single exception: 
the buffers used to isolate AaPurE1-S57C contained 20 mM 2-mercaptoethanol. Fresh 
column media were used for each mutant to avoid any possibility of cross-contamination. 
AaPurE1 mutants were concentrated to >3 mg mL-1 with an Amicon ultrafiltration device 
containing a YM30 membrane. The protein solutions were frozen by drop-wise addition 
to liquid N2 and stored at -80 °C. 
 
Mutant TdPurE2 Overexpression and Isolation. TdPurE2-S38X,F79W was 
overexpressed and isolated like wild-type TdPurE2 (Chapter 3),2 with two exceptions: the 
lysis buffer contained PMSF (1 mM) and the buffers used to isolate TdPurE2-S38C 
contained 20 mM 2-mercaptoethanol. Fresh column media were used for each mutant to 
avoid any possibility cross-contamination. TdPurE2 mutants were concentrated to >3 mg 
mL-1 with an Amicon ultrafiltration device containing a YM30 membrane. The protein 
solution was frozen by drop-wise addition to liquid N2 and stored at -80 °C. 
 
Quantitation of Free Sulfhydryl Groups in AaPurE1-S57C. AaPurE1-S57C was 
incubated with 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB, Ellman’s reagent) to 
determine the oxidation state of two Cys, one Cys (Cys97) near the surface and the active 
site Cys mutant. DTNB reactions were performed according to a previous protocol.15 A 1 
cm path length cuvette contained (final volume of 0.5 mL) 100 mM Tris-HCl, pH 8 with 
DTNB (10 mM) added immediately prior to the start of the experiment. Reactions were 
initiated by the addition of AaPurE1 or AaPurE1-S57C (10 nmoles, 20 µM) and the 
absorbance at 412 nm was monitored. The number of unmodified Cys (free thiols) was 
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determined by using the observed absorbance at 412 nm (ε412 = 14,150 M-1 cm-1).  
Proteins were quantified by the method of Bradford12 with bovine serum albumin as the 
standard. 
 
PurE1 and PurE2-Mediated Decarboxylation Assays. Continuous assays of PurE1 and 
PurE2-mediated CAIR decarboxylation were performed according to a published 
method.1 A final volume of 0.6 mL in a masked, 1 cm pathlength cuvette containing 50 
mM Tris-HCl, pH 8 and 100 µM CAIR was incubated at 30 °C for at least 3 min. High 
concentrations of CAIR (>100 µM) required the use of a 0.5 cm cuvette. Reactions were 
initiated by addition of either an AaPurE1 or TdPurE2 mutant (12-80 ng, 1.4-8.4 nM 
[subunits]). The initial velocity of CAIR decarboxylation to AIR (∆ε260 =8930 M-1 cm-1) 
was recorded at 260 nm, with a small background decarboxylation rate subtracted. CAIR 
was quantitated by endpoint assay using the same method, except that 50 µg mL−1 
TdPurE2 was the enzyme. A unit is defined as the amount of enzyme that forms 1 µmol 
of product per minute. 
 
PurE1 and PurE2 CAIR Decarboxylation pH-Rate Profiles. The initial rates of reaction 
for AaPurE1-S57C, AaPurE1-S57A, TdPurE2-S38C and TdPurE2-S38D were 
determined as above, except that a triple buffer system (100 mM Tris-HCl, 50 mM MES, 
50 mM acetic acid) was used across different pHs, and various ∆ε260 values for 
CAIR→NCAIR were used.1 Reactions contained variable amounts of CAIR (2-200 µM) 
and variable amounts of AaPurE1 and TdPurE2 (12-80 ng, 1.4-8.4 nM [subunits]). 
Velocity (units mg-1) at each pH was plotted as a function of [CAIR] and the data fit to an 
alternative Michaelis-Menten equation (equation 4.1) where j = (Vmax/Km). Values of kcat 
and kcat/Km were plotted as a function of pH and fit to equation 4.2 (or equation 4.3 for  
AaPurE1-S57C kcat, which accounts for two ionizations). AaPurE1-S57A kcat and kcat/Km 
were fit to equation 4.4, which accounts for two ionizations. 
! = ! !!! ! /!!                 Equation 4.1 
 !
129 
log ! = ! − !!×!!"     Equation 4.2 
log!!"# = log !!"#!!! !"! !! !!!!!!!!!!!    Equation 4.3 
 log! = log !!! !!!! !!!      Equation 4.4 
 
Determination of Extinction Coefficients for SAICAR at Varying pH. The extinction 
coefficient is known for SAICAR at pH 7.5, which allows for the computation of ∆ε282 
for CAIR→SAICAR at various pHs. SAICAR solutions (350-500 µM) were obtained 
from AIR carboxylation assays in which the reaction was allowed to go to completion. 
SAICAR solutions were diluted into varying buffers at different pHs (triple buffer at pH 
6, 6.5, 7, 7.5, 8, and 9) and recorded in at least triplicate and corrected for background 
ATP contribution at 282 nm. The recorded A282 was used to calculate a ∆ε282 for each pH 
(with the known SAICAR ∆ε282 = 8607 M-1 cm-1 at pH 7.5). Calculated ∆ε282 values were 
plotted against pH and fit to a linear equation.  
AaPurE1 NCAIR→CAIR pH-Rate Profiles. Continuous assays of PurE1-mediated CAIR 
carboxylation were performed according to a published method.16 Assays were carried 
out at 23 °C in in a final volume of 0.7 mL, 1x triple buffer (100 mM Tris-HCl, 50 mM 
MES, 50 mM acetic acid) of varying pH, 10 mM MgCl2, 2 mM PEP, 0.5 mM ATP, 10 
mM L-aspartate, 1 mM KHCO3, 1.2 units of pyruvate kinase (477 units mg-1, Sigma 
P9136), 5 units of H6PurK (isolated by Jesse Murphy), 4 units of H6PurC (isolated by 
Jesse Murphy), and varying amounts of AaPurE1s. After pre-incubation for 3 min the 
reaction was initiated by the addition of AIR (12.5-500 µM) and SAICAR formation 
monitored directly (∆ε282 = 128.04 x pH + 7684.4, units of M-1 cm-1). Velocity (units mg-
1) at each pH was plotted as a function of [CAIR] and the data were fit to equation 4.1. 
Values of kcat and kcat/Km were plotted as a function of pH and fit to equation 4.4. 
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Fluorescence Titrations. Spectra were obtained using a 1 cm pathlength fluorometer cell 
that contained 2.0 mL prior to the titration. The excitation wavelength was 295 nm (2 nm 
slit width) and emission spectra were collected from 305 to 450 nm (5 nm slit width). A 
buffer only-spectrum was subtracted from as the background from all spectra. The 
intensity of the fluorescence emission F for each titration point was measured at 320 nm 
and then corrected for dilution. 
 
Citrate Titrations (0-25 mM final concentration, added from a 200 mM stock, pH 4.6) 
were performed in 50 mM potassium acetate, 100 mM KCl, pH 4.6, with varying 
amounts of AaPurE1 or TdPurE2 at 25 °C. Emission intensities at 320 nm (F) were 
divided by the intensity at zero ligand (L) concentration (F0) to obtain fractional 
saturation values. The AaPurE1 titration data were fit using gnuplot 4.4 to a binding 
isotherm (equation 4.2) by allowing Kd and ΔF (the value of F/F0 as [L] →∞) to vary. 
!!! = 1− ΔF! [!][!]!!!        Equation 4.5 
AIR titrations (0-25 µM final concentration, added from a 600 µM stock in 50 mM Tris-
HCl, pH 8) were performed in 50 mM Tris-HCl, pH 8 with varying amounts of AaPurE1 
at 30 °C. Emission intensities at 320 nm (F) were divided by the intensity at zero ligand 
(L) concentration (F0) to obtain fractional saturation values. The data were fit using 
Origin to a binding isotherm (equation 4.5) by allowing Kd and ΔF (the value of F/F0 as 
[L] →∞) to vary.  
 
Solution Studies of AaPurE1s. Solution aggregation state was determined on an AKTA 
FPLC system (Amersham) using a Pharmacia G200-16/60 high-load column. The mobile 
phase was 50 mM Tris-HCl, 100 mM KCl, pH 8 applied at 1 mL min-1. Injections (100 
µL) contained 0.5 mg of protein adjusted to 5% (v/v) glycerol. Protein solution sizes and 
aggregation states were determined by comparison with protein size standards (29-669 
kDa; Sigma MW-GF-1000), blue dextran (2 MDa; Vo), and acetone (60 Da, Vi) using the 
Kav partition coefficient method 17. 
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Crystallization and Soaking of AaPurE1s. AaPurE1 forms intended for crystal production 
were buffer-exchanged into 5 mM Tris-HCl, 15 mM NaCl, pH 8 and concentrated to 10 
mg mL-1 using Millipore Ultra spin columns (MWCO 30000). Crystals were grown by 
the hanging drop vapor diffusion method using reservoir solutions containing 25-35% 
PEG 4000, 200 mM LiSO4, 100 mM Tris-HCl, pH 8.3. To generate nucleotide bound 
complexes, AaPurE1 crystals were soaked for 1-3 h in artificial mother liquor containing 
5 mM CAIR. 
 
Crystallization of TdPurE2s. TdPurE2 forms intended for crystal production were buffer 
exchanged into 5 mM Tris-HCl, 20 mM KCl, pH 8 and concentrated to 10 mg mL-1 using 
Millipore Ultra spin columns (MWCO 30000). Crystals were grown by the hanging drop 
vapor diffusion method using reservoir solutions containing 14-16% PEG 1000, 100mM 
MgCl2, 100 mM imidazole, pH 8.  
 
X-ray Data Collection and Processing. Prior to data collection, AaPurE1 crystals were 
placed briefly into a cryoprotectant solution that consisted of artificial mother liquor with 
an additional 2% PEG 4000 and 15% (v/v) ethylene glycol. TdPurE2 crystals were placed 
briefly into a cryoprotectant solution that consisted of artificial mother liquor and 20% 
(v/v) ethylene glycol. Crystals were immediately flash-cooled in liquid N2. X-Ray 
diffraction data were collected on either a MAR-225 or MAR-300 CCD detector at the 
LS-CAT beamline (Advanced Photon Source - Argonne National Laboratory). 
Diffraction data were indexed, integrated, and scaled with HKL-2000.. 
 
Structure Determination and Refinement. All crystals had the same space group with 
similar unit cell parameters, previously observed in structures of AaPurE1.1,18 Molecular 
replacement was performed using AutoMR/Phaser19 with AaPurE1 monomer (PDB code 
2fw1 chain A) as the search model. Structures for AaPurE1-S57A, AaPurE1-S57C, 
AaPurE1-S57T, AaPurE1-S57D, AaPurE1-S57N, and AaPurE1-S57V were determined 
by using the AaPurE1fwf  monomer (PDB code 4YCB chain A) as the search model. The 
TdPurE2-S38D crystal had the same space group with similar unit cell parameters, t to a 
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previous TdPurE2 structure.2 Early rounds of refinement were performed using rigid 
body, simulated annealing, Cartesian coordinate optimization, individual isotropic 
temperature factor refinement, and automatic water picking in PHENIX 20. Later rounds 
of refinement were performed using Cartesian coordinate optimization, individual 
isotropic temperature factor refinement, automatic water picking, automatic outlier 
correction, and occupancy refinement. Model building, manual inspection, and rebuilding 
were performed using Coot 21. Coordinates and structure factors have been deposited in 
the RCSB Protein Data Bank (PDB) with accession numbers TBD (AaPurE1-S57A), 
TBD (AaPurE1- S57C), TBD (AaPurE1-S57T), TBD (AaPurE1-S57V), TBD (AaPurE1-




Construction of CC1215 Strain. Recombinant PurE expression was carried out in 
BL21(DE3) cells that contain an endogenous copy of EcPurE1. The generation of the 
CC1215 strain ensures there is no contamination of endogenous EcPurE1 in recombinant 
PurE1 and PurE2 isolations.  
 
The Keio strain JW0152 contains an in-frame replacement of the purE1 gene with a 
kanamycin resistance cassette.23 The use of P1 phage transduction to transfer the 
kanamycin cassette to the BL21(DE3) strain was straightforward and successful on the 
first attempt.  
 
Creation of AaPurE1 and TdPurE2 Mutants. AaPurE1-S57X and TdPurE2-S38X 
mutants were generated to investigate the role of the absolutely conserved active site 
serine.  
 
The most stable AaPurE1 mutant, Ser→Thr was chosen as the background to test the 
stability of Trp introduction mutants. TdPurE2-M15W,S38T; TdPurE2-H17W,S38T; 
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TdPurE2-F79W; TdPurE2-F79W,S38T; and TdPurE2-F79W,S38C mutants were 
generated to determine if an intrinsic fluorophore (Trp) could be introduced into TdPurE2 
for obtaining kinetic parameters by fluorescence methods. 
 
Quikchange site directed mutagenesis was successful in generating the AaPurE1-S57X 
mutants and some TdPurE2-S38X mutants (Table 4.4). TdPurE2 mutants proved to be 
very difficult to generate by standard Quikchange mutagenesis. Therefore, cross-over 
PCR was employed to generate most TdPurE2 mutants. Cross-over PCR was performed 
using standard techniques with a single addition to the protocol, a DpnI digestion step 
was introduced after the primary PCR to ensure the parental plasmid did not contaminate 
the secondary PCR. This extra step significantly decreased the amount of false-positive 
colonies (data not shown). Finally, a cassette carrying the M15W mutation was generated 
from synthetic oligonucleotides and ligated into a plasmid encoding TdPurE2-
H17W,S38T to replace the H17W mutation. Multiple molecular cloning techniques were 
used to generate TdPurE2 plasmids because Quikchange repeatedly failed. Sequencing 
confirmed all the intended mutations were obtained.  
 
Functional Complementation of JW0512. Ser mutants were assessed for the ability to 
restore prototrophy to the Keio strain JW012 (ΔpurE1). Only wild-type PurE1 and PurE2 
complement a ΔpurE1 strain under normal atmospheric conditions. This is consistent 
with the low specific activites obtained for all S57X and S38X mutants (Tables 4.4 and 
4.6).  
Of the AaPurE1-S57X mutants, only AaPurE1-S57T complemented under high CO2 
conditions. Under high CO2 levels, TdPurE2-S38T complemented almost as well as wild-
type TdPurE2. While this mutant has the highest residual activity in vitro, it did not 
produce crystals and its combination with any additional mutation (M15W, H15W, or 
F97W) was highly destabilizing. There may be enough activity in TdPurE2-S38T to 
support growth on minimal media, or some component in vivo such as a chaperone may 
help to stabilize TdPurE2-S38T. Cells producing either TdPurE2-S38A or TdPurE2-
S38C grow after 120 h (Table 4.4).  
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Purification of Recombinant AaPurE1-S57X Mutants. The previously published isolation 
protocol1 was successfully used to isolate all AaPurE1 forms with varying specific 
activites and high purity (Table 4.9, Figure 4.5, and Figure 4.7).  
 
Purification of Recombinant TdPurE2-S38X Mutants. The previously published isolation 
protocol2 was successfully used to isolate all TdPurE2 forms with varying specific 
activites and high purity (Table 4.9, Figure 4.6, and Figure 4.7).  
 
Purification of Recombinant TdPurE Tryptophan Introduction Mutants. The previously 
published isolation protocol2 was successfully used to isolate all TdPurE2 forms with 
varying specific activites and high purity (Table 4.9 and Figure 4.8).  
 
Forms not suitable for further analyses were: TdPurE2-S38T,F79W (activity is lost when 
diluted and cannot be stored), TdPurE2-H17W,S38T (retains only 4% of TdPurE-S38T 
activity), and TdPurE2-M15W,S38T (precipitates out of solution during isolation). It 
appears the addition of multiple mutations to TdPurE2 creates an unstable protein.  
 
Solution Studies of AaPurE1 Forms. Analytical size exclusion chromatography was used 
to determine the biological unit and relative stability of each AaPurE1-S57X mutant. Gel-
filtration analyses confirmed the presence of the PurE octamer for all AaPurE1 forms, but 
also showed formation of some high molecular weight aggregates (Figure 4.9). AaPurE1-
S57V has a peak at ~76 mL that corresponds to dissociation into tetramers.  !
Citrate Titrations of AaPurE1-S57X Mutants. Citrate is a non-substrate active site ligand 
that binds AaPurE1 weakly, under acidic conditions, leading to protein fluorescence 
quenching.1 While it has little resemblance to CAIR, citrate interacts with the protonated 
form of the key His59 and all nucleotide-binding residues, except for the phosphate 
contact Ser32 and the exocyclic amine contacts in the 70s loop backbone. Therefore, 
titrations were carried out in 50 mM potassium acetate, 100 mM KCl, pH 4.6 with all 




The fluorescence of all AaPurE1-S57X mutants was quenched by the addition of citrate. 
Mutation of Ser decreases the affinity for citrate (Table 4.9 and Figure 4.10), indicating 
that the hydrogen bond provided by Ser is likely involved in binding citrate. The inactive 
mutant AaPurE1-S57D does bind citrate and, along with crystal structures, indicates that 
the active site is intact (Figure 4.17). 
AIR Titrations of AaPurE1-S57X Mutants. AIR is not a substrate for PurE1, it instead acts 
as a inhibitor.24 The addition of AIR to active AaPurE1 forms results in small increase as 
result of a fluorescent species present in AIR (Chapter 2). AIR titrations were carried out 
in 50 mM Tris-HCl, pH 8.0.  
The addition of AIR to AaPurE1-S57X mutants had little or no effect on fluorescence 
emission intensity, consistent with earlier studies of active PurE1s (Table 4.9 and Figure 
4.11).1,6 AaPurE1-S57A did have enough signal to obtain a Kd which was similar to wild-
type, indicating that Ser may not be involved in substrate binding. Alternatively, the 
replacement of Ser57 with a smaller side chain, could allow an adventitious water to 
provide a hydrogen bond to the AIR N3.  
Crystallization of AaPurE1-S57X Mutants. Structures were obtained for all six Ser 
mutants (Tables 4.7- 4.8 and Figure 4.12). The structures of AaPurE1-S57X mutants 
confirm that the active sites are intact, with the exception of AaPurE-S57C (Figure 4.13).  
The electron density surrounding the Cys57 residues clearly indicates the oxidized 
species are cysteine sulfenic and cysteine sulfinic acid, even before the acids are 
introduced into the model (Figure 4.13). The oxidation could be due to radiation damage 
or components (PEG 4000) in the crystallization solution.  
 
The existence of oxidized cysteines in the AaPurE1-S57C active site was examined using 
DTNB. AaPurE1-S57C isolated without 2-mercaptoethanol present was used to 
determine the oxidation state of the active site cysteine. AaPurE1 was used to determine 




Five independent replicates were performed with each form of AaPurE1 and the average 
amount of TNB formation was calculated. The amount of TNB formation for AaPurE1 is 
0.1 ± 0.01 thiol/subunit and the amount of TNB formation for AaPurE-S57C is 1.12 ± 
0.04 thiol/subunit. These results indicate Cys94 is largely inaccessible to DTNB and that 
a 1:1 molar relationship of TNB to the active site Cys57 exists. Therefore, the AaPurE-
S57C mutant is not oxidized in solution.  
Mass Spectrometric Analysis of AaPurE1-S57C. MALDI Mass Spectrometric analysis 
was performed with AaPurE-S57C to determine if Cys57 is oxidized in solution. The 
mass for AaPurE1-S57C is consistent with the presence of cysteines and not the oxidized 
form(s) (Table 4.6). 
 
Crystallization of TdPurE2-S38X mutants. Crystals of TdPurE2-S38X mutants were 
harder to obtain and most resulted in modest diffraction at ~6-8 Å. However, a 1.69 Å 
structure was obtained for TdPurE2-S38D (Tables 4.7-4.8 and Figure 4.14). A model of 
the Asp38 mutant, with AIR transferred from the TdPurE2•AIR structure (PDB code 
3rgg)2, reveals a steric clash between the Asp carboxylate and AIR N3. In addition, the 
active site His appears to be displaced by 2.0 Å in the S38D structure (Figure 4.14). The 
S38D mutant is active therefore; it is likely that a conformational change occurs in S38D 
that allows CAIR to bind and decarboxylation to occur.  
 
Kinetic Characterization of AaPurE1-S57X Mutants at pH 8.  Kinetic constants (Km and 
kcat) for CAIR decarboxylation were obtained for all active forms of AaPurE1-S57X 
mutants. Of the mutants tested, only Thr, Ala, Val, and Cys mutants had detectable 
catalytic activity. Asn and Asp mutants had no detectable activity.  
We then wondered if AaPurE1-S57D might be active at low pH, which could allow 
protonation of this more acidic residue. AaPurE1-S57D did not have activity at pH 6, 
indicating that protonation of the Asp may not be sufficient to allow catalysis. Both Asp 
and Asn are may be too bulky (and negatively charged in the case of the Asp) to permit 
CAIR binding. All active mutants, with the exception of AaPurE1-S57V, could be 
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saturated with substrate under assay conditions (Table 4.9 and Figure 4.15). The higher 
Km of AaPurE1-S57V may indicate that Val inhibits CAIR binding.  
The Kms of AaPurE1-S57X mutants (with the exception of S57V) are relatively 
unchanged relative to wild-type. This observation suggests that Ser57 is not essential for 
substrate binding, but that loss of the hydrogen bond provided by Ser does negatively 
affect catalysis. 
Kinetic Characterization of TdPurE2-S38X Mutants at pH 8. All Ser mutants retained a 
low level of activity, lower than the corresponding AaPurE1-S57X mutants, with the 
exception of TdPurE2-S38V. Of the mutants tested, only Thr, Ala, Val, Cys, and Asn had 
detectable activity. Asp mutants had no detectable activity at pH 8. However, TdPurE2-
S38D had detectable activity at pH 6 (Figure 4.16).  
Kinetic constants (Km and kcat) for CAIR decarboxylation were only obtained for the 
TdPurE2-S38C mutant at pH 8 (Table 4.8 and Figure 4.16, panel A). Comparison of the 
TdPurE2 and TdPurE2-S38C kinetic parameters suggests that both binding and catalysis 
are affected by the loss of a hydrogen bond normally provided by Ser57. 
 
At low substrate concentration, both TdPurE2-S38T and TdPurE2-S38A mutants had 
slightly sigmoidal saturation curves (Figure 4.16, panels B and C). These mutations 
appear to destabilize TdPurE2; crystals of either mutant were not obtained. Both 
TdPurE2-S38T and TdPurE2-S38V mutants show substrate inhibition above 100 µM  
CAIR, indicating that CAIR may act as an inhibitor at high concentrations (Figure 4.16, 
panels B and D).  
While mutation of the universal Ser appears to destabilize both AaPurE1 and TdPurE2, 
the mutation of Ser38 impacts TdPurE2 activity more profoundly. AaPurE1 demonstrates 
heat and acid stability beyond a protein from a mesophilic bacterium.1 We have 
uncovered that TdPurE2 cannot tolerate mutations as well as AaPurE1. 
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pH Rate Profiles. By determining the velocity of a reaction at varying pH we can obtain 
the pKa(s) of ionizable groups on the enzyme and substrate necessary for binding and 
catalysis to occur. We can also determine the proton stoichiometry of the ionizable 
groups involved. However, assigning the pKa values to a specific residue or a chemical 
moiety of the substrate is difficult. We generated pH rate profiles of AaPurE1-S57X and 
TdPurE2-S38X mutants to gain insight into the ionizations that occur when Ser57 is 
replaced by an ionizable residue. A triple buffer system was used to ensure constant ionic 
strength for each pH tested. 
 
The log kcat/Km versus pH rate profile reports on ionizations within the free enzyme and 
free substrate. Changes in the kcat/Km across pHs are suggestive of ionizations required for 
productive binding of substrate. The log kcat versus pH rate profile reports on ionizations 
within the Michaelis complex (ES). Changes in the kcat across pHs are suggestive of 
ionizations required in the ES complex for catalysis.  
 
CAIR Decarboxylation pH Rate Profiles for AaPurE1-S57X Mutants. To further 
investigate the effect of protonation at the Ser position in PurE1, pH rate profiles were 
constructed using the AaPurE1-S57C ionizable mutant. pH rate profiles were constructed 
with AaPurE1-S57A to examine the effect of pH without an ionizable residue at the Ser 
position. We expected the effect of pH on AaPurE1-S57A activity to match that of wild-
type but with lower activity. 
 
AaPurE1-S57A initial velocity data from each pH were fit using equation 4.4. Both the 
log kcat/Km versus pH and log kcat versus pH data produced bell shaped profiles consistent 
with two pKas. The likely origin of pK1 is the N3 of CAIR and pK2 is His59.1,6 AaPurE1-
S57C initial velocity data from each pH were fit to equations 4.2 and 4.3. The log kcat/Km 
versus pH data produced a log-linear fit with a slope near negative unity and the log kcat 




kcat/Km pH Rate Profiles. The log kcat/Km versus pH profiles for both wild-type and 
AaPurE1-S57A are similar bell-shaped curves with comparable pKas (pK1 = 6.0 ± 0.1 and 
5.9 ± 0.1, respectively; pK2 = 7.2 ± 0.1 and 8.3 ± 0.2, respectively) (Figure 4.17, panel 
A), indicating similar ionizations are required for CAIR binding in both AaPurE1 and 
AaPurE1-S57A.1  
 
The log kcat/Km versus pH profile for AaPurE1-S57C demonstrates log-linear dependence 
on pH, fit to equation 4.2 yielded a slope of -0.86 ± 0.03, indicating that a single 
ionizable proton is required for the free enzyme or free substrate to bind CAIR (Figure 
4.17, panel A). The proton required may be located on the active site His or on the ribose 
5’-phosphate (pKa = 6.3),24 but could be located on any ionizable group involved in 
CAIR binding. 
 
kcat  pH Rate Profiles. The log kcat versus pH profiles for both wild-type and AaPurE1-
S57A are similar bell-shaped curves with comparable pKas (pK1 = 5.1 ± 0.2 and, = 5.8 ± 
0.1 respectively; pK2 = 8.4 ± 0.1 and 8.6 ± 0.1, respectively)1 (Figure 4.17, panel B).  
 
The log kcat versus pH profile for AaPurE1-S57C fit to a model in which two protons 
with indistinguishable pKas (averaging ~6.7) are required for activity. One of the pKas is 
likely associated with the active site His. The other pKa may be associated with the active 
site Cys, however, this would require the pKa be lowered to around 7.  
 
CAIR Decarboxylation pH Rate Profiles of TdPurE2-S38X Mutants. To further 
investigate the effect of protonation at the Ser position in PurE2, pH rate profiles were 
constructed using the TdPurE2-S38C and TdPurE2-S38D ionizable mutants. TdPurE2-
S38C and TdPurE2-S38D initial velocity data from each pH were fit to equation 4.2. All 
the log kcat/Km versus pH and log kcat versus pH data produced log-linear fits.  
 
kcat/Km pH Rate Profiles. The log kcat/Km versus pH profiles for wild-type TdPurE2 is a 




The log kcat/Km versus pH profiles for TdPurE2-S38C and TdPurE2-S38D did 
demonstrate log-linear dependence on pH, fits to equation 4.2 yielded a slopes of  -0.21 ± 
0.06 and -0.90 ± 0.04, respectively (Figure 4.18, panel A). The Asp pKa is much lower 
than that of the Cys, indicating that Asp protonation is likely required for CAIR binding. 
 
kcat  pH Rate Profiles. The log kcat versus pH profile for wild-type TdPurE2 is a bell-
shaped curve with pK1 = 5.9 ± 0.5 and pK2 = 8.4 ± 0.1 (Figure 4.18 panel B).2  
 
The log kcat versus pH profiles for TdPurE2-S38C and TdPurE2-S38D demonstrate log-
linear dependence on pH, fits to equation 4.2 yielded slopes of -0.52 ± 0.09 and -1.5 ± 
0.08, respectively. This difference in slopes (exactly -1) of the two S38X mutants is 
likely due to the protonation of the Asp.  
   
NCAIR→CAIR pH Rate Profiles of AaPurE1 and AaPurE1-S57C. . To further investigate 
the effect of protonation at the Ser position in PurE1, pH rate profiles were constructed in 
the biosynthetic direction (NCAIR→CAIR) with AaPurE1 and AaPurE1-S57C. 
AaPurE1 and AaPurE1-S57C initial velocity data from each pH were fit to equation 4.4. 
The AaPurE1 log kcat/Km versus pH data produced a bell shaped profile consistent with 
two pKas, while the AaPurE1-S57C log kcat/Km versus pH data produced a log-linear fit. 
The log kcat versus pH data for AaPurE1 and AaPurE-S57C produced log-linear fits.  
 
kcat/Km pH Rate Profiles. The binding of CAIR to AaPurE1 requires His57 to be 
protonated and AIR to de deprotonated. However, due to the microequilibria, a small 
mole fraction will be present in the reverse protonation state. If this reverse protonation 
state is the “correct” protonation state for AaPurE1 to bind NCAIR, then the pKas 
obtained by fitting the log kcat/Km versus pH will be opposite relative to the pH rate 




The log kcat/Km versus pH profile for AaPurE1 fit to equation 4.4 results in is a bell-
shaped curve with pK1 = 8.8 and pK2 = 5.45, indicating a reverse protonation mechanism 
in the forward direction (Figure 4.19, panel A).  
 
The log kcat/Km versus pH profile for AaPurE1-S57C did not demonstrate log-linear 
dependence on pH, fit to equation 4.2 yielded slopes -0.094 ± 0.079, indicating that 
protonation is not required for the free enzyme or free substrate to bind NCAIR. 
 
kcat  pH Rate Profiles. The log kcat versus pH profiles for wild-type and AaPurE1-S57C 
did not demonstrate log-linear dependence on pH, fits to equation 4.4 yielded slopes of    
-0.12 ± 0.09 and -0.05 ± 0.12, respectively (Figure 4.19, panel B). The lack of 
dependence on pH indicates that protonation is not important for catalysis in the 
NCAIR→CAIR direction for either wild-type AaPurE1 or AaPurE1-S57C. 
 
4.4 Discussion !
Our initial hypothesis was that Ser assists in catalysis, but would not be as important as 
the absolutely conserved His acid-base catalyst.3 Our results show, however, that Ser→X 
mutants have substantially diminished activity in both PurE1 and PurE2, indicating that a 
hydrogen bond formed between Ser and N3 is very important for catalysis.  
  
Ser could support PurE1 and PurE2 function in one or more ways:  
 
1) In PurE1 and PurE2 (at high pH), Ser has been proposed to provide a 
hydrogen bond to (C)AIR N3 thereby directing protonation to C4.1,6 This 
would be an example of “negative catalysis”, whereby the Ser itself does not 
participate in catalysis but deters protonation of the N3.  
 
2) In PurE1, Ser57 has been proposed to provide a pivot-point that allows AIR in 
the AIR•CO2 ternary complex to “ring flip” to position either AIR C4 or N6 
 !
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for attack on the retained CO2 to produce CAIR or NCAIR, respectively. No 
similar behavior is suspected for PurE2, which cannot accommodate NCAIR 
(Figure 4.1).  
 
3) In PurE2, Ser38 may switch hydrogen bond polarity at low pH to become a 
hydrogen bond acceptor for a protonated N3.2 This role is not suspected for 
PurE1, since the active site is closed and N3 protonation is associated with 
inhibition of activity.  
 
Not one of these functions is mutually exclusive, so Ser could play any or all of these 
roles. To differentiate between these possibilities, ionizable mutants were used to 
construct pH rate profiles.  
 
A simple conclusion from site-directed mutagenesis is that Ser is indeed involved in 
hydrogen bonding, as the mutants with the highest detectable activity are able to supply a 
hydrogen bond. The Ser→Ala mutants may allow an adventitious water to perform this 
function. The pH rate profiles indicate that protonation at the Ser position is important for 
catalysis. 
 
pH Rate Profiles of PurE1 and PurE2 are Consistent with Different Mechanisms of CAIR 
Decarboxylation . pH rate profiles indicate that replacement of the Ser with an ionizable 
residue changes the shape of the pH profile, except for the AaPurE1-S57A mutant. 
AaPurE1-S57A does not posses an ionizable residue at the Ser57 position, but 
nevertheless has pK values similar to wild-type, indicating that both enzyme forms use 
the classic C4 protonation mechanism proposed! for CAIR decarboxylation3 (Figure 4.3, 
panel A).  
 
A log-linear pH dependence was observed in AaPurE1-S57C log kcat/Km, TdPurE2-S38C 
(log kcat/Km and log kcat), and TdPurE2-S38D (log kcat/Km  and log kcat) pH rate profiles. 
The different shape of Ser mutant pH rate profiles versus wild-type suggests a change in 
 !
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mechanism of CAIR decarboxylation. Loss of the hydrogen bond provided by the Ser 
hydroxyl may “break” the classic C4 protonation mechanism. A weaker hydrogen-
bonding partner provided by the Cys may actually facilitate protonation at AIR N3, 
allowing decarboxylation by the ylide (N3 protonation) mechanism (Figure 4.3, panel B). 
While this reaction may be slower, the Ser→X mutants are still able to catalyze CAIR 
decarboxylation. 
 
If decarboxylation occurs through the ylide mechanism, it may explain why we do not 
observe a pKa in the Ser→X mutant pH rate profiles. We know the pKa of N3 for CAIR 
and AIR in solution (~5.9 and ~6.05, respectively), but the pKa of the ylide intermediate 
N3 could be much higher. 
 
An observation unique to the AaPurE1-S57C mutant is that the log kcat pH profile shows 
loss of the inhibitory pK1, the one associated with N3 protonation of CAIR in wild-type 
AaPurE1. The shape of the S57C profile resembles the TdPurE2 log kcat versus pH 
profile, which could indicate that AaPurE1-S57C uses a PurE2-like mechanism. The Cys 
mutant cannot form a strong hydrogen bond with AIR N3, which may facilitate (or at 
least allow) N3 protonation and decarboxylation through the ylide reaction manifold.  
 
The Replacement of Ser with Asp or Cys May Have Electrostatic Effects on CAIR C4. In 
addition to diminishing the polarity of the Ser-N3 hydrogen bond, the effect of Cys and 
Asp may be to diminish the negative character of C4 (Figure 4.20). Our working 
hypothesis is that N3 protonation is favored over C4 protonation unless something 
decreases the likelihood of the former. If N3 is protonated, decarboxylation could occur 
by the proposed ylide mechanism.  
 
Mutagenesis and kinetic analysis versus pH both indicate that the polarized hydrogen 
bond provided by the Ser hydroxyl is important for C4 protonation. Therefore, this 
suggests the primary role for Ser is to direct protonation to C4 in both PurE1 and PurE2 
by thwarting N3 protonation. 
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The Asp in TdPurE2-S38D May Directly Participate in Catalysis. The pH rate profile for 
TdPurE2-S38D suggests that Asp38 may participate in catalysis (S38D retains 96% of 
wild-type activity at pH 5.8). Asp38 could share a proton with N3 and decarboxylation 
could proceed by the ylide mechanism. The AaPurE1 active site His mutant, AaPurE1-
H59D, is also a surprisingly efficient enzyme at low pH.2 This non-conservative mutation 
appears to support catlysis at either the Ser or His position. 
AaPurE1 NCAIR→CAIR Conversion Uses a Reverse Protonation Mechanism. The 
mechanism of CAIR decarboxylation requires a protonated His59 (its acid form) and a 
deprotonated AIR N3 (its basic form).26 At the optimal pH for CAIR decarboxylation, a 
small mole fraction of AaPurE1 is present in the reverse protonation state. Enzymes, 
which use a reverse protonation mechanism, are commonly associated with one direction 
of a reversible enzyme reaction.25, PurE1 catalyzes the fully reversible interconversion of 
NCAIR⇌CAIR and the reverse protonation state appears to be the “correct” protonation 
state for activity in the NCAIR→CAIR direction.  
The AaPurE1 log kcat/Km versus pH profile is a bell-shaped curve with two distinct pKas. 
The pKas obtained for the forward direction are opposite relative to the CAIR 
decarboxylation pKas (Figure 4.17 and Figure 4.19). The basic pK1 is likely associated 
with a deprotonated His and the acidic pK2 may be associated with the N3 position or the 
carbamate of NCAIR. These protonation states are required for NCAIR binding.  
However, the AaPurE1 log kcat pH profile is not dependent upon pH, indicating 
protonation is not required for catalysis. 
The replacement of the conserved Ser with Cys abrogates any detectable ionization 
within the pH range tested. The AaPurE1-S57C log kcat/Km  and log kcat pH profiles are 
not dependent upon pH, indicating the presence of a proton is not required for NCAIR to 




4.5 Future Directions 
 
Acquisition of pH rate profiles in the forward direction with both S57X and S38X 
mutants should be done to determine if the loss of a hydrogen bond at the Ser position 
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4.7 Figures and Tables !
 
Figure 4.1 CAIR decarboxylation reaction catalyzed by PurE1 and PurE2. Reactions are 
shown in the nonphysiological CAIR decarboxylase direction because CAIR is a 
substrate for both PurE1 and PurE2. (A) CAIR decarboxylation (R = R5P) begins with 
protonation at C4 by an essential His residue.1,2 Decarboxylation gives a ternary complex 
containing AIR and CO2, which only dissociates from PurE2. The PurE1 reaction 



































































Figure 4.2 PurE1 and PurE2 sequence alignment and active site structures with AIR 
bound. (A) Sequence alignment of the conserved residues in the active site of PurE2 and 
PurE1 (T. denticola numbering). Bold residues are conserved across the different classes; 
the red boxes are conserved among PurE2s and the blue boxes are conserved among 
PurE1s. The critical active site acid/base catalyst His is denoted by a star. Residues that 
are hydrogen bond acceptors are indicated by, ▲ and hydrogen bond donors ▼. (B) 
AaPurE1 (PDB code 2FWJ) (C) TdPurE2 (PDB code 3RGG) active site is shown with 
contacts to the AIR nucleotide shown. The hydrogen bond between the N3 of AIR and 
Ser is colored in salmon. Electron density maps for 2Fo-Fc (blue mesh) are contoured at 
1.0 σ and have a carve radius of 2.0 Å around the AIR ligand. “Place holder” waters that 
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Figure 4.3 Proposed mechanisms for decarboxylation by PurE1 and PurE2. Reactions are 
shown in the reverse biosynthetic direction. (A) Classic C4 protonation mechanism 
proposed for PurE1 and PurE2 (at high pH).1,2 (B) Ylide (N3 protonation) mechanism 
proposed for low pH decarboxylation in PurE2.2 !
 


















Table 4.1 Description of bacterial strains used in this chapter. 
Strain Description Source 
DH5α F′ φ80lacZΔM15 Δ(lacZYA-argF)U169 deoR recA1 endA1 
hsdR17(rK− mK+) phoA supE44 thi-1 gyrA96 relA1 
 
Lab stock 
BL21(DE3) F– ompT gal dcm lon hsdSB(rB- mB-)  
λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 nin5])  
 
Lab stock 
CC1215 F– ompT gal dcm lon hsdSB(rB- mB-) ΔpurE736::kan 
λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 nin5])  
 
This study 
JW0512 F- Δ(araD-araB)567 ΔlacZ4787(::rrnB-3) ΔpurE736::kan, λ-, rph-1 
Δ(rhaD-rhaB)568, hsdR514 
CGSG 





Table 4.2 Oligodeoxynucleotides (ODNs) used in this chapter.a 
ODN Sequence (5’→3’)  
1161 CGGATGACGTTGAGCTGATTCATTTTCC Sequencing 
1164 CAGCTCACCTAAACGATCAAACAC Sequencing 
2124 TAATACGACTCACTATAGGG T7 promoter 
2125 GCTAGTTATTGCTCAGCGG T7 terminator 
2203 GCGTACGATGTGCTGcAACAATGAGGG AaPurE1-S57A 
2204 CCCTCATTGTTgCAGCACATCGTACGC AaPurE1-S57A 
2205 CTGGCGTACGATGTGCgcAAACAATGAGGG AaPurE1-S57C 
2206 CCCTCATTGTTTgcGCACATCGTACGCCAG AaPurE1-S57C 
2207 GGCGTACGATGTGCTGtAACAATGAGGG AaPurE1-S57T 
2208 CCCTCATTGTTaCAGCACATCGTACGCC AaPurE1-S57T 
2285 CATGAAACCCTCATTGTTgtAGCACATCGTACGCCAG AaPurE1-S57V 
2286 CTGGCGTACGATGTGCTacAACAATGAGGGTTTCATG AaPurE1-S57V 
2316 CCGCTGTTTTATGCGCGGtACCGATGCGAATGGCATAC TdPurE2-S38T 
2317 GTATGCCATTCGCATCGGTaCCGCGCATAAAACAGCGG TdPurE2-S38T 
2320 GCTCCGCTGTTTTATGCGCGtcGCCGATaCGtATGGCATACTC TdPurE2-S38D 
2321 GAGTATGCCATaCGtATCGGCgaCGCGCATAAAACAGCGGAGC TdPurE2-S38D 
2235 GCGTACGATGTGCgtcAACAATGAGGG AaPurE1-S57D 
2236 CCCTCATTGTTgacGCACATCGTACGC AaPurE1-S57D 
2345 CATTCGCATCGGCgTCGCGCATAAAACAG TdPurE2-S38A 
2346 CTGTTTTATGCGCGAcGCCGATGCGAATG TdPurE2-S38A 
2355 CATTCGCATCGGCGtnGCGCATAAAACAG TdPurE2-S38V 
2356 CTGTTTTATGCGCnaCGCCGATGCGAATG TdPurE2-S38V 




2374 CCGCTGTTTTATGCGCGtTACCGATGCGAATGGCATAC TdPurE2-S38N 
2375 GTATGCCATTCGCATCGGTAaCGCGCATAAAACAGCGG TdPurE2-S38N 
2376 GGCGTACGATGTGCGTtAACAATGAGGG AaPurE1-S57N 




2398 GatcCAGTTCAGATtgGGGgCAtGCCGAGAAAATTG TdPurE2-M15W 
2399 ctaGCAATTTTCTCGGCaTGcCCCcaATCTGAACTG TdPurE2-M15W 




Table 4.3 Previously published plasmids used in this study. 
Plasmid Description  Source Protein encoded 
pJK175 purE1Aa in pET23a 1 AaPurE 
 
Table 4.4 Plasmids used in this chapter. 
Plasmid Description  Protein encoded 
pJK582 purE1Aa-S57A in pET23a AaPurE-S57A 
pJK583 purE1Aa-S57C in pET23a AaPurE-S57C 
pJK584 purE1Aa-S57T in pET23a AaPurE-S57T 
pJK608 purE1Aa-S57D in pET23a AaPurE-S57D 
pJK643 purE2Td-S38T in pET23a TdPurE-S38T 
pJK644 purE2Td-S38D in pET23a TdPurE-S38D 
pJK653 purE2Td-S38T, F79W in pET23a TdPurE-S38T,F79W 
pJK659 purE2Td-S38C, F79W in pET23a TdPurE-S38C,F79W 
pJK677 purE1Aa-S57V in pET23a AaPurE-S57V 
pJK684 purE2Td-S38V in pET23a TdPurE-S38V 
pJK685 purE2Td-S38N in pET23a TdPurE-S38N 
pJK686 purE1Aa-S57N in pET23a AaPurE-S57N 
pJK692 purE2Td-H17W, S38T in pET23a TdPurE-H17W,S38T 
pJK697 purE2Td-M15W, S38T in pET23a TdPurE-M15W,S38T 
 !  
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Table 4.5 Results of functional complementation of JW0512 (ΔpurE) Keio strain. 
Plasmid (PurE form) 
MMa + 
hypoxanthine MM 
MM+ CO2 b+ 
hypoxanthine MM + CO2  
pET23a +++c! $! ++++! $!
pJK175 (purE1Aa) +++! +++! ++++! +++!
pJK283 (purE1Aa-H59N) +++! $! ++++! $!
pJK582 (purE1Aa-S57A) +++! $! ++++! $!
pJK583 (purE1Aa-S57C) +++! $! ++++! $!
pJK584 (purE1Aa-S57T) +++! $! ++++! +!
pJK677 (purE1Aa-S57V) +++! $! ++++! $!
pJK686 (purE1Aa-S57N) +++! $! ++++! $!
pJK608 (purE1Aa-S57D) +++! $! ++++! $!
pJK376 (purE2Td) +++! ++! ++++! ++++!
pJK392 (purE2Td-H40N) +++! $! ++++! $!
pJK617 (purE2Td-S38A) +++! $! ++++! +!
pJK607 (purE2Td-S38C) +++! $! ++++! +!
pJK643 (purE2Td-S38T) +++! $! ++++! +++!
pJK684 (purE2Td-S38V) +++! $! ++++! $!
pJK685 (purE2Td-S38N) +++! $! ++++! $!
pJK644 (purE2Td-S38D) +++! $! ++++! $!
a  minimal media described above in experimental details  
b plates grown in a candle jar.  
c symbols:++++, large colonies at 24 h +++, small colonies at 24 h;, ++, small colonies at 48 h; +, small 




Figure 4.5 SDS-PAGE analysis of a representative AaPurE1-S57X (X = V) isolation. A 
12% polyacrylamide gel was loaded with 5 ug protein per lane: M, Sigma biotinylated 
marker; S, soluble lysate; CL, cleared lysate; HA, hydroxyapatite input; and ISO, isolated 
AaPurE1-S57V. Molecular weights (kDa) are denoted along the left side of the gel.  
 










Figure 4.6 SDS-PAGE analysis of a representative TdPurE2-S38X (X = A) isolation. A 
12% polyacrylamide gel was loaded with 5 ug protein per lane: M, Sigma biotinylated 
marker; S, soluble lysate; CL, cleared lysate; AS, ammonium sulfate supernatant; ; HA, 
hydroxyapatite input; and ISO, isolated TdPurE2-S38A. Molecular weights (kDa) are 
denoted along the left side of the gel. !!
!
Figure 4.7 SDS-PAGE analysis of isolated AaPurE1-S57X and TdPurE2-S38X forms. A 
12% polyacrylamide gel was loaded with 5 ug protein per lane: M, Sigma biotinylated 
marker; AaPurE1 is denoted by wt; and each mutation in Ser57 or Ser 38 is indicated by 
the one letter code. Note the slightly decreased mobility of S57D, which is presumably 
due to the addition of a negatively charged residue. Molecular weights (kDa) are denoted 














Figure 4.8 SDS-PAGE analysis of isolated TdPurE2 Trp introduction forms. A 12% 
polyacrylamide gel with 5 ug protein loaded per lane: 12% polyacrylamide gel was 
loaded with 5 ug protein per lane: M, Sigma biotinylated marker. Each mutation in Ser 38 
is indicated by the one letter code directly above each lane. Each mutation to introduce a 
Trp into TdPurE2 is indicated above the solid line. Molecular weights (kDa) are denoted 
along the left side of the gel. !
!
Figure 4.9 Gel-filtration analysis of AaPurE1-S57X mutants. The traces are shifted 0.1 
A280. The AaPurE1 octamer elutes at ~57 mL and aggregate elutes at the excluded 
volume (Vo). The completely excluded volume (Vo, 44.7 mL) and included volume (Vi, 
113.6 mL) volumes are indicated with arrows. A small peak at (~76 mL) observed in 



















Figure 4.10 Fluorescence titrations of AaPurE1-S57X mutants with citrate. (A) 
Fluorescence emission spectra of AaPurE1-S57C were recorded in 50 mM potassium 
acetate, 100 mM KCl, pH 4.6 at 25 °C with an excitation at 295 nm. (B) Fluorescence 
emission intensity at 320 nm plotted as a function of [citrate] for AaPurE1-S57T (black 
filled squares), AaPurE1-S57A (red filled circles), AaPurE-S57C (blue filled triangles), 
AaPurE1-S57V (pink filled inverted triangles), and AaPurE1-S57D (green filled 
diamonds). Titrations were performed with [subunit] of 0.4 µM, 1.29 µM, 0.4 µM, 0.4 
µM and 0.4 µM, respectively. Data were fit to equation 4.5 in Origin to obtain Kd values 
(Table 4.9). !!
 
Figure 4.11 Fluorescence titrations of AaPurE1-S57A with AIR. (A) Fluorescence 
emission spectra of AaPurE1-S57A were recorded in 50 mM potassium acetate, 100 mM 
KCl, pH 4.6 at 25 °C with excitation at 295 nm. (B) Fluorescence emission intensity at 
320 nm, plotted as a function of [AIR]. Titrations were performed with [subunit] of 0.4 
µM. Data were fit to equation 4.6 using Origin to obtain Kd values (Table 4.9). 
 !
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Figure 4.12 Active sites AaPurE1-S57X mutants with AIR modeled in from the 2fwj 
structure. (A) EcPurE1•CAIR complex (PDB code 2NSL). (B) AaPurE1•AIR complex 
(PDB code 2FWJ). (C) AaPurE1 (PDB code 1U11). (D) AaPurE-S57T (PDB code 
TBD). (E) AaPurE1-S57A (PDB code TBD). (F) AaPurE1-S57C (PDB code TBD). (G) 
AaPurE1-S57V (PDB code TBD). (H) AaPurE1-S57N (PDB code TBD). (I) AaPurE1-
S57D (PDB code TBD). An electron density map (final 2Fo−Fc, blue mesh) is shown for 
AIR atoms and residue 57 with a 1.0 σ contour and 2.0 Å carve. The Fo−Fc map is 
contoured at +3 σ (green mesh) and –3 σ (red mesh). Note the two “placeholder waters” 
shown as cyan spheres. These oxygen atoms occupy the same location as those in CO2 





Figure 4.13 Oxidized cysteines in the AaPurE1-S57C structure. (A) The density in 
subunit A is not consistent with Cys57. (B) The density in subunit B not consistent with 
Cys57. (C) The density in subunit A is consistent with the oxidized cysteine sulfinic acid. 
(D) The density in subunit B is consistent with the oxidized cysteine sulfenic acid. (E) 
Possible chemical structures for Cys57. An electron density map (final 2Fo−Fc, blue 
mesh) is shown for residue 57 with a 1.8 σ contour and 2.0 Å carve. The Fo−Fc map is 
contoured at +3 σ (green mesh) and –3 σ (red mesh).  !
Table 4.6 Mass spectrometric analysis of AaPurE1 forms. 
PurE1  Observed Mass (Da) Expected Mass (Da)a 
AaPurE1 (wild-type) 18869c 18867 
AaPurE1-S57C 18880 18882 
aMolecular masses ([M+H+]+) were determined by MALDI., Expected masses were  
calculated using ExPaSy ProtParam. All AaPurE1s have an additional N-terminal Met2  


























Figure 4.14 Active sites of TdPurE2 and the TdPurE2-S38D mutant. (A) TdPurE2 with 
AIR bound (PDB code 3rgg). (B) TdPurE2 (PDB code 3rg8) with AIR modeled in from 
alignment with the 3rgg structure. (C) TdPurE2-S38D (PDB code TBD) with AIR 
modeled in from alignment with the 3rgg structure. An electron density map (final 
2Fo−Fc, blue mesh) is shown for AIR atoms and residue 57 with a 1.0 σ contour and 2.0 
Å carve. The Fo−Fc map is contoured at +3 σ (green mesh) and –3 σ (red mesh). Note the 
two “placeholder waters” shown as cyan spheres.  
 
!  
Table 4.7 X-ray data collection statistics. 
 AaPurE1  TdPurE2 
 S57T_6 S57A_4 209_S57C S57V2 206_S57N S57D_102  207_S38D 
PDB entry TBD TBD TBD TBD TBD TBD  TBD 
Beamline 21-ID-D 21-ID-D 21-ID-F 21-ID-F 21-ID-F 21-ID-F  21-ID-F 
Wavelength (Å) 0.97856 0.97872 0.97856   0.97872 0.97872 0.97856  0.97872 
Space group b I422 I422 I422 I422 I422 I422  C2221 
Unit cell param. 






c=!164.409 a =b=!99.981 c=!164.716 a =b=!99.703 c=!165.606  a= 84.084 b=!154.958 c=!89.130 














No. meas. refl. 611,211 275154 360568 751400 1130009 124466  950714 
No. unique refl. 41,986 (2080) 29106 (1430) 28501 (1390) 37948 (1871) 39536 (1958) 11217 (535)  64883 (3188) 
Completeness 
(%) 100 (100) 99.3 (99.9) 100 (100) 100 (100) 100 (100) 99.8 (99.4)  99.9 (100) 
Multiplicity 14.6 (14.7) 9.5 (8.7) 12.7 (12.4) 19.8 (18.7) 28.6 (28.0) 11.1 (10.9)  14.7 (14.3) 
Rmerge (%) c 8.7 (86.6) 10.3 (30.9) 12.2 (80.2) 9.3 (44.2) 9.3 (83.5) 8.9 (63.9)  7.0 (50.4) 
Mean I/σ (I) 45.2 (2.9) 46.4 (9.8) 34.0 (3.9) 61.1 (10.7) 51.7 (6.3) 25.3 (3.4)  55.3 (5.3) 
VM (Å3 Da-1) d 2.49 2.48 2.48 2.47 2.50 2.50  2.71 
Est. solvent (%) 50.7 50.4 50.4 50.3 50.8 50.7  54.6 
a Values in parenthesis are for the highest resolution shell. 
b All have α=β=γ=90°. 
c Rmerge = 
!!!"!!!|!!!! !!" ! !(!!") |!!!"!!!!!!(!!")  , where Ii (hkl) is the ith measurement of the intensity of reflection hkl and !(ℎ!")  is its mean value. 








Table 4.8 Summary or refinement statistics. 
  AaPurE1    TdPurE2 
 S57T_6 S57A_4 209_S57C S57V2 206_S57N S57D_102  207_S38D 
















No. reflections used         
working 40297 27738 27435 37370 38493 10484  63737 
test set 1608 1391 1369 1863 1531 505  3189 
Completeness (%) 95.9 96.9 94.6 98.4 97.3 91.9  97.5 
Rcrystb(%) 18.1 (19.8) 16.2 (15.9) 16.1 (18.1) 16.0 (17.4) 15.5 (17.0) 17.3 (21.2)   19.5 (25.9) 
Rfreec(%) 18.8 (24.8) 18.6 (20.5) 18.2 (24.9) 17.6 (22.1) 17.4 (26.9) 21.3 (29.3)  22.3 (31.8) 
No. of atoms         
all atoms 2460 2577 2549 2971 2637 2321  5198 
protein atoms 2303 2347 2336 2351 2328 2312  4716 
solvent atoms 337 221 203 293 309 9  482 
R.m.s. deviations from ideality         
Bondlengths (Å) 0.007 0.007 0.007 0.006 0.007 0.008  0.006 
Bond angles (°) 1.008 0.997 1.011 1.002 1.009 1.051  1.097 
Average isotropic B factors (Å2)         
protein atoms 26.5 22.5 24.6 17.1 17.9 47.7  27.3 
ligand atoms - 48.5 49.9 - - -  - 
solvent atoms 37.1 35.7 38.1 31.9 32.0 45.1  33.9 
Ramachandran plot statistics (%)         
Residues in favored regions 98.7 98.8 99.4 99.1 99.8 98.4  98.2 
Residues in allowed regions 1.3 1.3 0.6 0.9 1.3 1.6  1.6 
Outliers 0 0 0 0 0 0  0.2 
MolProbity score [percentile] 1.02 (100) 0.92 (100) 0.71 (100) 1.08 (100) 1.9 (100) 1.49 (100)  2.84 (99) 
MolProbity clashscore 
[percentile] 
0.64 (100) 1.26 (100) 0.64 (99) 2.3 (99) 1.03 (100) 1.14 (100)  1.07 (100) 
    
a Values in parenthesis are for the highest resolution shell. 
b Rcryst = = 
!!!"!||!!!"#!|! !!"#!|!!!"!|!!!"#!|  





Figure 4.15 Saturation curves of active AaPurE1-S57X mutants. All data were collected 
in 50 mM Tris-HCl, pH 8 at 30 °C. The velocity (units mg-1) for CAIR decarboxylation 
of active AaPurE-S57X mutants was plotted against [CAIR] and fit to the Michaelis-
Menten equation in Origin, with the exception of AaPurE1-S57V, which was fit to a 
linear equation. Data for each active AaPurE-S57X mutant is shown above: A, AaPurE1-








Figure 4.16 Saturation curves of active TdPurE1-S38X mutants. All data were collected 
in 50 mM Tris-HCl, pH 8 at 30 °C. The velocity (units mg-1) for CAIR decarboxylation 
of active AaPurE-S57X mutants was plotted against [CAIR] and the TdPurE-S38C data 
fit to the Michaelis-Menten equation in Origin. Data for each active TdPurE-S38X 
mutant is shown above: A, TdPurE2-S38C; B, TdPurE2-S38T; C, TdPurE2-S38A; and 








Table 4.9 Kinetic parameters for PurE1 and PurE2 Ser→X mutants at pH 8. 
a rSA, % specific activity relative to wild-type AaPurE1 (39 units per mg protein) or TdPurE2 (185 units 
per mg protein), determined at 100 µM CAIR, pH 8, 30 °C. 
 b rel. kcat/Km, % kcat/Km relative to wild-type AaPurE1 or TdPurE2. 
c Citrate titrations carried out in 50 mM potassium acetate, 100 mM KCl, pH 4.6 at 25 °C. 
d AIR titrations carried out in 50 mM Tris-HCl, pH 8.0 at 30 °C. 
e is, insufficient signal.  
f nd, not determined. 
g na, not applicable. 
h Saturation curves show substrate inhibition above 100 µM CAIR. 
PurE form rSAa rel. kcat/Km b 
kcat/Km (M-
1 s-1) kcat (s
-1) Km (µM) 
Kd citrate 
(µM) c  
Kd AIR 
(µM) d 
AaPurE1 100 100 1.5 x 106 12.6 11 275 2.2 
AaPurE1-S57T 10 20 3.0 x 105 1.5 5 141 ise 
AaPurE1-S57A 1.4 1.2 1.8 x 104 0.2 11 133 is 
AaPurE1-S57C 0.03 0.02 2.8 x 102 3.9 x 103 14 102 is 
AaPurE1-S57V 0.03 0.2 2.9 x 103 ndf nd 132 is 
AaPurE1-S57D ~0 nag na na na 63 is 
AaPurE1-S57N ~0 na na na na nd is 
TdPurE2 100 100 7.2 x 106 65 9 nd na 
TdPurE2-S38Th 9 nd nd nd nd nd na 
TdPurE2-S38T,F79W 9 nd nd nd nd nd nd 
TdPurE2-H17W,S38T 0.4  nd nd nd nd nd nd 
TdPurE2-S38A 0.05 nd nd nd nd nd na 
TdPurE2-S38C 0.05 0.00002 1.13  5.7 x 102 51  nd na 
TdPurE2-S38C,F79W 0.11 nd nd nd nd 237 6 
TdPurE2-S38Vh 0.05 nd nd nd nd nd na 
TdPurE2-S38D ~0 na na na na na na 
TdPurE2-S38N 0.02 nd nd nd nd nd na 




Figure 4.17 pH-rate profiles for AaPurE1 CAIR decarboxylation. The wild-type (black 
circles) 2, AaPurE1-S57A (green circles), and AaPurE1-S57C (blue circles) kcat/Km and 
kcat data are shown above with fits to the data shown in the same color. (A) The log 
kcat/Km versus pH profiles are similar bell-shaped curves for both wild-type and S57A 
(pK1 = 6.0 ± 0.1 and 5.9 ± 0.1, respectively; pK2 = 7.2 ± 0.1 and 8.3 ± 0.2, respectively). 
The log kcat/Km versus pH profile for S57C has a log-linear dependence on pH with a 
slope of -0.86 ± 0.03. (B) The log kcat versus pH profiles for wt2 and S57A are similar 
bell-shaped curves (pK1 =5.1 ± 0.2 and, = 5.8 ± 0.1 respectively; pK2 = 8.4 ± 0.1 and 8.6 
± 0.1, respectively). The log kcat versus pH profile for S57C has two pKas averaging ~6.7. 










































Figure 4.18 pH-rate profiles for TdPurE2 CAIR decarboxylation. The wild-type (black 
circles)2, TdPurE2-S38D (red circles), and TdPurE2-S38C (blue circles) kcat/Km and kcat 
data are shown above with fits to the data shown in the same color. (A) The log kcat/Km 
versus pH profile for wt is bell-shaped curve with pK1 = 5.7 ± 0.2 and pK2 = 7.3 ± 0.1. 
The log kcat/Km versus pH profile for both S38C and S38D has a log-linear dependence on 
pH with slopes of -0.21 ± 0.06 and -0.90 ± 0.04, respectively. (B) The log kcat versus pH 
profile for wt is bell-shaped curve with pK1 = 5.9 ± 0.5 and pK2 = 8.4 ± 0.1. The log kcat 
versus pH profile for both S38D and S38C has a log-linear dependence on pH with slopes 









































Figure 4.19 pH-rate profiles for AaPurE1 NCAIR→CAIR conversion. The wild-type 
(black circles) and AaPurE1-S57C (blue circles) kcat/Km and kcat data are shown above 
with fits to the data shown in the same color. (A) The log kcat/Km versus pH profile for wt 
is a bell-shaped curve with pK1 = 8.8 and pK2 = 5.45. The log kcat/Km versus pH profile 
for AaPurE1-S57C has a log-linear dependence on pH with a slope of -0.09 ± 0.08. (B) 
The log kcat versus pH profiles for wt or AaPurE1-S57C have log-linear dependence on 
pH with a slopes of -0.12 ± 0.09 and -0.05 ± 0.12, respectively. !
 
Figure 4.20 The replacement of Ser with Asp or Cys may have electrostatic effects. The 
strong hydrogen bond provided by Ser is important for C4 protonation. The electrostatic 
effects of Cys and Asp may diminish the negative character of C4, making C4 more 

















































































CHAPTER 5 ROLE OF THE CONSERVED ACTIVE SITE LYSINE RESIDUE IN 




In Chapter 4 we examined the role of the universally conserved active site Ser. Crystal 
structures of PurE1 and PurE2 with AIR bound (PDB id 2fwj and 3rgg) reveal that the 
Ser makes similar contacts with the substrate and would appear to have similar roles. 
Surprisingly, this conserved residue appears to have different roles between PurE1 and 
PurE2. In this chapter we examine the role of the class-specific active site Lys in PurE2 
to determine if it has different roles in PurE1 and PurE2.  
 
The 40s Loop Basic Residue is Differentially Conserved. The strictly conserved 40s loop 
sequence SAH[R/K] contains a single absolute, class-linked divergence. The 
differentially conserved basic residue, Arg in PurE1 and Lys in PurE2, contacts the 
phosphate moiety of the nucleotide and appears to be involved in high affinity substrate 
binding. 1–3 The E. coli PurE1-R46K mutant, which replaces the class-specific Arg, is 
active, as expected for a residue that is mainly involved in substrate bidning.3 It is 
therefore, curious why there are no known exceptions to the class-linked divergence in 
the basic residue. 
Lys May Play a Role Beyond Substrate Binding. An absolute difference between PurE1 
and PurE2 is the source of CO2: PurE1 acquires it by decarboxylation of bound NCAIR 
(or CAIR), while PurE2 binds it directly from solution. The challenging acquisition of 
CO2 by PurE2 has been hypothesized to involve intermediate formation of an N-
carboxylated carbamate species on the conserved Lys. This function would be unique to  
 !
171 
PurE2 and not necessary in PurE1, as the carbamate moiety of NCAIR serves a similar 
role as a CO2 carrier. 
The ability to form a carbamate is limited to Lys or the N-terminus. Both urease and 
Rubisco reactions require the formation of a Lys-carbamate within the active site, and 
hemoglobin uses an N-terminal carbamate to carry CO2.4–6 PurE2 may instead use a Lys-
carbamate as a source of substrate. Formation of a Lys-carbamate could also function as a 
CO2 concentrating mechanism, which would be advantageous in environments with 
limited CO2 availability (Figure 5.1A). 
Alternatively, the AIR carbanion could directly attack the fixed carbonyl of the Lys-
carbamate (Figure 5.1B). In this scenario, the Lys-carbamate would play a role analogous 
to N-carboxybiotin in the reaction catalyzed by acetyl-CoA carboxylase, in which the 
acetyl-CoA carbanion attacks carboxybiotin to form malonyl-CoA and biotin (Figure 
5.1C).7 While this “deactivates” CO2 as an electrophile, it would confer an potentially 
compensatory entroptic advantage relative to collisional capture of a gaseous substarte.  
This chapter tests the hypothesis that formation of a Lys-carbamate is an obligatory 
intermediate in TdPurE2 catalysis. We show that the TdPurE2-K41R mutant retains both 
AIR carboxylase and CAIR decarboxylase activities, indicating that a N-carboxylated 
Lys is not a required intermediate in the TdPurE2 reaction. We cannot however, rule out 
a role for Lys-carbamate in other PurE2s under low CO2 conditions. 
 
5.2 Materials and Methods 
 
Materials. Chemicals were obtained from Sigma or Fisher in the highest purity available 
unless otherwise noted. CAIR was prepared as described in Chapter 2.8 AIR was 
generated enzymatically from CAIR using TdPurE2 and quantitated by Bratton-Marshall 
assay as described previously.2 Oligodeoxynucleotides (ODNs) were obtained from 
Integrated DNA Technologies and used without further purification. Restriction 
endonucleases, Q5 DNA polymerase, CIP, and T4 DNA ligase were obtained from New 
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England Biolabs. Phenyl Sepharose CL-6B was obtained from Sigma. Hydroxyapatite 
(Bio-Gel® HT) and Bradford reagent were obtained from Bio-Rad. PD-10 desalting 
columns were obtained from GE Health Care.  
 
Methods. Protein concentrations were determined by the method of Bradford with bovine 
serum albumin as the standard.9 Small-scale centrifugation steps were performed using an 
Eppendorf 5424 centrifuge. All other centrifugation steps were performed using a 
Beckman Avanti J-E centrifuge with a JLA-10.5 or JA-20 rotor. Cell disruption was 
performed by sonication using a Fisher Scientific Dismembrator 550 at 25% output for 3 
cycles (1 min each separated by 1 min cooling intervals) at 4 °C. Spectroscopic 
measurements were recorded on a Varian CARY-100 UV/Vis spectrophotometer 
thermostated by a Cary Dual Peltier Accessory temperature controller. Data were 
analyzed using gnuplot 4.4 by T. J. Kappock. Plasmid DNA was sequenced by the staff 
of the Purdue University Genomics Core Facility. 
 
Construction of TdPurE–K41M Construct Plasmid pJK687. The general cloning strategy 
is illustrated in Chapter 3 (Figure 3.4) A 0.21 kb primary PCR product containing purE2 
was amplified using standard Q5 PCR conditions from template pJK376 (14 ng), using 
ODNs 2124 and 2362. The crude product was digested with DpnI and purified using a 
Qiagen PCR purification kit. A 0.55 kb primary PCR product containing purE2 was 
amplified using standard Q5 PCR conditions from template pJK376 (14 ng), using ODNs 
2125 and 2363. The crude product was digested with DpnI and purified using a Qiagen 
PCR purification kit. Cross-over PCR product was obtained using standard Q5 PCR 
conditions, with a single exception: the annealing time was increased to 1 min, from a 
mixture containing primary PCR products (25 ng each) and ODNs 2124 and 2125. The 
0.723 kb cross-over product was digested with NdeI and XhoI, and ligated into the same  
sites of the destination vector pET23a to yield TdPurE2-K41M expression plasmid 
pJK687.  
Construction of TdPurE2–K41R Construct Plasmid pJK688. A 0.21 kb primary PCR 
product containing purE2 was amplified using standard Q5 PCR conditions from 
 !
173 
template pJK376 (14 ng), using ODNs 2124 and 2364. The crude product was digested 
with DpnI and purified using a Qiagen PCR purification kit. A 0.55 kb primary PCR 
product containing purE2 was amplified using standard Q5 PCR conditions from 
template pJK376 (14 ng), using ODNs 2125 and 2365. The crude product was digested 
with DpnI and purified using a Qiagen PCR purification Cross-over PCR product was 
obtained using standard Q5 PCR conditions, with a single exception: the annealing time 
was increased to 1 min, from a mixture containing primary PCR products (25 ng each) 
and ODNs 2124 and 2125.The product was digested with NdeI and XhoI, and ligated into 
the same sites of the destination vector pET23a to yield TdPurE2-K41R expression 
plasmid pJK688.  
Mutant TdPurE2 Overexpression and Isolation. TdPurE2-K41M was overexpressed and 
isolated as detailed for wild-type TdPurE2 (Chapter 3).2 TdPurE2-K41R was expressed 
using the same TdPurE2 protocol,2 but isolated using the AaPurE1 isolation protocol 
(Chapter 3).1 Fresh column media were used for each mutant to avoid any possibility of 
cross-contamination. TdPurE2 mutants were concentrated to >3 mg mL-1 with an Amicon 
ultrafiltration device containing a YM30 membrane. The protein solution was frozen by 
drop-wise addition to liquid N2 and stored at -80 °C. 
 
PurE2-mediated Decarboxylation Assays. Continuous assays of PurE2-mediated CAIR 
decarboxylation were performed according to a published method.1 A final volume of 0.6 
mL in a masked, 1 cm pathlength cuvette containing 50 mM Tris-HCl, pH 8 and 100 µM 
CAIR was incubated at 30 °C for at least 3 min. Reactions were initiated by addition of 
either TdPurE2-K41X (12-24 ng, 1.4-2.8 nM [subunits]). The initial velocity of CAIR 
decarboxylation to AIR (∆ε260 =8930 M-1 cm-1) was recorded at 260 nm, with a small 
background decarboxylation rate subtracted. CAIR was quantitated by endpoint assay 
using the same method, except that 50 µg mL−1 TdPurE2 was the enzyme. A unit is 
defined as the amount of enzyme that forms 1 µmol of product per minute. Kinetic 
constants were determined by fitting the plotted concentration versus velocity (units mg-
1) to the standard Michaelis-Menten equation. 
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PurE2-mediated AIR Carboxylation Assays. Continuous assays of PurE2-mediated AIR 
carboxylation were modified from published method for PurE1 NCAIR→CAIR 
carboxylation assays.10 Assays were carried out at 23 °C in in a final volume of 0.7 mL, 
1x triple buffer (100 mM Tris-HCl, 50 mM MES, 50 mM acetic acid) pH 7.5, 10 mM 
MgCl2, 2 mM PEP, 0.5 mM ATP, 10 mM L-aspartate, 1 mM KHCO3, 1.2 units of 
pyruvate kinase (477 units mg-1, Sigma P9136), 4 units of H6PurC (isolated by Jesse 
Murphy), AIR (100 µM), and varying amounts of TdPurE2s at 10 °C. After pre-
incubation for 3 min, the reaction was initiated by addition of CO2 (variable amounts of a 
53 mM solution in water, generated by constant bubbling of gas released from dry ice 
through nanopure water at 10 °C) and SAICAR formation monitored directly (∆ε282 = 
8607 M-1 cm-1) with a correction for PurE2-independent SAICAR formation. Reactions 
containing all assay components except PurE2 were performed to determine a 




Creation of TdPurE2-K41X Mutants. TdPurE-K41R mutants were created to investigate 
the role of the class-specific Lys in the TdPurE2 reaction. TdPurE2 mutants could not be 
created by standard Quikchange mutagenesis. Therefore, cross-over PCR was employed 
to generate both TdPurE2-K41X mutants. Sequencing confirmed that only the intended 
mutations were obtained. 
 
Purification of the Recombinant TdPurE2-K41M Mutant. The published isolation 
protocol2 was successfully used to isolate TdPurE2-K41M with relatively high specific 
activity and purity (Table 5.4 and Figure 5.2).  
 
Purification of the Recombinant TdPurE2-K41R2 Mutant. TdPurE2-K41R could not be 
isolated using the published TdPurE2 protocol.2 Unexpectedly, the published AaPurE1 
 !
175 
isolation protocol1 was successfully used to isolate TdPurE2-K41R with relatively high 
activity and purity (Table 5.4 and Figure 5.2). 
 
Kinetic Characterization of the TdPurE2-K41R Mutant at pH 8. Kinetic constants (Km 
and kcat) for CAIR decarboxylation were obtained for the TdPurE2-K41R mutant to 
determine if the diminished activity of K41R is due to binding, catalysis, or both. The 
substitution of Lys with either the positively charged Arg or uncharged Met residue does 
not abrogate activity in either K41X mutant (Table 5.4 and Figure 5.3). Formation of a 
Lys-carbamate is therefore not an obligatory catalytic intermediate in TdPurE2 catalysis. 
This does not exclude a role in CO2 enhancement or off-pathway formation of Lys-
carbamate in PurE2s. 
 
The Km of TdPurE2-K41R is ~3.6 times higher than TdPurE, indicating that the 
Lys→Arg mutation may impair CAIR binding.  
 
The observed TdPurE2-K41R AIR carboxylase activity is very low compared to wild-
type TdPurE2 (Table 5.4), but may be an underestimate, because the AIR carboxylase 
activity of TdPurE-K41R was likely recorded below its AIR Km. We did not obtain 
kinetic parameters for AIR carboxylation by TdPurE2-K41R, but we assume the mutant 




TdPurE2 Activity Does Not Require Formation of a Lys-Carbamate Intermediate. PurE2 
acquires CO2 directly from solution and this challenging acquisition was suggested to 
require the intermediate formation of an N-carboxylated species on the active site Lys. 
Therefore, we tested the hypothesis that formation of a Lys-carbamate is necessary for 
PurE2 function by replacing it with residues that are unable to form carbamates. We 
found that TdPurE2-K41R retains substantial activity and is capable of both CAIR 
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decarboxylation and CAIR generation from AIR and CO2, indicating the formation of a 
Lys-carbamate is not an obligatory intermediate in TdPurE2 catalysis.  
 
The Differentially Conserved Residue Appears to Have the Same Role in Both PurE1 and 
PurE2. Logic would dictate that the single differentially conserved side chain contact to 
the substrate should have different roles in each class. However, the observation that both 
EcPurE1-R46K3 and TdPurE2-K41R mutants retain activity suggests that this residue has 
a relatively simple role in substrate binding.  
 
The Conserved Basic residue is Not Critical for Catalysis. Perhaps the most 
unanticipated result in this chapter is that the non-conservative TdPurE2-K41M mutant 
retains substantial activity. We and others have thought that the electrostatic interaction is 
important for catalysis, as neither PurE form reacts with the AIR and CAIR nucleosides. 
Evidently an interaction between the phosphate moiety of the substrate and a positively 
charged residue is not essential for PurE2 function.  
 
Lys Could Have a Role Beyond Simple Substrate Binding. TdPurE2 is from the 
mesophilic bacterium T. denticola, which occupies an microaerophilic subgingival niche 
that may provide sufficient CO2 for catalysis. While formation of a Lys-carbamate is not 
obligatory for TdPurE2 it could be required for PurE2s from other organisms that face 
larger challenges in acquiring CO2.  
 
Under limiting CO2 conditions the formation of the Lys-carbamate could either 1) react 
directly with the AIR carbanion or 2) serve as a CO2 concentrating mechanism. (Figure 
5.1). We consider these possibilities separately, although they are not necessarily 
mutually exclusive.  
 
The first case, is analogous to the reaction catalyzed by acetyl-CoA carboxylase, in which 
the Lys-carbamate would be attacked by the AIR carbanion to form CAIR. However, 
examination of the PurE2•AIR crystal structure (PDB id 3rgg) suggests that a large 
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protein rearrangement would have to occur to allow the Lys-carbamate to position itself 
within range of AIR C4. There is no evidence for large-scale rearrangement of any PurE 
form.  
 
In the second case, formation of a Lys-carbamate as a CO2 concentrating mechanism 
could confer an advantage by increasing the local concentration of CO2 under low CO2 
conditions. This possibility is directly addressed by the results reported here. 
Environmental Constraints May Have Affected the Strict Conservation of Lys in PurE2. 
Environmental CO2 availability is influenced by a number of factors including CO2 
partial pressure, pH and most important, temperature. CO2 solubility is greatly 
diminished at high temperatures (Figure 5.4).  
If we assume that PurE2 evolved under warm, anaerobic, conditions on early Earth,11,12 
then the presence of abundant CO2 makes the ability to concentrate CO2 superfluous. 
However, as primitive organisms left the immediate vicinity of geological CO2 sources 
(e.g. deep ocean sediments)14 and as O2 appeared in the atmosphere, the ability to 
concentrate CO2 from the environment might have become advantageous. 
Under low CO2 conditions, a Lys acquired by mutation might have conferred a selective 
advantage in organisms that inherited a purE2 gene. Its strict conservation could be a 
consequence of its early evolutionary importance in these low CO2 environments. Lys 
could still be required in hot, low CO2 environments, which could explain the retention of 
purE2 genes in a small number of mostly thermophilic organisms (Chapter 1). 
Increasing the local CO2 concentration would also increase the substrate specificity for 
CO2 over the smaller, more reactive O2. In particular, this would have helped PurE2 avoid 
the fate of Rubisco, which evolved a catalytic strategy under anaerobic conditions that 
has liabilities under the modern oxic conditions (Chapter 6). 
Conserved Residues Have Different Roles and Differentially Conserved Residues Do Not. 
In PurE, the differentially conserved basic residue appears to have similar roles in ligand 
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binding. In contrast, the universally conserved Ser residue appears to have different roles 
in PurE1 and PurE2 (Chapter 4). Crystal structures of PurE1 and PurE2 with AIR bound  
(PDB id 2fwj and 3rgg) reveal that the Ser makes similar contacts with the substrate and 
would appear to have similar roles. Ser is usually associated with donation of a hydrogen 
bond, but is also capable of accepting a hydrogen bond, which may occur at low pH in 
the PurE2 reaction. 
 
Mutation of a single residue in either PurE class does not generate a PurE of the other 
class. We hypothesize that several amino acid changes occurred during the evolutionary 
divergence of one class of PurE from another. These are likely to occur in the other three 
loops surrounding the substrate: the P loop, the 70s loop, and the P loop from an 
neighboring subunit.  !
5.5 Future Directions !
The presence of a purE2 gene in a small number of thermophilic bacteria may require the 
intermediate formation of a Lys carbamate. This can be tested by the expression, 
isolation, and characterization of a monofunctional PurE2 from the thermophilic bacteria 
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5.7 Figures and Tables !!
 
Figure 5.1 Potential roles for the Lys-carbamate in the PurE2 reaction. (A) The 
reversible formation of a Lys-carbamate would increase the local CO2 concentration in 
the PurE2 reaction. (B) The AIR C4 carbanion may directly attack the carbonyl of the 
Lys-carbamate to form CAIR. (C) The acetyl-CoA carbanion directly attacks the 
carbonyl of enzyme-bound carboxybiotin to form malonyl-CoA. !
Table 5.1 Description of bacterial strains used in this chapter. 
Strain Description Source 
DH5α F′ φ80lacZΔM15 Δ(lacZYA-argF)U169 deoR recA1 endA1 
hsdR17(rK− mK+) phoA supE44 thi-1 gyrA96 relA1 
 
Lab stock 
CC1215 F– ompT gal dcm lon hsdSB(rB- mB-) ΔpurE736::kan 
λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 nin5])  
This study 
 
Table 5.2 Oligodeoxynucleotides (ODNs) used in this chapter.a 
ODN Sequence (5’→3’)  
2124 TAATACGACTCACTATAGGG T7 promoter 
2125 GCTAGTTATTGCTCAGCGG T7 terminator 
2362 GACACTACATGCTCaGCTGTcaTgTGCGCGGAGCCGATG TdPurE2-K41M 
2363 CATCGGCTCCGCGCAcAtgACAGCtGAGCATGTAGTGTC TdPurE2-K41M 
2364 GACACTACATGCTCaGCTGTTcTATGCGCGGAGCCGATG TdPurE2-K41R 
2365 CATCGGCTCCGCGCATAgAACAGCtGAGCATGTAGTGTC TdPurE2-K41R 





Table 5.3 Description of Plasmids used in this chapter. 
Plasmid Description  Source 
pJK687 purE2Td-K41M in pET23a This study 
pJK688 purE2Td-K41R in pET23a This study !!
 
Figure 5.2 SDS-PAGE analysis of isolated TdPurE2-K41X forms. A 12% 
polyacrylamide gel was loaded with 3 µg protein per lane: M, Sigma biotinylated marker; 
R, TdPurE-K41R; and M, TdPurE-K41M. Note the slightly increased mobility of K41M, 
which is presumably due to the deletion of a positively charged residue. Molecular 
weights (kDa) are denoted along the left side of the gel. !
 
Figure 5.3 Saturation curve of TdPurE2-K41R. All data were collected in 50 mM Tris-























Table 5.4 Kinetic parameters for TdPurE2-K41X mutants at pH 8. 
 rSAa rel. kcat/Km b kcat/Km (M-1 s-1) kcat (s-1) Km (µM) 
rSA 
AIR→CAIR c 
TdPurE2d 100 100 7.2 x 106 65 9 100 
TdPurE2-K41R 25 74 5.3 x 105 17.5 33 1.2 
TdPurE2-K41M 16 nde nd nd nd nd 
a rSA, % specific activity in the CAIR decarboxylation reaction relative to wild-type TdPurE2 (185 U mg-1) 
at 100 µM CAIR, pH 8.0, 30 °C. 
b rel. kcat/Km, % kcat/Km relative to wild-type TdPurE2 (7.2 x 106).  
c rSA, % specific activity in the AIR carboxylase reaction relative to wild-type TdPurE2 (195 U mg-1) at 
100 µM CAIR, pH 7.5, 10 °C. 
d  Published values.2 
end; not determined. !
 
Figure 5.4 Dissolved CO2 at various temperatures. CO2 availability in water decreases as 
temperature increases. 13 !
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In both PurE1 and PurE2, the active site His provides the essential proton to CAIR C4 for 
CC bond scission.1–3 However, crystallography shows that the His is not required for 
CAIR cleavage. A CAIR-soaked crystal of the completely inactive A. aceti PurE1-H59N 
mutant (PDB code 2fwp) contained AIR and CO2 in the active site (Figure 3.2, Chapter 
3), mimicking the ternary PurE•AIR•CO2 complex. This crystal structure was the first 
evidence that if the proton source is deleted, decarboxylation still occurs, indicating that 
PurE1, and possibly the PurE2 His mutants are not truly inactive. In this chapter we 
discuss an initial examination of oxygenase activity in the “inactive” TdPurE2-H40N 
mutant. 
PurE2 and Rubisco are the most abundant CO2-dependent carboxylases on the planet that 
do not require substrate activation by ATP or other energy inputs. Why these two 
enzymes have such different reactivities with O2 or CO2 is also considered in this chapter. 
CO2 Abundance Determines Rubisco Specificity. Most CO2 removed from the 
atmosphere is converted to carbohydrates by Rubisco (ribulose-1,5-bisphosphate 
carboxylase/oxygenase) during photosynthesis.4 Rubisco has a limited ability to promote 
reactions with CO2 over O2, a smaller, more abundant, and more reactive gas, leading to 
an “inevitable,” apparently wasteful oxygenase reaction.5 Rubisco generates a reactive 




is therefore under pure kinetic control, with reaction outcomes determined by the relative 
gas concentrations and ratio of specificity constants (kcat/Km).6  
Enzymes, including Rubisco that form a carbanionic intermediate often catalyze reactions 
with O2. Oxygenase activity can be the primary7,8 or a secondary (promiscuous) 
function.9,10  
PurE1 and PurE2 Do Not React with O2. PurE1 has no detectable oxygenase activity.10 
This is not surprising, as PurE1 supplies CO2 stoichiometrically from either of its 
substrates and scrupulously prevents transiently produced CO2 from escaping the active 
site. O2 therefore has no opportunity to gain access to the AIR carbanion intermediate. In 
addition, the proximity of the electron-deficient carbon in CO2 may be required to 
stabilize the AIR carbanion.  
PurE2 encounters essentially the same situation as Rubisco. Unlike PurE1, it must expose 
a portion of its active site, including Lys 41 and AIR C4 to small molecules. The “CO2 
portal” (Chapter 1) is a consequence of the need for CO2 to enter (or exit) after AIR, 
which comprises a large part of the gas-binding site and is probably required to ensure 
CO2 binds to PurE2 at all. 
Inspection of the proposed mechanisms for PurE2 and Rubisco shows they have a critical 
difference in the required sequence of deprotonation and CC bond formation. Rubisco 
encounters CO2 after carbon deprotonation. PurE2 flips the sequence of steps in CC 
bond formation: its substrate reacts with CO2 before carbon deprotonation (Figure 6.1).!
This apparently fundamental chemical difference in CO2 fixation appears to have been 
overlooked. This seemingly small difference in chemical strategy would bypass both 
sluggish carbon deprotonation and greatly improve CO2/O2 selectivity 
 
A Catalytically Inactive Form of PurE2 May React with O2. The TdPurE2-H40N mutant, 
which lacks the key His, was generated with the expectation that it would be inactive.3 
Surprisingly, functional complementation experiments in ∆purK and ∆purE1 E. coli 
strains (a functional PurE2 should complement both deletions) revealed that TdPurE2-
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H40N was not simply inactive but caused a growth defect: a ∆purK strain grew worse 
than a vector-only control on solid minimal medium. We wanted to know if the growth 
defect could be explained if TdPurE2-H40N were somehow capable of destroying AIR, 
CAIR, or both. 
An X-ray crystal structure of the TdPurE2•AIR binary complex shows good electron 
density for all parts of AIR (Figure 6.2A).3 In contrast, a higher-resolution crystal 
structure of TdPurE2-H40N co-crystallized with CAIR provides clear evidence that the 
aminoimidazole ring is disrupted by the “inactive” mutant TdPurE2-H40N (Figure 6.2B). 
The ligand contains an acyclic moiety of ≥3 non-H atoms that were tentatively modeled 
as 5-phosphoribofuranosylurea (PRU, Figure 6.2C).  
PRU is not the only ligand consistent with the observed electron density, but it is 
anticipated to be more stable than alternatives that fit in the difference electron density 
maps. While the oxygen atom is not well modeled, it is necessary to avoid highly labile 
structures such as am iminoamine substituent (R5P-NHCH=NH2+). We can however, 
infer that the terminal atom is a hydrogen bond donor based on proximity to backbone 
carbonyls. 
This chapter details the discovery of a very low level of oxygenase activity in the 
“inactive” PurE2 mutant, TdPurE2-H40N. 
 
6.2 Materials and Methods !
Materials. Chemicals were obtained from Sigma or Fisher in the highest purity available 
unless otherwise noted. CAIR was prepared as described in Chapter 2.11 AIR was 
generated enzymatically from CAIR using TdPurE2 and quantitated by Bratton-Marshall 
assay as described previously.3 Phenyl Sepharose CL-6B was obtained from Sigma. 
Hydroxyapatite (BioGel®-HT) and Bradford reagent were obtained from Bio-Rad. PD-




Methods. Protein concentrations were determined by the method of Bradford with bovine 
serum albumin as the standard.12 Small-scale centrifugation steps were performed using 
an Eppendorf 5424 centrifuge. All other centrifugation steps were performed using a 
Beckman Avanti J-E centrifuge with a JLA-10.5 or JA-20 rotor. Cell disruption was 
performed by sonication using a Fisher Scientific Dismembrator 550 at 25% output for 3 
cycles (1 min each with 1 min cooling periods in-between) at 4 °C. Spectroscopic 
measurements were recorded on a Varian CARY-100 UV/Vis spectrophotometer 
thermostated by a Cary Dual Peltier Accessory temperature controller.  
 
PurE1 and PurE2 Overexpression and Isolation. AaPurE1 and AaPurE1-H59N were 
overexpressed and isolated as detailed for wild-type AaPurE1 (Chapter 3).1 TdPurE2 and 
TdPurE2-H40N were overexpressed and isolated as detailed for wild-type TdPurE2 
(Chapter 3).3  
 
Aerobic AIR Destruction Assays. A reaction mixture (0.55 mL total) contained 50 µM 
AIR in 50 mM Tris-HCl (pH 8.0). The reaction mixture was incubated at room 
temperature for 3 min prior the addition of AaPurE1 (60 µM, 620 µg), TdPurE2 (60 µM, 
564 µg), AaPurE1-H59N (60 µM, 620 µg), or TdPurE2-H40N (60 µM, 564 µg). Controls 
lacking enzyme and containing BSA (1 mg mL-1) were performed in parallel. Aliquots 
(0.1 mL) were removed at 0 min, 1 h, 3h, 5h, and 8 h and immediately quenched by 
addition to 0.2 mL of pre-mixed 665 mM potassium phosphate in 10% TCA (w/v) and 
NaNO2 0.05% (w/v). Reactions were then derivatized by the Bratton-Marshall Assay,9 
which is highly specific for diazotizable amines, and the absorbance spectra recorded.  
 
Anaerobic AIR Destruction Assays. These experiments were performed in an anaerobic 
chamber (N2 atmosphere, ≤5 ppm O2) but were otherwise identical to above protocol for 
aerobic AIR destruction assay. After Bratton-Marshall derivatization samples were 






TdPurE2-H40N has detectable oxygenase activity. In all of our experiments, no evidence 
was obtained for any Bratton-Marshall reactive species other than AIR. AIR 
concentrations decreased in the presence of TdPurE2-H40N, with a half-life of about 4 h. 
No decomposition was observed in reaction mixtures prepared without enzyme (not 
shown), in the presence of small amounts of either AaPurE1 (6.7 nM, 68 ng) or TdPurE2 
(1.4 nM, 13 ng) (not shown), BSA, AaPurE1-H59N (±O2), or TdPurE2-H40N maintained 
in an anaerobic environment (Figure 6.3). We concluded that TdPurE2-H40N has a 
function not previously described: it catalyzes the irreversible, O2-dependent destruction 
of AIR to an unknown product. This low level of AIR oxygenase activity is the only 
known reaction performed by TdPurE2-H40N. !
6.4 Discussion 
 
PurE1 and PurE2 Do Not Have Detectable Oxygenase Activity. AIR is an inhibitor of 
PurE1,13 but binds in the same orientation as in PurE2. PurE1 was previously shown to 
lack oxygenase activity10 and our results confirm this. Neither AaPurE1 nor AaPurE1-
H59N had detectable oxygenase activity when incubated with AIR. This is likely due to 
one of two things: either 1) PurE1 disallows access of O2 to AIR or 2) an AIR carbanion 
is only formed when AIR•CO2, delivered by NCAIR or CAIR, are confined together. In 
addition, a crystal structure of AaPurE1-H59N•AIR•CO2 (PDB code 2fwp) contains no 
additional room for an O2 to enter the vicinity of AIR.  
The PurE2 reaction with CO2 is reversible, but the proposed reaction with O2 involves 
several irreversible steps. The first three steps are similar to the Rubisco oxygenation 
reaction, with the aminoimidazole ring opening being the first irreversible step. This is 
followed by a second hydrolysis step, which closely resembles 2′-deoxy-PRU formation 
in damaged DNA8 to produce diformamide and PRU (Figure 6.4). 
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In its solvent-exposed active site, Rubisco generates a reactive carbanion that irreversibly 
reacts with either O2 or CO2. PurE2, like Rubisco, generates a reactive carbanion in a 
solvent-exposed active site but catalyzes a reversible reaction with CO2. Although we 
cannot detect any reaction with O2, it is possible that active PurE2 still allows O2 to react 
with the AIR carbanion, but acts to prevent the subsequent irreversible steps including 
ring opening which would be required to detect products of the oxygenase reaction 
(boxed steps in Figure 6.4). Aminoimidazole ring opening would require a sterically 
demanding rearrangement within the rigid PurE2 active site, which cannot accommodate 
NCAIR or other analogs.14  
The Critical Active Site His May Shield the AIR Carbanion. The “inactive” TdPurE2-
H40N has oxygenase activity that has never been detected in wild-type TdPurE2 or any 
other PurE2 form. Wild-type PurE2 contains the general acid/general base His in the 
active site, which is located near the site of AIR carbanion formation at AIR C4. This 
residue could also serve to shield the reactive AIR carbanion from O2, an effect lost when 
Asn replaces His. Asn is smaller and cannot donate a proton, although it could provide a 
hydrogen bond; this difference may be enough to allow a slow reaction with O2.  
Our working hypothesis for CO2 selectivity, for both PurE1 and PurE2, is that the AIR 
carbanion does not form in the absence of CO2. The AIR•CO2 complex may be required 
to stabilize the AIR carbanion; therefore, without CO2 present, AIR does not form the 
reactive intermediate and is unavailable to react with O2 (Figure 6.1).  
Did PurE1 and PurE2 Evolve in an Anaerobic Environment with Accidental and Inherent 
Selectivity for CO2? PurE1, PurE2, and Rubisco developed in an anoxic environment. 
Modern Rubisco cannot suppress oxygenase activity without the support of carbon 
concentrating mechanisms within carboxysomes of CO2 fixing bacteria15 and CO2 
concentrating accessory systems in higher plants (C4 and crassulacean acid metabolism). 
All of these require specialized anatomy or extra catalysts that support CO2 fixation. The 
complete lack of associated carbon concentration mechanisms suggests that PurE1 and 
PurE2 always had the ability to selectively react with CO2 over O2. 
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Chemical considerations and phylogenetic analyses do not indicate if PurE1 evolved 
from PurE2 or vice versa (Chapter 1). Results presented in this thesis deepen the mystery 
of which came first, as it is clear that a point mutant in the differentially conserved 40s 
loop has no functional significance. If an “ambidextrous” bifunctional PurE1/PurE2 is 
never discovered, it will be difficult to reconstruct the series of events that gave rise to 
the modern stark functional difference between PurE1 and PurE2. 
PurE1 emerged either 1) in high-CO2 conditions as a way to exploit abundant NCAIR 
forming spontaneously from AIR or 2) in low–CO2 conditions, to exploit NCAIR 
produced by a serendipitous and likely promiscuous, activity of a PurK progenitor. In 
either case, PurE1 did not need to acquire selectivity for CO2; its dependence on NCAIR 
ensured CO2 would be available to shield the AIR carbanion. However, PurE2 may well 
have acquired increased CO2 selectivity as the atmospheric O2 levels on early Earth 
increased. The strict conservation of Lys in PurE2 (discussed in Chapter 5), suggests that 
it might have once served as a CO2 concentrating mechanism, a useful feature under 
increasing O2. 
Is PurE Class “Choice” a Result of Positive Selection or is it an Accident? CO2 is a 
membrane permeable gas produced by decarboxylations throughout cellular metabolism 
in both anaerobes and aerobes. Most early anaerobic environments probably contained 
abundant CO2. However, under modern aerobic conditions, CO2 produced from 
metabolism must be captured as bicarbonate or it will escape to the environment. This 
phenomenon explains why carbonic anhydrase is essential for aerobic bacteria and under 
low CO2 conditions. Aerobic bacteria lacking carbonic anhydrase cannot efficiently 
recycle CO2 so will starve for bicarbonate;16,17 which is important to support essential 
subsequent anabolic processes such as fatty acid, amino acid, and nucleotide 
biosynthesis.17 Carbonic anhydrase accelerates the spontaneous hydration of CO2 to 
bicarbonate by ~105 fold. Carbonic anhydrase does not exist in most anaerobes including 




Like PurE2, systems containing PurE1-only simply require high CO2 (Chapter 1). 
Selection of a PurE1+PurK system instead relies on bicarbonate as the source of CO2 for 
purine biosynthesis. This system may place a burden on carbonic anhydrase to ensure 
sufficient CO2 is recycled to support several high flux pathways. Selection of PurE2 
under an anaerobic environment may confer a selective advantage. Because PurE2 can 
directly use CO2, this would uncouple the demand for bicarbonate from the high flux 
purine pathway and lessen competition for available bicarbonate with other high flux 
pathways. 
 
6.5 Future work !
A TdPurE2-H40N crystal structure with authentic PRU nucleoside bound is a good first 
step to test the hypothesis that crystalline TdPurE2-H40N produces PRU.  
Synthetic PRU could also be used as a standard to unambiguously identify the AIR 
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6.7 Figures and Tables !
!
Figure 6.1 Rubisco and PurE2 reactions. (A) Rubisco carboxylase and oxygenase 
activities begin with the deprotonation of RuBP C3 to generate the reactive endiol(ate). 
This reactive intermediate can then react with either CO2 or O2. (B) PurE2 mediated AIR 
carboxylation begins with formation of the AIR•CO2 ternary complex followed by 






Figure 6.2 Destruction of AIR by the “inactive” mutant TdPurE2-H40N. (A) Crystal 
structure (1.82 Å resolution) of TdPurE2 bound to AIR (PDB code 3RGG).3 An electron 
density map (final 2Fo − Fc, blue mesh) is shown for nonprotein atoms with a 1.2σ 
contour and 1.8 Å carve. The Fo−Fc map is contoured at +3σ (green mesh) and –3σ (red 
mesh). (B) Crystal structure (1.45 Å resolution) of TdPurE2-H40N bound to a CAIR-
derived nucleotide modeled as PRU. Electron density maps are drawn as in panel A. (C) 
AIR and candidate PRU structures for the ligand in panel B. (T. J. Kappock and I. I. 
Mathews, unpublished observations). !
Table 6.1 Description of bacterial strains used in this chapter. 
Strain Description Source 
DH5 α F′ φ80lacZΔM15 Δ(lacZYA-argF)U169 deoR recA1 endA1 
hsdR17(rK− mK+) phoA supE44 thi-1 gyrA96 relA1 
Lab stock 
CC1215 F– ompT gal dcm lon hsdSB(rB- mB-) ΔpurE736::kan 
λ(DE3 [lacI lacUV5-T7 gene 1 ind1 sam7 nin5]) 
Chapter 3 !!
Table 6.2 Previously published plasmids used in this chapter. 
Plasmid Description  Source Protein encoded 
pJK175 purE1Aa in pET23a 1 AaPurE1 
pJK283 purE1Aa-H59N in pET23a 1 AaPurE1-H59N 
pJK376 purE2Td in pET23a 3 TdPurE2 
pJK392 purE2Td-H40N in pET23a 3 TdPurE2-H40N 
 
N40 










Figure 6.3!Decomposition of AIR (initially 50 µM) by 60 µM of the indicated enzyme 
form. The red dotted line is a fit of the aerobic TdPurE2-H40N data to a first-order decay 
function (half-life of 4 h), demonstrating that AIR is a substrate for a very slow 
oxygenase reaction.  
 
!
Figure 6.4 Oxygenase reactions of Rubisco and PurE2. Electron-pushing mechanism for 
the Rubisco ribulose-1,5-bisphosphate (RuBP) oxygenase reaction and electron-pushing 
mechanism for the PurE2 AIR oxygenase reaction. PurE2 is reversible and may react 
with O2 until a steric hindrance is imposed by the PurE2 active site (boxed in the dotted 










Figure A.1 Fluorescence titrations with wild-type AaPurE. Excitation wavelength was 
295 nm. Citrate titrations were performed with 0.64 µM [subunit] in 50 mM Potassium 
acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. Kd values are 
given in Table 3.7. AIR titrations were performed with 0.31 µM [subunit] in 50 mM Tris-
HCl, pH 8.0 at 30 °C. (A) Fluorescence emission spectra with increasing amounts of 
citrate. (B) Recorded emission at 320 nm upon citrate addition. (C) Fluorescence 
emission spectra with increasing amounts of AIR. (D) Recorded emission at 320 nm upon 




Figure A.2 Fluorescence titrations with AaPurE-H59N. Excitation wavelength was 295 
nm. Citrate titrations were performed with 0.68 µM [subunit] in 50 mM Potassium 
acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. AIR and CAIR 
titrations were both performed with 0.38 µM [subunit] in 50 mM Tris-HCl, pH 8.0 at 30 
°C and data were fit to equation 3.3.  Kd values are given in Table 3.7. (A) Fluorescence 
emission spectra with increasing amounts of citrate. (B) Recorded emission at 320 nm 
upon citrate addition. (C) Fluorescence emission spectra with increasing amounts of AIR. 
(D) Recorded emission at 320 nm upon AIR addition. (E) Fluorescence emission spectra 





Figure A.3 Fluorescence titrations with AaPurE-H59N,Y154F. Excitation wavelength 
was 295 nm. Citrate titrations were performed with 1.91 µM [subunit] in 50 mM 
Potassium acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. AIR 
and CAIR titrations were performed with 0.80 µM [subunit] and 0.10 µM [subunit] in 50 
mM Tris-HCl, pH 8.0 at 30 °C and data were fit to equation 3.3. Kd values are given in 
Table 3.7. (A) Fluorescence emission spectra for titration with increasing amounts of 
citrate. (B) Recorded emission at 320 nm upon citrate addition. (C) Fluorescence 
emission spectra with increasing amounts of AIR. (D) Recorded emission at 320 nm upon 
AIR addition. (E) Fluorescence emission spectra with increasing amounts of CAIR. (F) 




Figure A.4 Fluorescence titrations with AaPurE-Y154F. Excitation wavelength was 295 
nm. Citrate titrations were performed with 1.24 µM [subunit] in 50 mM Potassium 
acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. AIR titrations 
were performed with 0.50 µM [subunit] in 50 mM Tris-HCl, pH 8.0 at 30 °C and data 
were fit to equation 3.3. Kd values are given in Table 3.7. (A) Fluorescence emission 
spectra with increasing amounts of citrate. (B) Recorded emission at 320 nm upon citrate 
addition. (C) Fluorescence emission spectra with increasing amounts of AIR. (D) 





Figure A.5 Fluorescence titrations with AaPurEwwf. Excitation wavelength was 295 nm. 
Citrate titrations were performed with 0.63 µM [subunit] in 50 mM Potassium acetate, 
100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. Kd values are given in 
Table 3.7. AIR titrations were performed with 0.63 µM [subunit] in 50 mM Tris-HCl, pH 
8 at 30 °C. (A) Fluorescence emission spectra with increasing amounts of citrate. (B) 
Recorded emission at 320 nm upon citrate addition. (C) Fluorescence emission spectra 





Figure A.6 Fluorescence titrations with AaPurEwwf-Y154F. Excitation wavelength was 
295 nm. Citrate titrations were performed with 0.59 µM [subunit] in 50 mM Potassium 
acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. Kd values are 
given in Table 3.7. AIR titrations were performed with 0.59 µM [subunit] in 50 mM Tris-
HCl, pH 8 at 30 °C. (A) Fluorescence emission spectra with increasing amounts of 
citrate. (B) Recorded emission at 320 nm upon citrate addition. (C) Fluorescence 
emission spectra with increasing amounts of AIR. (D) Recorded emission at 320 nm upon 





Figure A.7 Fluorescence titrations with AaPurEwwf-H59N. Excitation wavelength was 
295 nm. Citrate titrations were performed with 0.74 µM [subunit] in 50 mM Potassium 
acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. AIR and CAIR 
titrations were performed with 0.59 µM [subunit] and 0.59 µM [subunit] in 50 mM Tris-
HCl, pH 8 at 30 °C and data were fit to equation 3.3. Kd values are given in Table 3.7. 
(A) Fluorescence emission spectra for titration with increasing amounts of citrate. (B) 
Recorded emission at 320 nm upon citrate addition. (C) Fluorescence emission spectra 
with increasing amounts of AIR. (D) Recorded emission at 320 nm upon AIR addition. 
(E) Fluorescence emission spectra with increasing amounts of CAIR. (F) Recorded 




Figure A.8 Fluorescence titrations with AaPurEwwf-H59N,Y154F. Excitation wavelength 
was 295 nm. Citrate titrations were performed with 0.89 µM [subunit] in 50 mM 
Potassium acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. AIR 
and CAIR titrations were performed with 0.59 µM [subunit] and 0.59 µM [subunit] in 50 
mM Tris-HCl, pH 8 at 30 °C and data were fit to equation 3.3. Kd values are given in 
Table 3.7. (A) Fluorescence emission spectra for titration with increasing amounts of 
citrate. (B) Recorded emission at 320 nm upon citrate addition. (C) Fluorescence 
emission spectra with increasing amounts of AIR. (D) Recorded emission at 320 nm upon 
AIR addition. (E) Fluorescence emission spectra with increasing amounts of CAIR. (F) 




Figure A.9 Fluorescence titrations with AaPurEfww. Excitation wavelength was 295 nm. 
Citrate titrations were performed with 1.49 µM [subunit] in 50 mM Potassium acetate, 
100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. AIR titrations were 
performed with 0.56 µM [subunit] in 50 mM Tris-HCl, pH 8 at 30 °C and data were fit to 
equation 3.3. Kd values are given in Table 3.7. (A) Fluorescence emission spectra with 
increasing amounts of citrate. (B) Recorded emission at 320 nm upon citrate addition. (C) 
Fluorescence emission spectra with increasing amounts of AIR. (D) Recorded emission at 





Figure A.10 Fluorescence titrations with AaPurEfww-Y154F. Excitation wavelength was 
295 nm. Citrate titrations were performed with 1.13 µM [subunit] in 50 mM Potassium 
acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. AIR titrations 
were performed with 0.87 µM [subunit] in 50 mM Tris-HCl, pH 8 at 30 °C and data were 
fit to equation 3.3. Kd values are given in Table 3.7. (A) Fluorescence emission spectra 
with increasing amounts of citrate. (B) Recorded emission at 320 nm upon citrate 
addition. (C) Fluorescence emission spectra with increasing amounts of AIR. (D) 





Figure A.11 Fluorescence titrations with AaPurEfww-H59N. Excitation wavelength was 
295 nm. Citrate titrations were performed with 0.65 µM [subunit] in 50 mM Potassium 
acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. AIR and CAIR 
titrations were performed with 0.65 µM [subunit] and0.65 µM [subunit] in 50 mM Tris-
HCl, pH 8 at 30 °C and data were fit to equation 3.3. Kd values are given in Table 3.7. 
(A) Fluorescence emission spectra for titration with increasing amounts of citrate. (B) 
Recorded emission at 320 nm upon citrate addition. (C) Fluorescence emission spectra 
with increasing amounts of AIR. (D) Recorded emission at 320 nm upon AIR addition. 
(E) Fluorescence emission spectra with increasing amounts of CAIR. (F) Recorded 





Figure A.12 Fluorescence titrations with AaPurEfww-H59N,Y154F. Excitation 
wavelength was 295 nm. Citrate titrations were performed with 2.11 µM [subunit] in 50 
mM Potassium acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. 
AIR and CAIR titrations were performed with 0.71 µM [subunit] and 0.71 µM [subunit] 
in 50 mM Tris-HCl, pH 8 at 30 °C and data were fit to equation 3.3. Kd values are given 
in Table 3.7. (A) Fluorescence emission spectra for titration with increasing amounts of 
citrate. (B) Recorded emission at 320 nm upon citrate addition. (C) Fluorescence 
emission spectra with increasing amounts of AIR. (D) Recorded emission at 320 nm upon 
AIR addition. (E) Fluorescence emission spectra with increasing amounts of CAIR. (F) 




Figure A.13 Fluorescence titrations with AaPurEwyf. Excitation wavelength was 295 nm. 
Citrate titrations were performed with 2.17 µM [subunit] in 50 mM Potassium acetate, 
100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. Kd values are given in 
Table 3.7. AIR titrations were performed with 0.89 µM [subunit] in 50 mM Tris-HCl, pH 
8 at 30 °C. (A) Fluorescence emission spectra with increasing amounts of citrate. (B) 
Recorded emission at 320 nm upon citrate addition. (C) Fluorescence emission spectra 





Figure A.14 Fluorescence titrations with AaPurEwyf-H59N. Excitation wavelength was 
295 nm. Citrate titrations were performed with 2.98 µM [subunit] in 50 mM Potassium 
acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. AIR and CAIR 
titrations were performed with 1.00 µM [subunit] and 1.00 µM [subunit] in 50 mM Tris-
HCl, pH 8 at 30 °C and data were fit to equation 3.3. Kd values are given in Table 3.7. 
(A) Fluorescence emission spectra for titration with increasing amounts of citrate. (B) 
Recorded emission at 320 nm upon citrate addition. (C) Fluorescence emission spectra 
with increasing amounts of AIR. (D) Recorded emission at 320 nm upon AIR addition. 
(E) Fluorescence emission spectra with increasing amounts of CAIR. (F) Recorded 




Figure A.15 Fluorescence titrations with AaPurEfwf. Excitation wavelength was 295 nm. 
Citrate titrations were performed with 0.12 µM [subunit] in 50 mM Potassium acetate, 
100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. AIR titrations were 
performed with 0.29 µM [subunit] in 50 mM Tris-HCl, pH 8 at 30 °C and data were fit to 
equation 3.3. Kd values are given in Table 3.7. (A) Fluorescence emission spectra with 
increasing amounts of citrate. (B) Recorded emission at 320 nm upon citrate addition. (C) 
Fluorescence emission spectra with increasing amounts of AIR. (D) Recorded emission at 





Figure A.16 Fluorescence titrations with AaPurEfwf-H59N. Excitation wavelength was 
295 nm. Citrate titrations were performed with 0.79 µM [subunit] in 50 mM Potassium 
acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. AIR and CAIR 
titrations were performed with 0.79 µM [subunit] and 0.79 µM [subunit] in 50 mM Tris-
HCl, pH 8 at 30 °C and data were fit to equation 3.3. Kd values are given in Table 3.7. 
(A) Fluorescence emission spectra for titration with increasing amounts of citrate. (B) 
Recorded emission at 320 nm upon citrate addition. (C) Fluorescence emission spectra 
with increasing amounts of AIR. (D) Recorded emission at 320 nm upon AIR addition. 
(E) Fluorescence emission spectra with increasing amounts of CAIR. (F) Recorded 




Figure A.17 Fluorescence titrations with AaPurEfwf-H59N,Y154F. Excitation 
wavelength was 295 nm. Citrate titrations were performed with 1.65 µM [subunit] in 50 
mM Potassium acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. 
AIR and CAIR titrations were performed with 1.01 µM [subunit] and 1.01 µM [subunit] 
in 50 mM Tris-HCl, pH 8 at 30 °C and data for the AIR titration was fit to equation 3.3. 
Kd values are given in Table 3.7. (A) Fluorescence emission spectra for titration with 
increasing amounts of citrate. (B) Recorded emission at 320 nm upon citrate addition. (C) 
Fluorescence emission spectra with increasing amounts of AIR. (D) Recorded emission at 
320 nm upon AIR addition. (E) Fluorescence emission spectra with increasing amounts 




Figure A.18 Fluorescence titrations with AaPurEfwf -Y154F. Excitation wavelength was 
295 nm. Citrate titrations were performed with 2.01 µM [subunit] in 50 mM Potassium 
acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. AIR titrations 
were performed with 0.61 µM [subunit] in 50 mM Tris-HCl, pH 8 at 30 °C and data were 
fit to equation 3.3. Kd values are given in Table 3.7.  (A) Fluorescence emission spectra 
with increasing amounts of citrate. (B) Recorded emission at 320 nm upon citrate 
addition. (C) Fluorescence emission spectra with increasing amounts of AIR. (D) 





Figure A.19 Fluorescence titrations with AaPurEfwf -Y154L. Excitation wavelength was 
295 nm. Citrate titrations were performed with 2.62 µM [subunit] in 50 mM Potassium 
acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. AIR titrations 
were performed with 0.69 µM [subunit] in 50 mM Tris-HCl, pH 8 at 30 °C and data were 
fit to equation 3.3. Kd values are given in Table 3.7.  (A) Fluorescence emission spectra 
with increasing amounts of citrate. (B) Recorded emission at 320 nm upon citrate 
addition. (C) Fluorescence emission spectra with increasing amounts of AIR. (D) 





Figure A.20 Fluorescence titrations with AaPurEfyw. Excitation wavelength was 295 nm. 
Citrate titrations were performed with 9.85 µM [subunit] in 50 mM Potassium acetate, 
100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. Kd values are given in 
Table 3.7. AIR titrations were performed with 4.25 µM [subunit] in 50 mM Tris-HCl, pH 
8 at 30 °C. (A) Fluorescence emission spectra with increasing amounts of citrate. (B) 
Recorded emission at 320 nm upon citrate addition. (C) Fluorescence emission spectra 





Figure A.21 Fluorescence titrations with AaPurEfyw-H59N. Excitation wavelength was 
295 nm. Citrate titrations were performed with 10.66 µM [subunit] in 50 mM Potassium 
acetate, 100 mM KCl, pH 4.6 at 25 °C and data were fit to equation 3.2. AIR and CAIR 
titrations were performed with 5.21 µM [subunit] and 5.21 µM [subunit] in 50 mM Tris-
HCl, pH 8 at 30 °C and data were fit to equation 3.2. Kd values are given in Table 3.7.  
(A) Fluorescence emission spectra with increasing amounts of citrate. (B) Recorded 
emission at 320 nm upon citrate addition. (C) Fluorescence emission spectra with 
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